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Abstract
Oxidoreductases are a diverse class of enzymes defined by their chemical role of transferring electrons
from one substrate to another. Comprising the functional cores of photosynthetic, chemosynthetic, and
cellular respiratory machinery, “redox proteins” and the catalysis they enable form the foundation
biological energy transduction. Mastering the mechanisms by which these enzymes work is the key to
understanding how life works and drives the improvement of an as of yet poorly developed theoretical
framework for describing the multiscale chemistry and physics crucial to future developments in
synthetic biology, mesoscale engineering, and macromolecular catalysis.
Redox proteins are characterized by their near universal incorporation of one or more cofactors, nonprotein molecules with notable electrochemical and/or photophysical properties that play a fundamental
role in the enzyme’s behavior. The functions of these enzymes can then be thought of as having two
aspects: the cofactor(s), whose physical chemistry dictates the general mechanism of energy
transduction, and the protein scaffold, which via microenvironment, relative positioning, geometric strain,
and other mechanical properties modulate the energetic landscape and gate the influx and efflux of
reactants and products.
Separation of these aspects in practice, however, is often hindered by the sheer structural complexity of
the natural machinery in question, even the simpler ones. Billions of years of evolution can incorporate
many inessential elements, creating what is known as irreducible Mullerian complexity.
Observational studies are useful but have their fundamental limitations. True validation of understanding
comes through construction and functional verification. In accordance with this philosophy, we set out to
recreate two representative redox chemistries in minimally designed model protein scaffolds to establish
the basic requirements for their respective catalytic processes. Specifically, we focus on the suppression
of heme-based superoxide formation and the promotion of photo-induced flavin activation in two classes
of four-helix bundle proteins with complementary biophysical properties. This thesis discusses the
implementation of both active sites in each of the two classes of scaffolds, and draws conclusions about
the essential components of each. With the long-term goals of engineerability and biological integration in
mind, we also demonstrate the ability of these model scaffolds to interface with two types of natural
membrane transport complexes. In addition, we show that the 4-helical bundle domain retains functional
independence even as a polymer of up to 16 alpha helices. The thesis ends with a discussion on the
present limits and future potential of minimal models and protein engineering as a whole.
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ABSTRACT
UNCOVERING BIOPHYSICAL DETERMINANTS OF OXIDOREDUCTASE
FUNCTION THROUGH DE NOVO PROTEIN DESIGN
Dirk Auman
P. Leslie Dutton

Oxidoreductases are a diverse class of enzymes defined by their chemical role of
transferring electrons from one substrate to another. Comprising the functional cores of
photosynthetic, chemosynthetic, and cellular respiratory machinery, “redox proteins” and
the catalysis they enable form the foundation of biological energy transduction.
Mastering the mechanisms by which these enzymes work is the key to understanding
how life works and drives the improvement of an as of yet poorly developed theoretical
framework for describing the multiscale chemistry and physics crucial to future
developments in synthetic biology, mesoscale engineering, and macromolecular catalysis.
Redox proteins are characterized by their near universal incorporation of one or
more cofactors, non-protein molecules with notable electrochemical and/or photophysical
properties that play a fundamental role in the enzyme’s behavior. The functions of these
enzymes can then be thought of as having two aspects: the cofactor(s), whose physical
chemistry dictates the general mechanism of energy transduction, and the protein
scaffold, which via microenvironment, relative positioning, geometric strain, and other
mechanical properties modulate the energetic landscape and gate the influx and efflux of
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reactants and products.
Separation of these aspects in practice, however, is often hindered by the sheer
structural complexity of the natural machinery in question, even the simpler ones.
Billions of years of evolution can incorporate many inessential elements, creating what is
known as irreducible Mullerian complexity.
Observational studies are useful but have their fundamental limitations. True
validation of understanding comes through construction and functional verification. In
accordance with this philosophy, we set out to recreate two representative redox
chemistries in minimally designed model protein scaffolds to establish the basic
requirements for their respective catalytic processes. Specifically, we focus on the
suppression of heme-based superoxide formation and the promotion of photo-induced
flavin activation in two classes of four-helix bundle proteins with complementary
biophysical properties. This thesis discusses the implementation of both active sites in
each of the two classes of scaffolds, and draws conclusions about the essential
components of each. With the long-term goals of engineerability and biological
integration in mind, we also demonstrate the ability of these model scaffolds to interface
with two types of natural membrane transport complexes. In addition, we show that the 4helical bundle domain retains functional independence even as a polymer of up to 16
alpha helices. The thesis ends with a discussion on the present limits and future potential
of minimal models and protein engineering as a whole.
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Chapter 1 Introduction
1.1 Biological Electron Transfer: Bioenergetics, Oxidoreductases,
and Why It All Matters
The oxidoreductases are a large and diverse class of enzymes, representing
approximately a quarter of all known proteins, and are defined by their catalytic role in
coupling the oxidation of one substrate center to the reduction of another; in other words,
electron transfer. These transformations are mechanistically diverse, and can via direct
electron transfer, proton-coupled electron transfer, or hydride transfer. Oxidoreductases,
commonly called “redox proteins”, comprise the functional cores of photosynthetic,
chemosynthetic, and cellular respiratory machinery (Figure 1.1, Figure 1.2), and the
catalysis they perform, when coupled to the processes of ion transport and ATP
mechanosynthesis1,

forms

the

foundation

of

biological

energy

transduction.

Oxidoreductases are involved in peripheral aspects of metabolism and cell signaling, and
are also vital to functions like superoxide generation, gaseous transport and fixation, DNA
damage repair, and even magnetic sensing.

Figure 1.1: The mitochondrial electron transport chain, comprised of complexes I-IV, membrane-soluble
quinones, and water-soluble carrier proteins (and ATP-synthase). The system is structurally complex with 81
individual protein units comprising the four complexes, many of which have individual oxidoreductase

1

activity (45 subunits in Complex I, 4 in Complex II, 11 in Complex III, and 21 in Complex IV). Adapted
from2.

Figure 1.2: The photosynthetic electron transport chain, comprised of photosystem I, photosystem II,
Cytochrom-b6f complex, membrane-soluble quinones, and several soluble carrier proteins (in addition to
ATP synthase). Adapted from 3.

The importance of oxidoreductases extends beyond mere academic interest into
clinically relevant medical science. There are a number of diseases and medical problems
that can trace their origin to malfunctions in cellular respiration or redox metabolism.
Mitochondrial diseases result from one or more genetic malfunctions in the aforementioned
electron transport components, affecting one in 5000 individuals, and can contribute to
anything from poor growth and low energy to systemic organ failures and
neurodevelopmental problems4. Much of detoxification in the human body relies on P450
cytochromes in the liver, which a broad class of enzymes that employ redox catalysis to
break down drug compounds and other “toxic” molecules in the bloodstream.
Understanding the activities of these molecules and potential strategies for inhibition
dominate the pharmacokinetic aspects of drug development and formulation. In fact,
engineering P450 enzymes for ex vivo generation of metabolites is of great interest to the
2

pharmaceutical industry5–8. Finally, defects and dysregulation in mitochondrial oxidative
phosphorylation and redox homeostasis, as well as issues in redox metabolism, are
intimately linked with aging associated phenotypes. A better understanding of how these
electron transport components work, on lower levels of mechanistic physical chemistry as
well as higher levels of interactive and homeostatic regulatory networks is central to the
advance of medical science and the formulation of new therapies for affected individuals.
The prospective applications of the remarkable catalytic and energy transduction properties
of redox enzymes have garnered the interest of those in pharmaceutical industry, and some
have already come to light. Perhaps the most commercially successful application so far
has been the glucose oxidase sensor utilized in the ubiquitous blood sugar test strips9. Other
biosensors include those for nitrite and oxygen10,11. The incorporation of redox proteins in
traditional ELISA assays, allows for transduction of molecular binding events directly into
electrical signals, in one instance applied to the detection of HIV antibodies12. Redox
protein conjugates in fuel cells are of interest in the development of biological fuel cells
capable of running on blood glucose for application in implantable prosthetic devices13,14.
Redox enzymes are also attractive candidates for applications outside of healthcare.
Organisms containing heme-based oxidative enzymes, bacterial P450s in particular, show
promise for “bioremediation” of environments containing toxic compounds otherwise
resistant to degradation. There is also interest in applying enzymes to both oxidative and
reductive steps in traditional synthesis of common commodity chemicals, where
production costs can benefit from milder reaction conditions, yields can benefit from the
catalytic stereoselectivity imparted by the protein microenvironment, and the environment
can benefit from a greener synthesis with fewer toxic byproducts15,16. An extreme example

3

of this is the Haber-Bosch production of ammonia from nitrogen gas, a high-pressure, hightemperature process which today consumes more than 1% of the world’s energy supply in
annual production of fertilizer17. Nitrogenase, an enzyme produced by nitrogen-fixing
bacteria, performs the same reaction in ambient conditions with high efficiency and no
toxic waste.
Better understanding in vivo redox catalysis can also have huge implications for
agriculture. An excellent example is ribulose-1,5-bisphosphate carboxylase/oxygenase,
also known as rubisco. Likely the most abundant protein on earth by mass, it catalyzes the
essential first step of carbon fixation in all photosynthetic organisms, and controls the rate
limiting step for conversion of CO2 to biomass. Given that the enzyme evolved in the
anaerobic environment of early earth, it cannot easily distinguish between CO2 and
structurally similar O2, and is no longer in a position to evolve better performance (see later
section on Muller’s ratchet). This causes organisms to incorporate oxygen instead of carbon
dioxide about 25% of the time, which is not only a waste of time and substrate, but also
inefficient in that it creates a toxic compound that plants have to redirect a significant
amount of energy (through a parallel-evolved process called photorespiration) to
decompose. Reengineering a rubisco enzyme with even marginally improved CO2
specificity, or improving any aspects of photorespiration18, could produce tremendous
improvements in crop growth rates and resource requirement.
Though not comprehensive, this description should provide an appreciation for why
biological redox processes are important to scientists and of value to society. But what
makes redox proteins different from other enzymes, and how does that affect how we study
them?

4

1.2 Catalysis and Redox Cofactors: Biology’s Little Assistants
Readers may be familiar with the classic biochemical concept of an active site,
often a “pocket” in a protein with the geometries and electrostatics of the bordering amino
acid residues to bind a substrate, and then, via structural changes over a conformational
coordinate, stabilize a reaction intermediate and ultimately the product species. Within this
site, there are often catalytic residues, like basic and acidic amino acids, that play role in
the remodeling of bonds. It is sometimes the case, however, that the chemical diversity of
amino acid side chains alone is insufficient for a particular type of reaction. Such enzymes
incorporate one or more “cofactors”, defined as non-protein chemical compounds or metal
ions required for catalytic activity. It is not uncommon for enzymes of other classes
(transferases, hydrolases, lyases, isomerases, or ligases) to incorporate a first- of secondcolumn metal ion (like zinc, calcium, or magnesium) in or near their active site, which
often plays a catalytic role but does not undergo redox chemistry. However,
oxidoreductases are characterized by their near universal incorporation of one or more
molecular cofactors. Dubbed “redox cofactors”, they comprise a diverse set of organic,
inorganic, and organometallic molecules, which are chemically and structurally distinct
from amino acid side chains, and have notable electrochemical and/or photophysical
properties that play a fundamental role in the enzyme’s behavior. These cofactors are
typically scavenged or synthesized independently of the protein component and then
incorporated into the final folded structure.

5

Figure 1.3: From right to left: Heme A, Heme B, and Heme C. These are the three most common naturally
occurring variants of heme, an iron porphyrin, and are employed in a variety of functions.

The most common organometallic compounds consist of tetrapyrrole rings (like
porphyrin and chlorin) housing a coplanar metal atom. The core structure of a tetrapyrrole
is a symmetric, planar, aromatic macrocycle of 20 carbons and four interior-facing
nitrogens. The four nitrogen lone pairs facing the center of the macrocycle allow the
tetrapyrrole to coordinate a single metal atom in the center of the ring. Tetrapyrroles can
accommodate a wide variety of transition metal ions in their centers, and can be made
(naturally and synthetically) with a variety of outer ring substitutions. The coupling the
large delocalized ring area with the electronic structure of the coordinated metal gives rise
to a unique range of molecular orbitals. Magnesium tetrapyrroles make up a class of
compounds known as chlorophylls which are tuned absorb different regions of the solar
spectrum in photosystem complexes. Iron tetrapyrroles, commonly known as hemes, are
ubiquitous and are found in electron transport proteins and a variety of enzymes that do
oxygen chemistry (Figure 1.3).

6

Figure 1.4: The basic structures of aromatic cofactors often used in proton-coupled 2-electron transfer.

Common “organic-only” redox cofactors include quinones, pterins, and flavins
(Figure 1.4). These compounds have one, two, or three six-membered ring systems
(respectively) which allows for the stable existence of both and oxidized and reduced state
with the total transfer of two protons and two electrons. The fast redox cycling
characteristics of quinones make ubiquinone and plastoquinone are vital intra-membrane
electron carriers between the different component complexes of mitochondrial respiration
and photosynthesis, respectively. Soluble flavin in the form of FADH, alongside the
nicotinamides NADH and NADPH, acts as analogous carrier of reductive potential across
and within aqueous components of the cell, undergoing reduction and oxidation. Flavins
also comprise the catalytic centers of enzymes like photolyases and cryptochromes where
their blue-light photosensitivity is exploited for spin radical chemistry.
Common inorganic cofactors include iron-sulfur clusters and transition metal atoms
of iron and copper. Iron sulfur clusters are observed in nature in a variety of geometries,
including [Fe2S2] and [Fe4S4] (Figure 1.5), as well as more esoteric configurations in the
7- and 8-Fe clusters of nitrogenase. Iron and copper, both as lone atoms or in multinuclear
groups, are both metals that can adopt a variety of different potentials and geometries, and
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can consequently adapt to catalyzing a variety of different reactions.

Figure 1.5: Structures of canonical [2Fe-2S], [3Fe-4S] and [4Fe-4S] clusters.

The function properties of redox proteins are defined by the nature of their redox
cofactors, and the exact behavior of an otherwise catalytically versatile cofactor is
determined by the protein. The complete description of a redox protein can then be thought
of as having two aspects: the cofactor(s), whose physical chemistry dictates the general
type of electrochemistry, and the protein “scaffold”, which modulates it. Just as in
nonbiological electrochemistry, redox-active elements are described in terms of one or
more redox couples, i.e., the version of the compound both with and without the electron
in question (reduced and oxidized, respectively)19.

1.3 Electrochemistry: The Nernst Equation
The Nernst equation for the potential of a traditional electrochemical cell
(composed of two “half cells”, i.e. two redox couples) is given by:
Ecell = ΔE° −

[ ARed ][BOx ]
RT
ln (
)
[AOx ][BRed ]
zF

(𝐸𝑞. 1.1)

Where ΔE° = (E°A – E°B) is the difference in the standard potentials of reactants
A and B, R is the ideal gas constant, T is the temperature in Kelvin, z is the number of
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electrons transferred in the reaction, and F is Faraday’s constant (96,493 J/V).
The electron affinity of the oxidized state of a single redox couple is typically
described by its midpoint potential Em. This is the environmental potential where half of
the population is in the oxidized state and half is in the reduced state (at thermodynamic
equilibrium), and is an experimentally derivable value. Since electrochemical midpoint
cannot be defined on an absolute scale, it is typically reported relative to the standard
hydrogen electrode (SHE), corresponding to the half-cell reaction H2 ⇌ 2H+ + 2e-.
Substituting this reaction for component A in Equation _ gives us an expression for a single
redox couple B:
Eh = ΔE𝐵° −

[BRed ]
RT
ln (
)
[BOx ]
zF

(𝐸𝑞. 1.2)

Where Eh is the potential of the environment, measured relative to the SHE. When
the applied Eh at which the reduced and oxidized populations of B are equal, Eh = ΔE𝐵° ,
which defines the Em for the species.
Midpoint potentials provide a valuable means for modeling the driving forces for a
redox transformation as well as for predicting electron transfer rates between cofactors,
since the difference in midpoints between the two species ΔEm corresponds directly to the
Gibbs free energy for the process:
ΔG = −zFΔE𝑚

(𝐸𝑞. 1.3)

An electron transfer from a lower Em cofactor to a higher Em cofactor (ΔEm > 0) is
energetically favorable, i.e. exergonic. Conversely, an electron transfer from a higher Em
cofactor to a lower Em cofactor (ΔEm > 0) is energetically unfavorable, i.e. endergonic.
Redox processes that are proton-coupled are accordingly dependent on pH, and [H+] must
be factored into the Nernst expression:
9

[RedH ]
RT
ln (
)
[Ox][H+ ]
zF

(𝐸𝑞. 1.4)

[RedH ]
RT
ln (
) − (0.06 ∗ pH)
[Ox]
zF

(𝐸𝑞. 1.5)

Eh = ΔE𝐵° −
Which can be expanded to:
Eh = ΔE𝐵° −

Which indicates that the Em will change by 60mV for each unit shift in local pH.
The degree to which a protein can affect the Em of a cofactor is remarkable (Figure 1.6). In
cytochrome c proteins, which all possess the same c-heme cofactor, the reduction potential
of the heme varies from -400 to +500 mV. In iron-sulfur proteins, even clusters of the same
geometry and stoichiometry (in this case [Fe4S4]) can have Em values as low as -700 mV
and as high as +450 mV. Aspects of the protein scaffold that can affect midpoint potential
include the degree of solvent exposure, the identity of ligating residues, local electrostatics
of the protein environment, proximity of the cofactor in question to others in the protein,
and potential geometric distortion of the cofactor or its ideal orbital geometry20.

Figure 1.6: Range of midpoint potentials observed for common cofactors in biological redox centers. Adapted
from 21.
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It is intuitive to understand the value of tuning the midpoint potentials of otherwise
identical centers in a transport chain. A series of two or more isoenergetic centers within
transfer distance of each other should, at equilibrium, have the electron in question equally
distributed between the two sites (vis-à-vis the Boltzmann distribution). Conversely,
having protein components evolve a downhill energy gradient along the “intended”
direction of transfer would dramatically improve the kinetics of the overall transport chain
(albeit at the cost of energy conversion efficiency).
Though important, midpoint potentials are not the only consideration in
understanding natural redox processes and in the creation of engineered systems. To gain
a more complete picture, some additional theory is warranted.

1.4 Electron Transfer Theory
The theoretical framework for modeling redox reaction rates starts with Arrhenius’
original conception of a reaction coordinate between reactants and products, a projection
of a potentially abstract geometric space of all the conformations and configurations a
system can adopt22. When the total energy of the system is plotted against the coordinate,
an energy landscape of peaks and troughs is obtained. Troughs correspond to reactants and
products, where peaks correspond to higher-energy transition states that represent kinetic
barriers to conversion from one to the other. Transition State Theory, outlined by Eyring
and others, proposed that the movement along this reaction coordinate could be wholly
addressed by molecular vibrations23.
Classical Marcus Theory applies the idea of transition states to electronic
configurations (Figure 1.7). For single electron redox couples, the systems to which Marcus
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theory is usually applied, the activation energy has to do with reorientation of the
solvent/surrounding environment to accommodate the new charge distribution24. This is a
departure from the Eyring description, for which activation energy applies to changes in
relative nuclear coordinates of the molecule itself. In Marcus’ description, the transition
state describes an orientation of the solvent molecules midway between that which would
be optimal for pre- and post- electron transfer, with a corresponding activation energy Eact.
Furthermore, since electron transfer occurs much faster than solvent reorientation, electron
transfer is dependent on the cofactor-solvent system reaching the transition state via
thermal motion before it can occur.

Figure 1.7: Classical Marcus curves for outer sphere electron transfer. The reaction coordinates represent
environmental restructuring around the redox centers. Depicts the normal region, where −ΔG < λ. (b) Depicts
the special case where –ΔG = λ and there is no activation energy to serve as a barrier to transfer. (c) Shows
the inverted regime where −ΔG > λ. Adapted from 25.

The “reorganization energy”, λ, represents the difference in energy between the
optimal pre-ET solvent configuration and the optimal post-ET solvent configuration
without the actual electron transfer taking place; in other words, how much energy is
required to rearrange the solvent molecules completely in advance of the electron transfer.
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According to Marcus theory, the activation energy associated with an electron transfer is
given by:
𝐸𝑎𝑐𝑡 =

(λ + ΔG°)2
4λ

(𝐸𝑞. 1.6)

Where ΔG° is the free energy change associated with the electron transfer alone.
Through some algebra, we can see that:
𝐸𝑎𝑐𝑡 = 0; for ΔG° = −λ

(𝐸𝑞. 1.7)

Indicating that the reaction rate is highest for an exergonic ΔG° equal in magnitude
to the reorganization energy. Perhaps strikingly, the theory predicts that for an even more
“favorable” ΔG°, exceeding λ in magnitude, the reaction rate plot enters an inverted regime
where rate of transfer slows down. In physical terms, this equates to the necessary solvent
rearrangement being so extreme (and thus so rarely sampled) that it presents a kinetic limit
to the reaction.
Electron transfer is ultimately a quantum mechanical phenomenon dependent on
the molecular wavefunctions of each of the participating chemical centers and the degree
of overlap between them. Incorporating the expression for activation energy into a semiclassical model of electron transfer yields the following expression for electron transfer
rate:
𝑘𝐸𝑇 =

(λ + ΔG°)2
2𝜋
1
|𝐻𝐴𝐵 |2
exp (−
)
ħ
4λk 𝐵 𝑇
√4𝜋λk 𝐵 𝑇

(𝐸𝑞. 1.8)

With HAB being the electronic coupling between electronic states A and B. This is
an off-diagonal element of the Hamiltonian matrix for the system, and essentially a
quantifier for the degree of overlap between molecular wavefunctions26. Calculating HAB
is difficult and often impractical for even simple organic molecules, let alone systems as
13

complex as entire proteins. However, electronic coupling decays exponentially with
increasing separation, meaning the electron transfer rate should do the same. The distance
dependence on electron transfer rate (assuming constant temperature ΔG°) can thus be
described with the following expression:
𝑘𝐸𝑇 ∝ exp(−𝛽𝑅)

(𝐸𝑞. 1.9)

Where 𝛽 is a scalar with units of Å and is a property of the intervening medium.
The value of 𝛽 for proteins has a history of interest and in discussed in the following
section.
Not long after the biochemical research into respiratory chain proteins began, it
became evident that electrons were being shuttled through and between the component
proteins. It was initially proposed that large-scale conformational changes in proteins was
responsible for transiently bring centers into extremely close, almost physical contact to
facilitate an overall electron transfer rate in agreement with empirical biochemical
studies27. Subsequent pioneering experiments with laser-induced electron transfer to
bacterial cytochrome c showed that electron transfer proceeded at a temperature
independent rate (even below 100 K), which ruled out large conformational changes and
instead implicated a “long-distance” quantum tunneling phenomenon28.
Once it was established that that biological electron transfer was a tunneling
phenomenon, the natural question arose as to how the protein functioned as a medium. 20
years after the original cytochrome c experiment, Beratan et al proposed the pathway model
for electron transfer, which posited that an electron transferred between two redox centers
travels through the protein bond networks that connect the two centers29. The Pathways
model approximates the electronic coupling HAB as a proportion of the product of all partial
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decays in the electronic path30,31:

(𝐶)

𝐻𝐴𝐵 = 𝐾 ∏ 𝜀𝑖

(𝐻𝐵)

∏ 𝜀𝑗

𝑖
(𝐶)

Where 𝜀𝑖

𝑗

(𝑇𝑆)

(𝐸𝑞. 1.20)

∏ 𝜀𝑘
𝑘

(𝐻𝐵)

=

(𝑇𝑆)

=

≡ 𝜀 (𝐶) = 0.6 is a decay per covalent bond mediated step, 𝜀𝑗

(𝜀 (𝐶) )2 exp[−1.7(𝑅 − 2.8)]is a decay per hydrogen bond mediated step, and 𝜀𝑗

𝜀 (𝐶) exp[−1.7(𝑅 − 1.4)] is the decay per through-space jump (R is the jump distance, Å)32.
Assuming a maximum electron transfer rate of ~1013 s-1at a separation of 3 Å, (two covalent
bond steps)32 leads to the following expression for the maximum electron transfer rate:
2
(𝐶)

𝑘𝐸𝑇 ≈ 1 ∗ 1014 𝑠 −1 (∏ 𝜀𝑖
𝑖

(𝐻𝐵)

∏ 𝜀𝑗
𝑗

(𝑇𝑆)

∏ 𝜀𝑘

)

(𝐸𝑞. 1.21)

𝑘

In this framework, the β value for an ET reaction is case-dependent, since it is a
function of the intervening bonds between the two cofactors in the protein. This model was
tested by Gray, Beratan, and others with spectroscopically-monitored electron transfer
experiments in a series of modified redox proteins33,34. Both zinc-substituted cytochrome
c (predominantly alpha helices) and azurin copper proteins (mostly beta sheets) had
histidine residues introduced to solvent-facing surfaces, to which ruthenium containing
photo-oxidizing groups were covalently coupled. The ET rate data for both types of
ruthenium constructs showed an overall better exponential fit to “through-bond” separation
versus simple “through-space” separation, though there were notable outliers. Subsequent
molecular dynamics analyses by Beratan were aimed at estimating the time-averaged
electronic coupling between the cofactors in new and existing ruthenium-modified
proteins, in an attempt to address the outliers. The work ultimately attributed the outlying
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behavior to the presence of multiple competing electron transport pathways, in contrast to
proteins where one transport pathway dominated35.
Dutton, Moser, et al introduced an alterative model of electron transfer rate in
proteins, which treats the protein interior as a homogenous medium and disregards
individual bond networks. In its general form for the exergonic case, the expression for the
“Dutton-Moser Ruler” is36:
𝑙𝑜𝑔10 𝑘𝐸𝑇 = 13.0 − (1.2 − 0.8ρ)(R − 3.6) − 3.1 (

(λ + ΔG)2
)
λ

(𝐸𝑞. 1.22)

Where R is the cofactor separation in angstroms and ρ is the packing fraction. The
packing fraction is the percentage of the volume lying between the cofactors falling within
the Van der Waals radii of the intervening atoms. Which correlates directly to β. A survey
of redox protein crystal structures in the PDB shows yields an average packing fraction of
approximately 0.75. Fixing the value of ρ at 0.75 yields a β of 1.4. Thus, in contrast to a β
that varies significantly with molecular context, the “Dutton-Moser Ruler” assumes that a
fixed β value of 1.4 is generally applicable37,38. This simplifies the original expression to:
𝑙𝑜𝑔10 𝑘𝐸𝑇 = 13.0 − 0.6(R − 3.6) − 3.1 (

(λ + ΔG)2
)
λ

(𝐸𝑞. 1.23)

In the case of endergonic transfers, which are common in multi-cofactor redox
proteins, the rate can be calculated using the equation for the opposite exergonic transfer
adjusted with the temperature dependent Boltzmann factor ( 10ΔG/0.06 for room
temperature)36,39:
𝑙𝑜𝑔10 𝑘𝐸𝑇

(λ + ΔG)2
ΔG
= 13.0 − 0.6(R − 3.6) − 3.1 (
)−
λ
0.06

(𝐸𝑞. 1.24)

Moser et al have compiled calculated and experimental ET rate data for 13 natural
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cofactor pairs from bacterial photosynthetic complexes and 12 different ruthenium
modified proteins from the studies of Beratan et al. Theoretical ET rates were calculated
using both the fixed general value for rho (0.75) and a protein-specific value calculated
from the crystal structure40. Both models fit the data reasonably well, and neither one
consistently outperforms the other, suggesting that we can take advantage of the simpler
model without loss of accuracy.
How do the two frameworks compare? It should be noted that the two models are
not in any fundamental type of disagreement. Both the Beratan pathway model and the
Moser-Dutton ruler are built on Marcus theory, and correctly predict the inverse
exponential relationship between electron transfer rate and cofactor separation. They differ
in the manner and extent to which they mathematically simplify the problem of quantum
mechanical coupling to something computationally tractable. The pathway model could be
said to be the more detailed approach of the two, but its formulation in equation 1.21
requires numerical evaluation coupled time-averaged structural analyses from molecular
dynamics situations. The Moser-Dutton approach distills the important information of
atomic pathway analysis to an average packing density, and can be solved analytically
given 3D structural information. The pathway model appears to be better at distinguishing
secondary structure between some specific ruthenium-modified proteins (for instance,
transfer through beta-sheet structure, which is rare in nature). The Moser-Dutton ruler,
whose constants are derived from a larger set of natural protein structures, may be more
representative of natural redox systems. Both frameworks, however, are equipped to
achieve correspondence with an absolute quantum mechanical molecular mechanics
treatment.
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The two frameworks do differ in their implications for how natural selection
impacts electron transfer rates, at least at first glance. The pathway model implies that both
primary sequence and secondary structure are important if not the dominant determinants
of electron transfer rate, and are thus acted upon by natural selection to modulate it. The
Moser-Dutton approach, with the observation that packing does not vary appreciably
across diverse protein folds, implies that electronic character of the protein medium is
relatively invariant and is thus not effectively operated upon by natural selection. A high
sensitivity of electron transfer rate to specific sequences and structural motifs (overall
cofactor separation being the same) would make redox proteins far less robust to mutation
and thus resistant to evolution36,40.
The simplified Moser-Dutton Ruler is employed in the interpretation of
experimental results in chapter 4. It is worth noting that, in the absence of precise 3D
structural data, and given the dynamic nature of the systems discussed, the errors in
assumed distances (on the order of a few Angstroms) likely outweigh any would-be
differences between pathway model and Moser-Dutton ruler calculations.
The key takeaway from this work is that there are three effective contributors to
electron transfer rate, driving force, reorganization energy, and cofactor separation
distance. The realization that the competence and rate of electron transfer does not have a
inscrutably complex dependence on primary sequences or bond paths (notwithstanding
conjugated or otherwise closely-coupled cofactors) adds support to the idea that the protein
and cofactor components of redox systems are separable to a degree. This provides a
philosophical foundation for understanding natural redox proteins by recreating the
chemistry in simpler proteins. This provides encouragement to the field of redox protein
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engineering in creating modified or completely new systems.

1.5 Learning about Proteins: Caveats of Natural Systems
We have discussed the fundamental physical chemistry of electron transfer, as well
as a scope for how it can be tuned by the protein environment. Assuming all the conceptual
components are in place, we should now be equipped to start interrogating the interplay
between protein environment and electrochemical behavior.
It turns out that there are two intertwined obstacles to the systematic study of natural
proteins, both related to their evolutionary origin. Proteins have three primary selective
pressures operating on them: they must fold quickly, they must perform their function at
some minimum efficiency, and last long enough in their environment for their “yield” to
outweigh their metabolic cost. Contrary to the teleological metaphors often offered by
evolutionary biologists, evolution is simple, unreasoning process; natural selection does
not contemplate the future. This means that once a protein folds well enough and enough
of the time in its native environment to do its job, the driving selective pressure stops
operating and stability stops improving.
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Figure 1.8: Normal distribution representing the free energy of folding for protein sequence space. The
majority of sequences are above a critical threshold for stability (i.e., ΔG ≤ 0) and hence do not result in
functional molecules. It is proposed that existing proteins (black dots) are marginally stable due to neutral
evolution processes. Adapted from 41.

This is termed “marginal stability” (Figure 1.8). For many natural proteins, the
stability of the fold, i.e., the difference in free energy between folded and unfolded states,
is only about 10 kcal/mole42. This is roughly the energy of two ordinary hydrogen bonds43
or the barrier to ring flip in a cyclohexane molecule44, which may seem small considering
a typical protein molecule (30,000 kDa) is composed of over 4,200 atoms. Thus, even
changes of a single amino acid residue can induce a significant shift in the tertiary structure
of a protein. Moreover, the energy landscapes defining the folding pathways are poorly
understood for all but the simplest proteins, so even mutations not predicted to be
significantly destabilizing based on analysis of a crystal structure can render mutants nonfunctional due to destabilization of a key folding intermediate45. It is worth noting that a
number of protein structures studied are energetically frustrated46, in that some residues
appear to destabilize the native conformation of the protein, but mutating them, even to
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something perceived to be more energetically accommodating to the fold, disrupts its
function.
This is an example of functional complexity, in the sense that the contributions or
importance of the structural elements are not transparent. Over long periods of evolutionary
time, genetic systems tend to acquire interdependency and irreversible mutational load,
through a process first described by Muller47,48 and later dubbed by Felsenstein49 as
Muller’s Ratchet. This arises in part due to neutral evolution (akin to genetic drift in
population genetics), which describes the emergence of non-adaptive characteristics that
can nevertheless persist through future replications if they don’t initially produce a
selective disadvantage. In some cases, accumulated changes can make a protein robust to
mutation in certain aspects. A series of mutations, none of which significantly impacted
function at their time of introduction, can end up compensating for an initially vital amino
acid, so if that vital amino acid were now removed, the protein would still function. In this
case, the latter mutations go from being optional to necessary, with the original role of the
altered residue position now obscured. Without detailed a priori knowledge of the
evolutionary events, a biochemist interested in a more functionally transparent,
“engineerable” version of the fold would be unlikely to arrive at the original structure.
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Figure 1.9: Illustration of Muller’s Ratchet. A functional assembly of parts in an efficient form as a bridge,
is added to a redundant part, which can allow formerly necessary parts to be removed. Once these parts are
removed, the formerly non-essential part is now necessary, creating irreversible complexity of the system as
it is now more complicated and fragile than previously engineered. Adapted from reference 50.

Figure 1.9 provides a good visual analogy of this phenomenon, where the elements
of the bridge correspond to biochemical elements of a protein, and whether or not the bridge
can be crossed corresponds to whether or not the protein is functional50. At first, it is
possible to simply walk across on the stones to get from one side to the other. This
represents the most transparent structure. A mutation is then made wherein a plank is
added, which adds has little functional effect (Figure 1.9B). At this point, removing either
the plank or the middle stone would not impair the function of getting across; if one were
studying this crossing removing either of the two individually would not clearly
demonstrate how these pieces contribute to getting across. This figure depicts another
problem as well, one of evolved complexity. In Figure 1.9A, the function is simple, as it is
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in Fig. 1.9B as well, though slightly improved. However, when a mutation is made as in
Fig. 1.9C, the middle stone is removed, making the plank critical to the function. Removing
any piece would now completely wipe out the ability to cross the river. In natural proteins
these types of mutations can occur greatly complicating the study of a natural function by
adding complexity that obfuscates a clear picture of what is going on.

Figure 1.10: Representation of Darwin’s principle of multiple utility at the protein level. Shown here are
twelve of conceivably many more “functions” of a residue or structure motif as prescribed by typical
biochemical analyses. The green segments represent the minimal set of properties that residues have to
collectively confer to make a “functional” holoprotein (defined as one that reliably folds and incorporates a
bioinorganic cofactor).

Another source of biological complexity arises from Darwin’s principle of multiple
utility (Figure 1.10)51. The principle originally applied to organisms recognizes that any
one trait in an organism is subject to be selected by multiple forces. At the protein level,
the principle indicates that any one amino acid will pick up multiple structural and
functional roles during the protein development; twelve of many possible utilities are
shown on the pie chart. The combined influences of Mullerian and Darwinian processes
tend to confound efforts in protein biochemistry to move beyond case-specific proximate
23

descriptions and toward a more ultimate framework for mapping sequence/structure to
function (and vice-versa). Doing so can be considered one of the principle goals of protein
biochemistry, as it would help propel biological science from its discovery phase to a
mature engineering discipline, where scientists can define the desired properties of an
enzyme or biological machine and then design the sequences in a knowledge-driven
manner.
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Chapter 2 Protein Engineering
2.1 Two Approaches to Protein Engineering: Rational Design and
Directed Evolution
Broadly speaking, the field of protein engineering is concerned with creating new
proteins (i.e. not found in nature) possessing certain desired properties to achieve some
functional goal. Approaches to protein engineering can be loosely classified as either
rational design or directed evolution, though protein engineering projects may incorporate
elements of both.
In rational design, the exact sequence changes and /or structural design elements in
the new protein are deliberate and motivated by a priori knowledge. Traditionally, this
involved introducing single to several mutations into natural proteins of known structure
at sites believed to be important to the property of interest (stability, catalytic turnover
rate)1. This strategy is not so different from traditional knockout mutagenesis experiments,
and is limited in the functional improvements it can produce (usually reducing the fitness
of the protein, vis-à-vis marginal stability and complexity). In recent decades,
computational approaches to evaluating folding and stability of a protein have become
popular. Through numerical evaluation of a global energy function, algorithms can assess
the structural stability of a mutated protein relative to its original structure2.
In addition, computational approaches allow protein engineers to begin with a
tertiary structure in mind and then employ an iterative search to find sequences likely to
adopt the desired structure. A caveat here is that the target structure may not be an energetic
minimum for the physical polymer, meaning the target fold can be an intermediate along
the folding path or not sampled at all.
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This type of “bottom-up” design is a complex problem, in essence the inverse of
the protein folding problem3. Relevant issues include approximation-associated
inaccuracies in the force fields and energy functions used, and algorithmic issues associated
with adequate sampling and convergent optimization. Nevertheless, the associated
methods and technologies continue to improve at a rapid pace, and the approach has already
yielded several successes. Groups have used computational approaches to engineer
antibodies to bind specific epitopes4, create a protein fold not found in nature5, and produce
enzymes that catalyze non-biological reactions6,7.
In directed evolution, naturally occurring diversity-generating mechanisms and
selective pressures are replaced by human-imposed ones, aimed at evolving a system to
meet the demands of a target application. In the first phase of this two-step iterative process,
stochastic diversity-generating procedures like combinatorial mutagenesis, error-prone
PCR and/or domain shuffling are used to create gene libraries8. The high throughput
expression of these genes is then coupled to an appropriate screen, commonly a
fluorescence-coupled assay, to assess the desired property9. The highest performing
gene/proteins are then often used as the input for one to several additional rounds of
diversification and screening.
Directed evolution techniques have already proven successful in enhancing or
adapting functionality for a number of naturally-occurring and rationally-designed
templates10. Arnold and colleagues succeeding in adapting naturally occurring cytochrome
P450 enzymes to catalyze non-natural reactions, including alkene aminohydroxylation11,
alkyne cyclopropanation12, and organoborane synthesis13. Hecht and coworkers have
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evolved non-natural helical bundle proteins capable of monooxygenase chemistry from an
inert template14. Finally, Baker et al have applied directed evolution to a functional but
weakly-active rationally-designed enzyme catalyzing the retro-aldol reaction, achieving a
4400-fold improvement in catalytic turnover15.

2.2 Computational Prediction and Refinement: The ab initioStatistical Continuum
Arguably most famous and successful toolkit for computational protein design is
the Rosetta software suite16, which is geared towards both the structure design and folding
prediction facets of protein engineering. Rosetta tackles the folding prediction problem by
dividing a given sequence into smaller fragments (typically 3, 6, or 9 residues in length).
It then scans the PDB for proteins of known structure that contain similar or identical
sequence fragments. The 3D structures observed for the fragments are then weighted
according to the frequency they were observed, and are then stitched together via an
iterative, Monte-Carlo based method to create initial estimates of the structure of the
sequence in question. Initial structures generated in this fashion are then subjected to
rounds of “scoring” that consider energetic factors like hydrophobic burial and hydrogen
bonding, as well as how well-represented statistically the structure is in the PDB.
The most computationally costly aspects of protein design lie in spatial sampling
and in the consequent evaluation of the energy function. In principle, computational models
of biomolecular interactions can be based exclusively on physical principles, for example,
by using a full molecular mechanics model with explicit treatment of solvent17. However,
the cost of exhaustively testing every possible backbone conformation grows exponentially
with each additional residue, so in practice, using purely physical energy functions quickly
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becomes computationally intractable. Additionally, many of the most simplified models
that might otherwise be practical (e.g., the centroid model in Rosetta) compromise too
much on accuracy to be useful on their own17. On the other hand, empirical models, those
derived from published experimental and structural data, can provide foundations for
accurate and efficient modeling and design. These statistical energy functions (also called
knowledge-based energy functions) use frequencies of a particular structural motif or
sequence fragment in a sampling of PDB structures as a proxy for physically evaluated
energetic stability, and are relatively cheap to implement. Such statistical energy functions
can be used alone, or they can be used in combination with physics-based models of
complementing strengths16,18, to boost the accuracy and efficiency of both structural
modeling and sequence design of proteins5,19.

2.3 Untangling Complexity with Minimalism: An Argument for De
Novo Design
The caveat with statistical elements of the energy function is that it restricts design
space to naturally occurring motifs, and can be thought of as a high-resolution shuffling of
naturally occurring protein sequences. Harkening back to the previous section, this imports
the structure-function complexity of naturally evolved systems into the designed product.
Protein domains designed in this manner may very well fold as intended, and successfully
produce (or at least yield a starting point for) the desired functionality. If functionality is
the only goal, then this is perfectly fine. However, the lack of transparency into the basic
physical requirements of the protein fold, like the results obtained via directed evolution,
preclude an understanding of the scope of possible design space beyond the constraints of
those natural proteins have thus far been crystalized.
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Given the discussion in the previous sections, we now understand why probing
protein structure-function relationships through mutagenesis of naturally evolved systems
is problematic, and how statistical rational design and directed evolution, though
remarkable in their functional outcomes, don’t really escape this issue. However, empirical
validation is a vital component, if not the most important aspect, in the development of
scientific theory. A comprehensive framework for understanding macromolecular catalysis
is no exception. It follows, then, that to understand the fundamental principles by which
proteins fold, assemble, and manipulate cofactor chemistry, scientists must engage in the
creation of hypothesis-testing protein constructs without reliance on natural protein
constructs. Avoiding naturally occurring enzymes as structural starting points, and instead
designing amino acid sequences based on physical and chemical knowledge, is referred to
as de novo design (“from the beginning”). The term “de novo” is somewhat ambiguously
used in the protein engineering literature, in the most liberal sense referring to anything
that isn’t directed evolution. This thesis will define “de novo design” as a subset of rational
design (either computational or non-computational) that that bases sequence choices on
physical and chemical arguments rather than statistical ones.
Minimal de novo design, then, refers to the goal of establishing the minimum
physical requirements and level of sequence complexity necessary for a particular protein
fold. The idea is that well-defined design constraints provide well-defined degrees of
freedom for optimal design transparency and adaptability. If such a minimal template for
a fold is achieved, it should in principle be possible to reliably make sweeping changes to
the protein sequence without the integrity of the tertiary structure being affected.
Minimal de novo protein design is particularly attractive for the study of cofactor-centric
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redox chemistry. Assuming the requisite cofactors can be reliably incorporated, minimal
scaffolds simplify the interpretation of experimental outcomes by divorcing those results
from the accumulated complexity of their naturally occurring counterparts, and generally
yield valuable information regardless of the result. That is, a minimal de novo redox protein
that captures the essential physical chemistry of a natural one establishes what elements of
the natural protein scaffold are unimportant. Conversely, a minimal de novo redox protein
that properly incorporates its cofactor but functionally deviates in some way from its
natural counterpart, provides insight into what aspects of the natural protein not built into
the minimal protein are relevant.
Though the scientific merits of minimal design efforts apply to any fold, the work
in this thesis will make use of the four-helix bundle motif. The four-helix bundle is an
attractive fold for study given its demonstrated utility as a redox cofactor scaffold in nature
and its tractability for de novo design (since all of the secondary structure is locally
determined). The following section will discuss the history of de novo design efforts
relevant to the thesis project.

2.4 De Novo designed helical bundles: A Transparency Initiative
Some of the first attempts at bottom-up de novo protein design, as well as many subsequent
projects up to this day, have focused on alpha helices and the formation of alpha helical
bundles. Alpha helical structures are particularly amenable to transparent protein design
because the secondary structure is entirely locally determined; i.e., unlike structures
containing beta sheet elements, the atoms of the peptide backbone hydrogen bond only
with close neighbors in the primary sequence. This fact, along with some basic geometric
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understanding of peptide helices (3.5-3.6 residues per turn), allows for the reliable
engineering of self-assembling helical bundles through binary patterning. Binary
patterning refers to the systematic alternation of polar/charged residues and hydrophobic
residues (of those amino acids with high alpha-helical propensity) to construct an alphahelical peptide segment with a distinct hydrophobic and hydrophilic faces. Partitioning
drives the helices to self-assemble, with the hydrophobic faces facing a central core and of
the hydrophilic faces facing out towards solution, forming a stable structure.

Figure 2.1: Binary patterning in a minimally designed four helix bundle. Blue represents positively charged
residues, red represents negatively charged residues, and purple represents hydrophobic residues. Arranging
these residues in a primary sequence based on these properties as shown (bottom text) allows for the
spontaneous formation of an alpha helices (A) that self-assemble into four-helix bundles in aqueous solution,
In which the nonpolar residues are buried and the charged residues form salt bridges along the outside of the
helices. Shown here are two possible dimer topologies formed from disulfide coupling of single helices (A):
anti (B) and syn (C).

The first such minimally-designed alpha helix was reported by Eisenberg et al in 1986,
using only leucine, lysine and glutamate to encode the alpha helix (Figure 2.1)20. The
subsequent first round minimal binary-patterned helical bundle was reported in 1988 by
Regan and DeGrado21, with said alpha helices connected by interhelical loops containing
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proline and arginine.
These simple scaffolds became the template for those subsequently used by the Dutton
group with the intent of creating biochemically functional proteins. Initial development
goals focused on binding and doing chemistry with heme, one of the most studied redox
cofactors. Thus began, in the spirit of minimal de novo design, the careful introductions of
mutations to alter properties while maintaining design transparency. The most important
changes included the addition of two histidine residues to the protein core (to ligate heme)
and the addition of a cysteine at the N-terminus to allow a disulfide bridge to be formed
between two helices, creating the “dimer of dimers” assembly. This protein, named
H10H24, was able to bind four heme B cofactor in its interior, all of them having
discernable midpoint potentials and Kd values22. This protein was later changed into
H10A24, replacing one of the histidine residues in each helix with an alanine residue23. In
this variant, each dimer unit could only bind one heme, which simplified electrochemical
characterization and affinity measurements. The H10H24 protein was subjected to
structural studies as well. Huang et. al. obtained a crystal structure from a modified version
of H10H24 homotetramer (no disulfide linkages), providing structural information useful
for both the current designs and as a guide for future variants (Figure 2.2)24.
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Figure 2.2: Crystal structure of apo H10H24-L6I-L31F-L31M from axial (left) and longitudinal views (right).
Histidines are represented in red.

In this crystal structure, the protein dimers were stably in an anti-conformation.
This was exploited to create a new variant, where instead of four separately synthesized
helices, the new protein was dimer of two helix-loop-helix motifs. This structural change
revealed many possibilities, as the symmetry of the protein was now reduced from four
identical helices to two identical helix-loop-helix motifs16,17. This allowed for heme
binding knockout studies and enabled sequence diversification for better dispersion in
NMR studies. This protein was further modified to include a disulfide bond covalently
linking the dimers together, forming what was referred to as a “candelabra” structure, or
the HD-3 scaffold for heme-binding25.
Up to this point, research in de novo-designed proteins had been limited by the
technology available to synthesize them. Even optimal solid-phase peptide synthesis
protocols had practical upper limits of 60-70 amino acids per oligomer26, which prevented
the synthesis of most useful proteins as a single peptide chain. This changed with the
emerging cost-effectiveness of gene synthesis and the transition from solid-phase peptide
synthesis to E coli-based recombinant expression. The candelabra design could then be
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converted into a true monomer by expressing all four helices as a single primary sequence,
with the helical regions separated by a series of glycine-rich loops (Figure 2.3)27 . This new
protein scaffold, referred to as the “single chain” structure or the HM-1 scaffold, had the
same helix sequences and orientations as the candelabra, however with less conformational
freedom where the second loop now was. This design change lowered the symmetry of the
construct even further, as the entire sequence could be expressed as a single gene, whereas
in the candelabra it had to be expressed as two identical dimers that were later disulfidelinked27.

Figure 2.3: Bundle constructs and their associated symmetry constraints. .A The simplest four-helix bundle
with no loops, the homotetramer. It assembles via hydrophobic interactions only and, in the absence of a
bound cofactor like heme, can take on many possible alignments. B. Incorporating disulfide tethers creates a
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dimer construct that now can take on only two possible arrangements. C. Synthesizing two helices as a
continuous peptide and incorporating a new disulfide tether forces a syn arrangement of the helices. D.
Expressing the entire construct as a single-chain polymer leads to it being permanently assembled regardless
of the environment’s reducing capacity, and can be modified freely.

This reduction in symmetry created new degrees of freedom in the incorporation of
functionality. Binding sites that incorporated dipoles or other uneven attributes could now
be built, which was not possible when the amino acids had to be identical. For example, a
variant of a bis-his heme binding protein could be made to have a single histidine binding
site, which could discriminate between Fe and Zn tetrapyrrole cofactors. True to prediction,
these single-chain bundles have been successfully used to study of a number of synthetic
and naturally occurring cofactors beyond the hemes and flavins to be discussed in the
following chapters, including bilins, quinones, chlorins, and iron-sulfur clusters (Figure
2.4).

Figure 2.4: Cofactors (and corresponding potentials) studied in these de novo bundle constructs. Left shows
range of potentials of cofactors, as divided into families, when incorporated into four-helix bundles. (Low
potential flavins seen in organic solvents, but all other potentials measured in aqueous solutions). Right shows
cofactors that have been incorporated into four-helix bundles.

2.5 Tertiary Structure Dynamics: Molten Globules vs Native-like
Scaffolds
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Studies on the original 4-heme binding homotetramer “H10H24” indicated that,
while the scaffold was highly alpha helical, the final assembly lacked a well-defined
tertiary structure (on the NMR timescale) in both its apo and holo form, making it a highly
dynamic “unstructured scaffold (Figure 2.5). Hereafter, unless otherwise specified, a
largely constant alpha helical secondary structure will be assumed, and “structured” and
“unstructured” will refer to how singular the tertiary structure is.

Figure 2.5: Reaction scheme for the protein-heme binding reaction of the minimal homotetramer constructs.
k1: describes the protein forming an appropriate binding site. k2: describes a heme molecule becoming
available to assemble. k3: describes the rate of partitioning forming an unligated assembly. k4: describes the
formation of coordinate bonds between the ligating residue and the heme iron, forming the final holoprotein.

While the redox functionality of the holo H10H24 construct demonstrated
(remarkably for the time) that singular structures were not necessary for canonical heme
protein redox behavior (insofar as reversible single-electron oxidation and reduction), it
was nevertheless desirable to obtain a scaffold with a predictable tertiary structure.
Successive rounds of redesign introduced 33 complementary large- and small chain
hydrophobic residues (including β-branched-chain amino acids) while retaining the
histidine residues, and succeeded in creating a well-structured (i.e. “native-like”) apo
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protein that could be characterized by NMR and X-ray crystallography (Figure 2.2)24. This
version, however, now became less structured upon the binding of heme. Analysis of the
structure indicated that, in order for the histidines to be in a conformation capable of
ligating heme, the helices would have to undergo a rotation that destabilized the core
packing. A further large-scale modification to the bundle designed to accommodate this
rotation yielded a scaffold that was unstructured in the apo form and which became
structured upon the binding of heme (Figure 2.6)28. It is this scaffold that was preserved
through the candelabra (HD-3) and single-chain variants (HM-1) of the heme-binding
bundle.

Figure 2.6: A-F. 750 MHz 15N-HSQC showing changes in NMR spectral dispersions upon heme binding.
Similar results are seen for the candelabra (A-C) and the single-chain constructs (D-F). In the absence of
cofactor (here, Fe(III) protoporphyrin IX), NMR resonances are relatively dispersed, indicating an
unstructured protein (A,D). Adding one equivalent of cofactor induces partial dispersion(B,E), and addition
of a second equivalent induces further structuring(C,F). G-I. Close-up of tryptophan peaks for HSQC of HM1. Addition of 1 equivalent of cofactor creates two populations(H), and adding a second completes the
transition (I). Figure adapted from data originally published in 27.

2.6 Towards a Native-like Scaffolds: The Coiled-Coil Domain
In their typical low-energy conformation, alpha helices have approximately 3.6
residues per turn. However, in coiled-coil helical bundle domains, alpha helices can wrap
around each other into a left-handed supercoil in an antiparallel topology with such high
affinity that the coiling of individual right-handed alpha helices “tightens” the periodicity
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to 3.5 residues per turn29. This helical geometry positions side chains on neighboring
helices in a way that they can pack in between each other via “knob-into-hole”
interactions30. Since this helical conformation is characterized by an integer number of
revolutions for every seven amino acids, these domains can be characterized (and thus
designed) by a series of repeating “heptad” units with binary patterning of polar/charged
and non-polar amino acids31. The seven residues in the coiled-coil heptad are
conventionally designated “a” through “g”32, with positions a and d being the most buried,
b, c, and f facing the solvent, and e and g being interfacial (Figure 2.7).

Figure 2.7: One heptad of an antiparallel four-helix bundle protein. The distance of an amino acid from the
view is represented by the size of the heptad letter designation. Dotted lines represent hydrophobic
interactions within a layer. In helices, thick ribbons connect α-carbons, while thinner lines represent Cα-Cβ
bonds. Image rendered using PyMOL.

The hydrophobic effect is typically the most important driving force in protein
folding, particularly at the onset of folding33. However, complementary core packing is
considered a hallmark of native-like (i.e., uniquely structured) proteins, and likely makes
key energetic contributions to the ΔG of folding, guiding what might otherwise be an
ensemble of molten globule states to the protein’s final stable form (Figure 2.8).
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Figure 2.8: Free energy funnel representation of protein folding. Starting from random coil distribution of
geometries, population of peptide molecules undergo hydrophobic partitioning and secondary structure
formation along potentially many discrete coordinates to produce a variety of partly folded species. A.
Proteins without a single dominant energy well may adopt a spectrum or heterogenous population of
conformations in their native environment (e.g., some apo proteins and intrinsically disordered proteins). B.
Having a singular, steep energy well corresponds to a singularly structured “native-like” protein fold at
equilibrium. Negative and positive design strategies aim to favor a single conformation for a protein, by
raising the energy of unwanted conformations or lowering the energy of the desired conformation,
respectively (represented by the blue arrow).

In coiled-coil four-helix bundles, the a and d residues can be thought of as forming
successive layers in the protein interior, with each helix contributing one residue per
layer34–36. These segregate layers are evident in a number of natural bundles, including
Rop, bacterioferritin, the lac repressor domain, and cytochrome b (Figure 2.9). Packing in
these bundles is optimized when each layer has roughly the same total volume, which
avoids distortion in the helices and prevents unstable pockets or frustrated conformations.
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Previous work has shown that consistently using large residues in d positions and small
residues in a positions facilitates a regular helical structure with good van der Waals
contact between interior residues. In particular, a wider surface on each helix becomes
buried in a four-helix bundle compared to a two-stranded coiled coil, which means that
interfacial residues can play a key role in dictating the fold. The role of interfacial residues
is demonstrated in studies of various coiled coil mutants in which charged amino acids at
e- and g-positions favor a two-stranded coiled coil, whereas nonpolar amino acids such as
alanine at e- and g-positions stabilize four-helix bundles37,38.

Figure 2.9: Layers in natural four-helix bundle proteins.

Of course, natural coiled-coil proteins rarely follow this design prescription
perfectly. Stutters and skips in the binary patterning, or imperfections in core packing, can
be compensated for by local distortions. Moreover, layers tend to be more disorganized at
the ends of the coiled coil. Nevertheless, the idea of core layering remains a useful tool in
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analyzing and engineering core packing in coiled-coil proteins.
Combining the ideas of binary-patterned heptads, core-layering, and negative design has
proved successful in the engineering of a variety of de novo designed cofactor binding
proteins.

2.7 Narrowing the Folding Funnel: Bundle Topologies and Negative
Design
A protein that adopts a singularly structured, native-like state can be thought of as having
a conformational energy landscape with deep and narrow energy well, versus one that
assumes a heterogeneous ensemble of molten globule states having a broader, shallower
one. The strategy of optimizing core packing for a desired structure amounts to lowering
the energy of the bottom of the funnel, and can be called an example of “positive design”.
The complementary approach would be to raise the energy of the unwanted conformations
relative to your target structure, a strategy known as “negative design”.
For four-helix bundles, where secondary structure is essentially invariant, the
primary structural concern is helical threading (related to bundle topology) which refers to
how the component helices are aligned relative to one another. Figure 2.10 illustrates this
point with the earlier monomeric constructs. Even with monomeric four-helix bundles,
there are several possibilities which may be very similar to one another in energy in the
absence of negative design. Though some proteins may be functional despite existing in an
ensemble of topologies, others, especially those intended to bind multiple cofactors and/or
do so asymmetrically, require a predictable singular structure.
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Figure 2.10: Possible threadings for a single-chain four-helix bundle. An antiparallel helical topology can be
realized through two different threadings, U or U’. A mixed parallel-antiparallel topology can be realized
through either a Z or a Z’ threading. Cofactor attachments made with core “a” or “d” residues are symmetric
across the two possible threadings for a given topology.

There are several parameters a protein engineer might vary to destabilize one
topology versus the other. One method for limiting parallel orientations of helices is
shortening loop length. In order for a single-chain four-helix bundle to have more than two
helices with a parallel orientation, the bundle would need to have inter-helical loops that
are at least as long as a helix. Short loops obviate the possibility of a topology with all
helices parallel, or with three helices parallel and one antiparallel. Connecting loops can be
designed to favor left- or right- turning topologies, though loop structures tend to have a
weaker effect than inter-helix interactions. Hydrophobic core residues might be chosen in
such a way that the complementarity of core packing is worse in the undesired topology.
Given the binary patterning scheme underlying four-helix bundle design, perhaps
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the easiest design parameter to vary is interhelical charge pair interactions. One topology
can conceivably be stabilized over the other if the desired threading positioned oppositely
charged residues within salt-bridging distance of one another, whereas the alternate
topology might unfavorably position like charges near each other. (Figure 2.10) Charge
patterning has been successfully used in the redesign of Rop-like antiparallel bundles34,35.
DeGrado and colleagues have employed charge patterning to specify topology in a series
of metal-binding hetero-tetrameric bundles39,40.
The groups of Saven, DeGrado, and others have developed computational tools to
facilitate negative design in protein engineering. The computational scheme looks for a
variety of possible sequences that have the possibility to fold to a target structure,
regardless of whether a particular sequence is the lowest possible energy for a fold. The
algorithm then returns statistical possibilities for residues at each position, allowing the
user to make informed modifications to a sequence likely to discourage alternate topologies
yet unlikely to disrupt the target fold. The approach has proved particularly useful in the
design of a variety of four-helix bundles (both oligomeric and monomeric), including those
that incorporate di-iron centers, synthetic porphyrins, iron-sulfur clusters.

2.8 Another Design Consideration: Loops in Four-Helix Bundles
The inter-helical loops of a four-helix bundle protein are usually among the most
dynamic parts of the protein, but they can play a role in determining the structure. A short
loop can force the helices it connects to be antiparallel instead of parallel, and loops can
have a significant influence on the overall stability of the bundle.
A loop that is too long will decrease the stability of the four-helix bundle by raising
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the entropic cost of folding. Indeed, a study on the helix-loop-helix Rop protein, which
folds into a homodimeric antiparallel four-helix bundle, showed that when the native AspAla loop was replaced by a polyglycine linker, increasing the number of glycines in the
linker progressively lowered the melting temperature. The mutant with 10 loop glycines
denatured at a temperature 23°C lower than that of the mutant with a single glycine in the
loop. It was estimated that each loop glycine lowered the stability of Rop by 0.26
kcal/mol41. A loop that is very short, however, may sometimes cause misfolding or
aggregation, as was observed in the α2B(P) scaffold42 and Rop variants with altered loops
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. The latter study demonstrated that the wild-type homodimeric Rop could be converted

to a monomeric four-helix bundle by adding polyglycine loops to connect the helices.
While a 3-glycine loop resulted in aggregation, the variant with 4 loop glycines was
monomeric with comparable RNA substrate affinity and higher stability than the wild-type
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. In a similar manner, the single-chain four-helix bundle HM-1 was developed from the

dimer construct HT-1 by rearranging the loops. In this case, 9-residue glycine-rich linkers
were used to produce the single-chain HM-1, which retained its affinity for heme and was
expressible in E. coli27.
The designed loops described above are all glycine-rich unstructured loops, which
are usually sufficient to make stable, functional four-helix bundles, but a structured loop
can add stability to the protein. However, the design of a stable loop in a four-helix bundle
is difficult because it lacks a stable secondary structure, is highly exposed to solvent, and
is located at the ends of the helices where the protein is most dynamic. The DeGrado group
has explored the use of loop structures that are found in natural proteins to connect the
helices of four-helix bundles. In the di-metal bundle DF2t, a structured loop was found to
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increase stability and expression yield44, and a similar protein, DF3, used a different loop
conformation to confer even greater stability and solubility45. X-ray crystal and NMR
structures demonstrated that the loops folded as designed. While a structured loop
sometimes can impart subtle improvements to a protein’s structure, unstructured loops are
generally sufficient, because four-helix bundle folding and function is dictated primarily
by the α-helices.

2.9 MZH3: The first minimally designed coiled-coil bundle
The first functional de novo designed coiled-coil bundle in the Dutton group was designed
by Ennist46 with the goal of creating a minimal model of a photosynthetic reaction center,
by incorporating electron donors, a pigment, and an electron acceptor (Figure 2.11). The
scaffold was named MZH3 for the cofactors it binds: Metal, Zinc tetrapyrrole, and Heme
(the donor, pigment, and acceptor, respectively). MZH3 was designed to have an
antiparallel topology, which is common to the natural carboxylate-bridged diiron and
dimanganese family of proteins as well as cytochromes b and b6. MZH3 is a 196-amino
acid protein with an extinction coefficient of 12,490 M-1cm-1 at 280 nm, a molecular
weight of 22.5 kDa, and a theoretical isoelectric point at pH 5.5 in the apo-state. An
informative depiction of the sequence of MZH3 is given in Table 2.1. The winding
“snaked” sequence in the second row, which is written backwards in helices 2 and 4, shows
which amino acids form layers together in the hydrophobic core.
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Figure 2.11: Coiled coil heptad positions a through g are denoted in the top row for both forward (N- to Cterminus) and reverse (C- to N-terminus) sequences, and they are aligned with corresponding positions in the
MZH3 amino acid sequences. Residues highlighted yellow are a-position residues. The MZH3 amino acid
sequences have each helix written on a new line with loops separated from the helices by a space. The Nand C-terminal ends of each helix are denoted by the letter in parentheses at either end of each helix, and “Nterm” and “C-term” denote termini of the protein. Green amino acids belong to the cytochrome b-like
tetrapyrrole binding section of MZH3, whereas blue amino acids belong to the Due Ferro-like di-metal
binding section of the protein. In the MZH3 “snaked” sequence, helices 2 and 4 are written in reverse so that
amino acids that are spatially close together in the folded protein are close together in the snaked sequence
diagram. Red boxes enclose layers of the hydrophobic core, each of which includes two a- and two d-position
residues. The N-to-C forward sequence is written conventionally, from the N-terminus to the C-terminus.

The protein formed diffraction-quality crystals in a variety of cofactor-bound states,
and high-resolution crystal structures were obtained. As designed, MZH3 folded as a lefthanded coiled coil (Figure 2.12). All eight structures are similar overall and largely
consistent with the design. Helices begin and end at the intended positions, a- and dposition amino acids are directed into the core, each helix is oriented antiparallel to its two
adjacent neighboring helices to form e-e and g-g interfaces, the bundle has the intended
left turning topology, and cofactors bind to intended sites in accordance with the design
(Figure 2.13).
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Figure 2.12: Crystal structure of holo MZH3 from axial (left) and longitudinal views (right).

Coiled coil structural parameters of MZH3 were evaluated by the programs
SOCKET47, TWISTER48, and CCCP49. These programs assess the structure of a coiled coil
by taking atomic coordinates from a PDB file as input and searching for knob-into-hole
interactions and/or determining the Crick parameters, a set of parameters that can be used
to define the amino acid backbone coordinates in an idealized coiled coil50,51. All three
programs designate MZH3 as a canonical coiled coil with a left-handed superhelix. Each
one assigned heptad registers (the abcdefg designations) for each helix that match the
register that was intended by design. For a set of coordinates that included only the residues
between and including the core a-d-a-d layers at either end of the MZH3 bundle, CCCP
calculated an average of 3.51 residues per turn (canonical coiled coils have 3.5 residues
per turn) and a 0.968 Å RMSD deviation from an idealized coiled coil structure. SOCKET
identified extensive knob-into-hole interactions involving a, d, e, and g positions across
each helix. SOCKET also calculated the average pairwise helix crossing angle between
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adjacent helices to be 19.9°; idealized coiled coils with left-handed supercoils tend to have
crossing angles near 20° 52. This analysis shows that the secondary and tertiary structure of
MZH3 is consistent with the design.

Figure 2.13: Possible threadings for a single-chain four-helix bundle. The intended design, as well as the
observed threading, are consistent with negative design philosophy which places energetically unfavorable
like-charge residues in close proximity to one another in all but the desired threading.

MZH3 formed layers in the hydrophobic core that are consistent with the design.
Each helix contributes two heptad a- and two d-positions to each layer to make groups of
four amino acids each that are roughly aligned in the same plane. This validates the original
design approach of connecting the set of layers from a di-heme protein such as cytochrome
b to the set of layers from a diiron protein such as bacterioferritin to form a long string of
layers in an extended four-helix bundle. The left panel in Figure 2.14, shows how the a-d-
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a-d layers of cytochrome b and bacterioferritin were essentially strung together to make
the core of MZH3. While the exact identities of each core a- and d-position are not copied
from nature, the total size of the amino acid side chains and cofactors in each layer is kept
consistent throughout the length of the holo-state bundle, with small exceptions to aid
cofactor binding and function. The right panel of Figure 2.14 shows the simplified cartoon
backbones and cofactors of cytochrome b and bacterioferritin to show how MZH3 retains
structural properties of both a transmembrane hemoprotein and a water soluble diiron
protein. When connected, they create a metal-tyrosine-pigment-electron acceptor tetrad
that should be competent for light-activated electron transfer and the trapping of a chargeseparated state.

Figure 2.14: Layering of the hydrophobic core in MZH3 is similar to that of a cytochrome b-like protein
joined to a bacterioferritin-like protein. Upper left is crystal structure of cytochrome b (14). Lower left is
crystal structure of bacterioferritin (15). Layers of a-d-a-d positions are shown as spheres. Colors of layers
in MZH3 match up with layers in cytochrome b and bacterioferritin, as indicated by arrows. Right: Cartoon
of MZH3 with cofactors (green, structure CS-B) is shown alongside cytochrome b in cyan (16), and
bacterioferritin in magenta (17). Cofactors are labeled A for electron acceptor, P for pigment, Y for
tyrosine, and M for di-metal center. Images rendered using PyMol.
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Charge patterning interactions between c-position glutamates and lysines in the
tetrapyrrole-binding section of MZH3 did not result in stable salt-bridging hydrogen bonds.
In some crystal structures, some of the distances between lysine nitrogens and glutamate
oxygens are close enough for hydrogen bonding, but these flexible, solvent-exposed side
chains tend to have relatively high temperature factors, indicating that hydrogen bonding
interactions are transient. It may be that the g-g interfaces in MZH3 are too wide for
persistent hydrogen bonding between c-position residues. In addition, the high ionic
strengths of the three crystallization conditions may shield the charges to some extent and
destabilize surface-exposed polar contacts. Despite the lack of stable salt bridges, the
cumulative effect of all of the inter-helical electrostatic interactions may be involved in
determining the topology.

2.10 Two Complementary Scaffolds: Structured and Unstructured
Bundles
Efforts in the area of four helix bundle de novo design thus far has given us two
effective classes of scaffold: Those that are unstructured in the apo state and gain structure
and stability in the apo state, typical of parallel-antiparallel bundles of Dutton and
colleagues and exemplified by HM-1, and those that possess a native-like fold in both the
apo and the holo state, typical of the antiparallel coiled-coil bundles and exemplified by
MZH3. Given the complementary dynamics and energetics of backbone motion and
cofactor incorporation, both scaffolds have something to offer in the construction and study
of minimal redox centers. The goal of this thesis will be to establish both heme-based
oxygen binding and flavin photoactivation sites in both types of scaffold as model systems
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for studying the minimal requirements of each respective chemistry.
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Chapter 3 Redox Modulation I:
Suppression of Oxidation in a HemeOxygen Complex
3.1 Oxygen Reactivity in Biology: A Double-Edged Sword
Bioenergetics and metabolism deal with the acquisition of high-energy electrons
from the environment and using them to forge bonds in the molecules necessary for life.
With the atmosphere of early earth being a highly reducing environment (composed almost
solely of nitrogen), the earliest organisms evolved to derive energy where they could from
the oxidation of compounds like methane and sulfur-containing minerals. Three billion
years ago, Earth saw the evolution and proliferation of photosynthetic cyanobacteria, which
could exploit energy from readily available sunlight in the extraction of electrons from
ubiquitous water molecules, oxidizing water to molecular oxygen and expelling it as a
byproduct. So successful where these organisms that they changed the atmosphere of the
planet from a reducing environment to a highly oxidizing one, a process which spiked about
2.5 billion years ago in what is known as the great oxygenation event1. This changed the
evolutionary course of life on Earth to favor aerobic life.
In contrast to dinitrogen, dioxygen is a powerful oxidant that readily reacts with
other compounds. It is central to aerobic life, which evolved to exploit the reactivity of
molecular oxygen by coupling its reduction to the oxidation of C-C bonds in organic
substrates for energy. However, oxygen will also readily oxidize lipids, proteins, and other
biological molecules if not carefully regulated in the cell. The emergence of oxygen on
Earth thus spelled doom for anaerobic lifeforms, which had no way of preventing or
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managing oxidative damage to their metal centers and other cellular components. The
surviving descendants of Earth’s earliest life forms are now relegated to extreme
environments where oxygen cannot reach.
The challenges of an oxygen-driven metabolism drove the evolution of a variety of
proteins that could manage the reactivity of the molecule. These include superoxide
dismutases and peroxidases to catalyze these reactive oxygen species to something useful
or benign, as well as various classes of globins to sequester, store, and transport oxygen2.

Figure 3.1: Left: The molecular orbital diagram of an oxygen-iron complex. The electrons from the Fe(II)

bind with the two pi electrons of the dioxygen species in a weak pi bond and strong sigma bond. The resulting
oxygen-iron complex is diamagnetic with all paired electrons. Right: illustration of the planar iron ion in
heme when oxygen is bound to it.

The chemistry of oxygen can be complex despite its relatively simple structure.
This is in large part because dioxygen exists as a triplet in its ground state, unlike most
diatomic and organic molecules which are singlets in their ground state. Since quantum
mechanics forbids spin flips simultaneous with electronic transitions or bond formations,
reactions and/or coordinations with diatomic oxygen must have some mechanism to
accommodate this transition. Heme cofactors interact readily with triplet oxygen, in part
due to the unpaired electrons in high-spin configurations of the central iron that the oxygen
61

can readily form a molecular orbital with (Figure 3.1). Heme cofactors are either
pentacoordinate or hexacoordinate inside their protein scaffolds, referring to whether the
central iron has one or two axial ligands in addition to the to the four pyrrole nitrogens
serving as planar ligands. Hexacoordinate hemes have the iron in an octahedral geometry,
which is a stable conformation for both ferrous and ferric states and thus often found in
heme proteins involved in simple one-electron transfer events. Pentacoordinate hemes,
with the iron in a square pyramidal geometry, have an axial orbital available for bonding,
and thus often found in catalytic heme proteins. In terms of oxygen chemistry,
pentacoordinate hemes are represented in oxygen carriers like myoglobin and oxygenmediated catalysis like that carried out by cytochrome P450s.

3.2 The Globin Fold
The globin superfamily includes a large number of structurally similar proteins,
found in all kingdoms of life,3–7 which employ a heme cofactor (either hexacoordinate or
pentacoordinate) to perform chemistry with gaseous ligands. The canonical globin fold is
an “all-alpha” fold consists of eight alpha helices surrounding a heme b cofactor8. Globins
can be active as monomers (like myoglobin), dimers (cytoglobin9), or tetramers
(hemoglobin). Classically known and characterized as reversible oxygen binding proteins,
globins have additionally been found to play roles in nitrous oxide scavenging, electron
transfer, and protection of the cell against reactive oxygen species2.
Oxygen-binding functionality was typically thought to be restricted to
pentacoordinate heme-binding globins (like myoglobin and hemoglobin), with an open
axial orbital necessary for gaseous ligand binding. However, genetic analyses indicate that
these pentacoordinate globins evolved from hexacoordinate heme binders, which may
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themselves have evolved the ability to bind oxygen prior to stable pentacoordinate heme
binding (Figure 3.2)4. In fact, these pentacoordinate globins still possess a second histidine
at the so-called “distal site” near the open orbital which, while too far away to coordinate
the iron, acts to stabilize bound dioxygen via hydrogen bonding. The placement of this
histidine in such close proximity to a pentacoordinate heme without it binding requires
extreme stabilization and rigidity to the heme-binding site. This structural tuning presents
a considerable evolutionary challenge, likely taking numerous iterations. These iterations
would involve evolving through hexacoordinate oxygen binding intermediates for which
one histidine ligation was weakened but not fully removed from the iron coordination
sphere.

Figure 3.2: Hexacoordinate and pentacoordinate modes of heme binding, represented by neuroglobin (top)
and myoglobin (bottom) respectively.
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For all oxygen transport globins, there are energetic requirements that must be met
for both oxygen binding and release to be possible at physiological conditions. Whether a
globin contains pentacoordinate or hexacoordinate heme site, for oxygen binding to occur
one axial binding site must be open for oxygen to bind. In the case of hexacoordinate heme
binders, such as neuroglobin, this requires the removal of one histidine. In order to lower
the thermodynamic barrier for histidine release, it has been suggested that natural
hexacoordinate oxygen-binders place structural strain upon one of the ligating histidines
so the iron can become pentacoordinate10. This barrier must be sufficiently lowered that
the histidine-off rate is high enough such that the iron spends enough time in the
pentacoordinate form for oxygen to bind. If this condition is not met, the iron will oxidize
to its ferric form, in which it cannot bind oxygen. Hexacoordinate oxygen binders mediate
local oxygen reactivity in cases of oxidative stress, so only need to bind for short periods
of time 11. However, pentacoordinate-heme-ligating oxygen binders have evolved for longrange oxygen transport and therefore must stabilize the oxyferrous state more.
The ideal KD for oxygen binding is organism-specific depending on the oxygen
concentration its environment, such that globins become oxygen-saturated in highly
oxygenated tissues and release their oxygen in those tissues requiring oxygenation. No
matter the environment, however, the natural KD for oxygen to a pentacoordinate heme is
not low enough to allow for efficient oxygen binding. In order to improve the stability of
the oxyferrous state, pentacoordinate heme binders have conserved the distal histidine at
such a distance from the open axial heme site that it can hydrogen bond to dioxygen when
bound12. Additionally, when oxygen binds to the ferrous iron, an energetically favorable
event of the iron fitting into the center of the porphyrin ring occurs due to the iron atom
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shrinking in size as it goes from high spin to low spin (Figure 3.3)13. Once the oxygen
settles into the porphyrin ring, the distal histidine is positioned such that it can accomplish
the dual task of stabilizing the binding of dioxygen and sterically inhibiting the binding of
more-linear carbon monoxide that would otherwise bind 200-fold better, posing a problem
to oxygen transport even under the low normal physiological levels of CO14.

Figure 3.3: Distortion of the heme cofactor as a function of oxidation state. A illustrates the nonplanar iron
ion in heme when there is no oxygen bound to it. B illustrates the planar iron ion in heme when oxygen is
bound to it. The iron ion is colored orange and is found in the center of the heme group. The four pyrrole
nitrogens of the heme group and the nitrogen of the proximal histidine are colored blue.

Not all globins are designed to bind oxygen; there are other globins that participate
in ROS mediation, electron transfer and NO scavenging, as well as a whole family of
globin-coupled receptors that bind dioxygen and other gaseous ligands15. Recently, some
tissue hexacoordinate-heme-binding globins have been identified including neuroglobin
and cytoglobin with neural and nuclear locations, respectively. These globins appear to
have evolved from the same early globins as oxygen transport proteins and are highly
conserved 16. Both neuroglobin and cytoglobin are capable of binding oxygen, though for
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much shorter periods of time than typical oxygen-transport globins17. While it has been
postulated that neuroglobin, in particular, may be responsible to tissue-level oxygen
delivery to mitochondria, its up-regulation in hypoxic conditions and biochemical traits
point to its more prominent role being an electron transport protein used to scavenge
ROS18,19. Cytoglobin, which is also upregulated in hypoxic conditions, may play a role in
providing oxygen to dioxygen mediated enzymes such as hydroxylases in addition to ROS
mediation

18,20

. Even though the specific biological role of these globins has yet to be

identified and more of their kind are still being identified

19

, their strong conservation

across species suggests a primary role in mediating oxidative damage caused by ROS in
tissues that are difficult to repair and/or are prone to hypoxic injury or increased ROS
production.

3.3 Understanding Redox Suppression Through Minimal De Novo
Design
In the presence of oxygen, the iron center in heme oxidizes readily to its ferric state
outside the context of the specific globin folds discussed above. Hemes in cytochromes or
other model solubilizing scaffolds, whether pentacoordinate or hexacoordinate, tend to
transition directly from the reduced unoxygenated state to the oxidized state without
transitioning through an observable oxyferrous intermediate (i.e., one that lasts for longer
than milliseconds, the mixing time for a typical stopped-flow setup)21–23. Examining
globins from the cofactor-centric oxidoreductase perspective outlined in the first chapter,
we can say that the role of the protein scaffold here is the suppression of an otherwise rapid
electron transfer event between a heme and an oxygen molecule (Figure 3.4).
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Figure 3.4: An oxy-ferrous heme complex (left), once formed, has a tendency to undergo inner sphere
electron transfer to form a ferric heme with a superoxide adduct (middle) from which superoxide
subsequently dissociates (right). NADH oxidase (Nox) is an example of an enzyme that promotes this
pathway. Globin proteins involved in oxygen storage and/or transport have to suppress superoxide formation
and preserve the ferrous state of the heme.

Given the central importance of oxygen chemistry to aerobic organisms (including
ourselves) and a particular medical interest in the special properties of hemoglobin, decades
of research across many groups have been invested in understanding the oxygen-related
structure-function relationships of the globin fold. A functional oxygen storage or
transporter protein must simultaneously tune both the kinetics of oxygen binding while
suppressing a deleterious and otherwise spontaneous reaction path once bound. Multiple
hypotheses have arisen about what makes specific globins special, including key
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interactions from specific residues (e.g., the distal histidine), protein breathing dynamics
(particularly in studies of myoglobin), and important conformation changes induced by
allosteric binders (carbon dioxide and glutathione in mammalian hemoglobin). There is
also the question of the importance of heme redox potential in oxygen binding, whether
the several hundred mV elevation in midpoint potential of the longer-lived oxyferrous
lifetimes in myoglobin and hemoglobin relative to neuroglobin and other cytochromes is a
dominant factor, a minor one, or a largely incidental characteristic.
Studies on these proteins via traditional mutagenesis and more recently molecular
dynamics simulations have yielded valuable information on globin biochemistry, but
systematic hypothesis testing is difficult owing to their marginal stability and complexity.
Attempting to recreate chemistry in de novo designed proteins can establish minimal
requirements for oxygen binding and inform on what is and isn’t crucial about the globin
fold.

3.4 Oxyferrous State Formation in a Dynamic Bundle
Experimentation with heme oxygen chemistry in minimally designed bundles started
shortly after the first successes with simple heme binding with the homotetrameric solidphase synthesized bundles. The relevant protein, HT-1 (H10H24), bound a total of four
hemes, each of which could be reversibly oxidized and reduced but with no observable
oxyferrous intermediate at room temperature. However, experiments at cryogenic
conditions (-15 °C in glycerol solution) show the formation of an oxyferrous state that is
stable for more than an hour when reduced protein is exposed to oxygen. This demonstrates
that the oxidation of histidine-ligated heme does mechanistically proceed through an
oxyferrous intermediate that is simply too short-lived under ambient conditions.
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Figure 3.5: Designs of the initial oxygen binding proteins. Blue highlights mark heptad divisions, and red
font indicates amino acid changes made through the design intermediates. In HT-1 through HT-4, helical
sequences shown are linked by cysteine disulfide loops and self-assemble in four-helix bundles, whereas in
HD-3 a longer loop (red) unites two identical sequences, with the loops themselves now disulfide-linked.

For the purpose of examining the effects of protein structure on oxyferrous stability, the
structure of the protein was simplified by reducing the number of hemes from four to two
by replacing H24 on each helix with a phenylalanine. Inspection of model apo structures
showed that a substantial rotation greater than 50 degrees around the helical axes was
required on heme binding to accommodate the histidine rotamers typical of natural bishistidine heme-binding proteins. This rotation exports hydrophobic interior residues into,
and imports polar residues from, the aqueous phase. Modelling identified four amino acids
for substitution to interfacially-compatible alanines or glutamines24 and one for deletion to
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more favorably realign the binary pattern after heme addition, yielding HT-3. However,
three inwardly rotating b-position glutamates at positions 11, 18 and 25 were deliberately
left in place25 to apply strain to weaken one of the two histidine-heme iron ligation
interactions, as occurs in neuroglobin. This created an “entatic state”26, referring to an
enzyme structure that is energetically poised to interact with its substrate. Fourier transform
infrared spectroscopy (FTIR) showed that these strain-inducing glutamates have pKa
values (that is, pH values at which the residues are half protonated) increased by more than
two units and, as in natural heme proteins, are strongly electrostatically coupled to heme
oxidation-reduction, changing the pKa by more than three units27. NMR showed that
addition of two heme Bs transformed unstructured apo-4 into a well-defined tertiary
structure28. It appears that the histidine-iron polar bond can also provide a nucleus for
interior packing that promotes a singular structure around different porphyrin cofactors28.
To facilitate NMR structure determination and assignment of 90% of the peptide backbone,
external residues were also diversified at this time, yielding HT-4. The sixth design
iteration transitioned the helical sequences of HT-4 from the dimer construction to the
candelabra, HD-3 (Figure 3.5).
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Figure 3.6: heme spectra in the designed proteins. a, b, At -15 °C, these spectra are stable for more than an
hour: oxidized (green), reduced (blue), carboxy-ferrous (black) or oxy-ferrous (red) HD-3 with either heme
B (a) or heme A (b) as the cofactor. c, d, Stopped-flow spectral changes for mixing the reduced heme B
proteins with oxygen at 15 C. HD-3 (c) shows the transformation of the reduced heme (blue) to the oxyferrous state (red), which eventually becomes oxidized (green), whereas the earlier intermediate HT-1 (d)
proceeds directly and rapidly to the oxidized form.

Despite the improvements to core packing and helical register, none of HT2-HT4
yielded any appreciable improvement to oxygen binding at room temperature. However,
all three of them, like HT-1 H10H24 , yield an oxyferrous state at -15 °C form with a nearly
100% yield. Given the temperature dependence of the oxyferrous lifetime, it was
hypothesized that room temperature instability was being facilitated by water and proton
access to the active site. This idea is supported by studies of heme in organic solvent where
the oxyferrous state is relatively stable in the complete absence of water. The introduction
of the topology-restricting loop in design HD-3 sharply limited the helix-pair associationdissociation dynamics and consequently the time-averaged accessibility of solvent to
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interior residues. In contrast to the dimer constructs, HD-3 displayed a room-temperature
oxyferrous state stable with a lifetime of approximately 14 seconds (Figure 3.6),
representing an improvement in oxyferrous lifetime of at least four orders of magnitude
(the lifetimes of the other constructs necessarily being on the order of a millisecond or
less).

3.6 Oxyferrous Lifetime Dependence of Heme Midpoint Potential
The measurable oxyferrous lifetime of this construct affords the opportunity to
evaluate another proposed determinant of oxygen binding stability; the midpoint potential
of the heme. The redox couple of interest is the ferrous (Fe2+) and ferric (Fe3+) states of
the central heme. Many model proteins with histidine-ligated heme b, including both
natural proteins and the minimal constructs described here, have reduction potentials
around -300mV. Myoglobins and hemoglobins, containing histidine-ligated cofactors with
oxyferrous lifetimes on the order of hours to days, have reported reduction potentials
between +50 and +150 mV. Given that the Eh of pure near-neutral water is between +200
and +250 mV, the ferric state is always lower in energy than the ferrous state for these
proteins, with a higher heme Em representing a smaller energy gap between the two.
Relative to a heme of lower Em, a high Em heme has a more stable reduced state. It can be
argued then that the tuning of the heme midpoint potential by the protein (by whatever
means) to more positive values is an important “strategy” for oxygen-storing proteins in
slowing the transition from the oxyferrous state to the oxidized state.
In addition to heme b, HD-3 also readily binds other iron porphyrins, including
heme a. Heme a has the same core structure as heme b, but has different peripheral
substitutions on the macrocycle that shift the midpoint potential more positive by
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approximately 200 mV relative to heme b (midpoint of heme a is -100 mV vs SHE at pH
8). 200 mV corresponds to roughly 4.6 kcal/mol for a single electron transfer, about the
energy of an ordinary hydrogen bond. Substituting heme a for heme b is a convenient way
to probe the dependence of lifetime on midpoint potential in isolation. Repeating the
oxygen binding experiment in HD-3 with heme a yields an oxyferrous lifetime of roughly
30 seconds, about 3-fold longer than that for heme b.
Although increasing the midpoint potential of the heme did lead to a modest
increase in oxyferrous lifetime, the magnitude of the effect is nowhere near sufficient to
account for the long lifetimes of myoglobin and hemoglobin ,which is still 1000-10,000
times longer than that observed for HD-3. The midpoint potential for the 2+/3+ heme redox
couple represents the ΔG for a direct one-electron transfer between a heme and an
electrode, crucially measured under anaerobic conditions. This value says little to nothing
about the mechanism of aerobic oxidation, or what the activation energy for the oxyferrous
transition to the oxidized state is. It is known that the transition from oxyferrous to oxidized
is practically irreversible, as hemoglobin in red blood cells requires other enzymes to
regenerate reduced heme when oxidation eventually does occur.
With HD-3 possessing an oxyferrous lifetime well within detection limits, it
became possible to test whether or not the histidine strain that was incorporated into the
designs of HT-2 through HD-3 was indeed important to oxygen binding. To this end, the
b-position glutamates of HD-3 (at positions 11, 18 and 25) were mutated to alanine
residues. This variant failed to form a detectable oxyferrous state, undergoing complete
oxidation within the mixing time of the instrument (Figure 3.10). As opposed to HT-2
through HT-4, where oxidation occurred through a very short-lived oxyferrous
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intermediate, it is plausible that this protein oxidized via outer-sphere electron transfer (i.e.,
through-space, not through-bond), since the rotation model implies that oxygen can no
longer access the iron’s axial orbital. Another cryogenic oxidation experiment would
confirm this, although it has not been performed at this time.
Thus, the removal of the modelled entatic state26 by converting the interfacial
glutamates to alanines disabled the exchange-gated rotational mechanism of oxygen
binding. In exploring the effectiveness of loops to control mobility of free helices and
thereby exclude water from the interior, it was found that the oxyferrous heme is not
stabilized by looping together helices already linked by heme (HT-4), but is stabilized by
looping together helices not linked by heme (HD-3). Interestingly, the disulfide linkage of
the loops in HD-3 proved unessential, because eliminating disulfide bond formation
through a cysteine-to-serine substitution maintained oxyferrous heme stability (Figure 3.7).
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Figure 3.7: Restricting helix dissociation and solvent access by linking together the heme-binding helix pairs
is sufficient for establishing an observable oxyferrous state under ambient conditions.

Finally, to test the degree of independence between the two heme sites, our
development of helical strain and motion constraint to promote dioxygen binding to ferrous
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heme is not confined to one site, but extends along the four-helix bundle to heme at other
positions. A single-heme variant with histidine only at position 42 displayed oxyferrous
heme properties similar to that observed in HD-3. (Figure 3.8).

Figure 3.8: Oxygen binding shows functional domain independence. In the same HM-1 scaffold with oneheme (top left) and two-hemes (top right) bound, the same spectral bands are seem for the oxidized (green),
reduced (blue), oxyferrous (red) and carbon monoxide bound (black) with exactly two times the absorbance
for the two-heme version. The oxyferrous state formation (lower left) and decay (lower right) are also within
error of each other for the one-heme (green) and two-heme (black) proteins. Figure generated from data first
published in29.

3. 7 Oxygen Binding in a Single-Chain Dynamic Bundle
For further exploration of oxygen binding, it was of interest to escape the symmetry
constraints of the dimer-of-dimer and candelabra structures, as well as to test whether the
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more limited loop topologies available to a single continuous peptide chain could afford
the same motion restriction as that observed in the candelabra. To this end, the helical
sequences of HD-3 were translated into a monomeric single-chain protein design,
designated HM-1, as described in chapter 2. Stopped flow measurements of both di-heme
and mono-heme variants demonstrate the formation of the oxyferrous state with a lifetime
of approximately 10 seconds, recapitulating the essential chemistry of HD-3.
The establishment and characterization of the single-chain analog of the bundle the
removal of helical symmetry constraints afforded an opportunity to return to minimalist
principles in the sequence design of a four-helix bundle. In particular, iterative minimal
design enabled an examination of how binding site sterics and overall core packing affected
heme binding affinity. Adhering to the principle of binary patterning for the helical regions
using just three different amino acids, and using glycine-rich segments for the connecting
loops, the water-soluble four-helix bundle MT-2 was produced. In the subsequent variant,
the sole introduction of four histidine residues conferred the ability to bind two hemes (MT3). The next variant replaced two hydrophobic leucines that would become solvent exposed
upon heme binding to glutamates, and removed steric bulk surrounding the heme sites by
replacing the adjacent leucines with smaller alanines (MT-4). The next and final variant
improved the core packing away from the heme by replacing eight leucines with
phenylalanines (MT-5)..
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Figure 3.9: The design of the MT series of single-chain proteins.Cartoon representations are color coded by
hemes (brown) and amino acids that are charged (grey),hydrophobic (purple), histidines (green) and alanines
(black).

The introduction of four histidines in the transition from MT-2 to MT-3 was
sufficient to confer heme binding ability to the otherwise non-functional scaffold, albeit
with a relatively weak affinity. Removing steric clashes near the heme sites improved
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binding affinity 10-fold. Subsequently improving the core packing in the rest of the bundle
yielded a remarkable 1000-fold increase in heme affinity in MT-5 over MT-4.
In order to lengthen the lifetime of the oxyferrous state, the oxygen-binding affinity
at natural aqueous concentrations was improved through restricting water access to the core
in protein MT-5. Introduction of a heme-binding pocket in MT-4 may have also allowed
for increased water access to the core in comparison to MT-3 as seen through the
destabilization of the oxyferrous state. For MT-5, it was desired to add back some core
bulk without removing the heme-binding pocket . The H7 and H14 positions of each helix,
which are internal to the protein directly above the histidine residues, were all mutated to
phenylalanine to add hydrophobic core bulk, as has been suggested in previous work. These
positions for phenylalanine were also chosen due to their ability to interact through pistacking with the porphyrin ring of the heme bound to the opposing helix at the H+14
position and improve the heme-binding affinity. These mutations removed the alanines
introduced on opposing helices in MT-4, but maintained the alanines introduced at the 9
positions. Further improvement of heme-binding affinity was seen with the addition of
phenylalanines in MT-5, which has a KD of 170 pM. This affinity is greater than any
designed oxygen-binding protein and allowed for much cleaner determination of its
character. Because the design of MT-4 from MT-3 including the removal of both solvent
exposed hydrophobic residues and addition of a heme-binding pocket and such a strong
improvement of affinity was observed with the addition of core phenylalanines in MT-5,
the necessity of the heme-binding pocket was tested through the removal of half of the
pocket by mutating interfacial alanines on the first and third helix to glutamate. The
resulting MT-5-5A9EA79E did not bind heme, indicating all of the alanines at the 9
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positions of each helix are necessary for heme binding. MT-5 showed a similar redox
potential to 4 at -202 mV as it has a net charge of +2 and both have well-buried hemes.
There was also little difference in their thermal melting temperatures, despite previous
designs showing a drastic increase in melting temperature with phenylalanine content. In
this case, both MT-4 and MT-5 have high melting temperatures, showing only
uncooperative fraying with increased temperatures. Strong oxygen-binding and heme
affinity of MT-5 is evident in the UV-visible spectra taken at -15°C. Clearly defined
oxidized, reduced, oxyferrous and carbonmonoxyferrous states are seen, which correspond
to those observed for natural hexacoordinate globins17. The addition of phenylalanines in
MT-5 prevents water access to the heme while allowing for tight heme binding, preventing
heme loss and resulting in singular state spectra. By stopped-flow kinetic measurement of
the Q-band at 574nm, a near complete oxyferrous state formation with a lifetime of 22.4
seconds was observed for MT-5. This matches those observed for natural hexacoordinate
globins17,19,30 and is slightly longer than the 14 second lifetime observed for HD-329,31.
To confirm that the single-chain topology preserved the oxygen binding mechanism
of the candelabra construct, the b-position glutamates of MT-5 (positions 11, 18 and 25 of
each helix) were mutated to alanine residues, analogous to the variant made for HD-3. As
before, his variant failed to form a detectable oxyferrous state (Fig. 3.9).
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Figure 3.10: Enthalpic gain to oxygen coordination is vital to oxyferrous formation in bis-his bundles. Both
HD-3 (upper left) and MT-5 upper right) share the same mechanism of oxygen binding, unaffected by the
change in loop topology. Both depend on the bis-his ligation of heme being slightly frustrated by the
movement of glutamate residues on separate helices closer together and more towards the hydrophobic core,
which is partially relieved by the displacement of one of the axial histidines with dioxygen. Removing these
glutamates in either construct preserves heme binding but abolishes observable oxygen binding.

The lifetimes achieved by that of the best-performing bundles is on par with that of
natural hexacoordinate globins, and may represent a practical limit of what can be achieved
with that ligation. The next step would be to investigate pentacoordinate heme geometries
in analogous de novo constructs to assess the differences in oxygen binding they can afford.
The parallel-antiparallel scaffolds discussed so far cannot accommodate a pentacoordinate
heme; studies with the HM-1 scaffold show knocking out one of the axial ligands at a site
abolishes heme binding altogether. Tertiary structuring for this scaffold depends on
cofactor binding, which for heme requires a histidine on each participating helix.
Interestingly enough, zinc porphyrins, which only adopt pentacoordinate ligations, can still
be ligated to these single-his sites. What was needed was a scaffold that is well-structured
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in the apo state to begin to experiment with pentacoordinate ligations.

3.8 Development of a coiled-coil analogue of the Dynamic Di-Heme
Bundles
The next goal was to create a well-structured analog of the dynamic bundle, capable
of pentacoordinate binding, to be able to compare properties of heme and oxygen binding
between the two coordinations. To do so, design inspiration was taken from the cytochrome
b-like heme-binding portion of the MZH3 scaffold discussed in chapter 2. The resulting
two-site heme binding bundle, analogous in size and symmetry to HM-1, was called
DDH2.
DDH2 was kept as similar to the relevant MZH3 section as possible, in accordance
with the heptad repeat design strategy (Figure 3.11, Figure 3.12). DDH2 has helix caps and
loops in place of helical sections that in MZH3 continue onwards through the diironbinding section. In addition, the original zinc chlorin pigment site of MZH3 was converted
into a second heme binding site. Two a-position glycines in MZH3 were change to
alanines, because the helices are expected to be relatively flexible in that region of DDH2.
DDH2 is 135 amino acids long with a molecular weight of 14.99 kDa in the apo-state, an
extinction coefficient of 11,000 M−1cm−1 at 280 nm due to two tryptophan residues, and a
theoretical isoelectric point of 6.1, as estimated using the ExPASy ProtParam server.
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Figure 3.11: The design of DDH2 relative to the porphyrin-binding portion of MZH3.

Figure 3.12: 3D-modeled structure of DDH2, with backbone coordinates based on the crystal structure of
MZH3. Loops were modelled via MODELLER. Graphic rendered with PyMol 2.3.

DDH2 has properties that are very similar to the porphyrin binding section of
MZH3. DDH2 has high affinity for heme B, binds heme B in vivo, is stable, and shows the
same decrease in ellipticity at 222 nm upon binding heme. Therefore, the removal of the
Due Ferro section of MZH3 does not significantly perturb the structure or heme-binding
function of the tetrapyrrole-binding section of MZH3; both the tetrapyrrole-binding and
Due Ferro sections of MZH3 can function as standalone proteins. In effect, MZH3 can be
regarded as the joining of two separate functional proteins into a single fold. DDH2 is a
viable candidate for the testing of other functions performed by BT6/HM-1, including
electron transfer, energy transfer, and oxygen binding.
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3.9 Differential Ligations and Oxygen Binding in Coiled-Coil Bundles
With the proof-of-concept of a well-structured, coiled-coil heme protein in hand,
the next step was to determine what kinds of heme ligations the active sites could
accommodate. The MZH3 scaffold was used for these experiments instead of DDH2, for
several reasons. Heme incorporation, affinity measurements, and assessment of redox state
(for electrochemical and stopped flow experiments) all rely on UV-Vis spectra of the heme.
DDH2 has two spectrally identical heme binding sites, so any experiments based on
mutations to just one heme site would have to account for the spectroscopic contribution
of the bis-his heme. At the time, no one-site knockout mutants of DDH2 had been made
and compared to two-heme DDH2 to assess the independence of the two sites. MZH3, on
the other hand, had been shown to yield similar high-resolution crystal structures with or
without the central zinc tetrapyrrole. That is, MZH3 demonstrably folds into a stable
structure even with heme as the only spectroscopically active component.
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Figure 3.13: Viable heme-binding ligations achieved in the MZH3 construct by varying only the two ligating
residues, with examples of natural proteins employing the ligation whose chemistry might be modeled with
the construct.

The residues surrounding the MZH3 heme site were thus varied as part of a broader
project to explore what combinations of ligating residues a coiled-coil could support, with
a goal of seeing how altered ligations in isolation from fold changes affected properties
like heme affinity and midpoint potential (Figure 3.13)32. Two “his-ala” ligations, intended
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to bind heme in a pentacoordinate geometry, were included with particular interest in their
oxygen binding potential. These two MZH3 variants were identical proteins, except that
the positions of the ligating histidine and the opposing alanine were switched (Figure 3.14).

Figure 3.14: Axial views of models for the two MZH3 his-ala variants that form an oxyferrous state (middle
and right) relative to the original bis-his MZH3 that does not (left). The protein backbone is colored according
to the B-factor from the bis-his crystal structure, with red representing higher values/greater disorder, blue
representing lower values/lower disorder, and white representing intermediate values.

Both his-ala variants were capable of binding heme. What stood out is the
remarkable difference in oxyferrous lifetime between the two proteins. Whereas MZH3
H9A autoxidized quickly within seconds, MZH3 H110A had an oxyferrous lifetime of
nearly 38 hours, unprecedented in any engineered protein to date. Examination of the
original bis-his heme crystal structure provides some insight into this result. Overlaying
the B-factor on the protein structure reveals that the heme-ligating helices are not
equivalent. The N-terminal helix is far more dynamic relative to the third helix of the
protein. Having the oxygen binding site on the first helix results in a fast auto-oxidation,
whereas having it near the more structured helix confers a long-lived oxygen-bound state.
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In the absence of any hydrogen bond donor stabilizing the bound oxygen in MZH3 H110A,
it can be surmised that better solvent exclusion of the oxygen pocket relative to the MZH
H9A pocket is the dominant factor.
Given the dramatic difference observed in the two MZH3 variants, a series of four
DDH2 his-ala variants were constructed, where for each bis-his site, the two possible hisala ligations were tried while heme binding in the other site was “knocked out” by replacing
the two histidines with phenylalanines, which experiments with the parallel-antiparallel
bundles showed stabilized the bundle core similarly to a bis-his ligated heme as the same
position (Figure 3.15).

Figure 3.15: Thermal denaturation of alpha helical content of HM-1 constructs monitored as a loss of circular
dichroism at 222 nm. A: Tm of apo HM-1 (with 4 histidines across two heme binding sites) increases from
37 to 55 and 95 °C as the histidines are replaced by hydrophobic but relatively poorly-packing alanines (black
traced) and better-packing phenylalanines (red trace), respectively. B. The impact of binding one and two
equivalents of heme to two-site HM-1 (blue and red traces, respectively) and one equivalent of heme to
single-site HM-1 (green trace) relative to apo HM-1 (black trace).
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Figure 3.16: The design of single-site DDH2 variants from the initial two-site bis-his heme coordinating
protein. The two heme sites are not equal, with the “A” site displaying significantly higher pentacoordinate
heme affinities than the “B” site. All pentacoordinate variants exhibit fast autooxidation, with oxyferrous
lifetimes on the order of seconds or less.

Both DDH2a and DDH2b (Figure 3.16) have a high affinity for heme in the bis-his
coordination. Both single-site scaffolds tolerate “his-ala” pentacoordinate heme binding in
both orientations, although, as with MZH3, at a much-reduced affinity relative to their bishis analogues. A summary of the oxygen affinities of the various coiled-coil proteins is
given in Table 3.1.

Table 3.1: Oxygen affinities of the various coiled-coil oxygen binding proteins alongside those of natural

88

pentacoordinate globins.

3.10 Comparison of MZH3 H110A with DDH2 H72A
DDH2a H78A (site 2 knockout) is analogous to MHZ3 H110A, identical at the Nterminal side of the bundle (including the loop regions) and for three a-d layers interior of
the heme site. Despite this, DDH2a H78A’s oxygen affinity is two-fold weaker than that
of MZH3, and DDH2 auto-oxidizes quickly relative to MZH3. This implies that the distal
diiron-binding segment of the longer MZH3 protein has an impact on the solvent
accessibility of the heme site. It is possible that the shorter design of DDH2, though still
possessing an antiparallel topology, has a lesser degree of supercoiling in the tertiary
structure than does MZH3. This looser packing particularly in the interfacial regions may
allow easier diffusion of water molecules to the axial heme site.
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3.11 Conclusions
Work shows that forming an oxygen heme complex in aqueous systems is almost
completely independent of the protein scaffold. Work in the parallel-antiparallel bundles
indicates two requirements for stabilizing an oxyferrous state: a means for destabilizing
one of the axial coordinate bonds to promote oxygen coordination over outer-sphere
electron transfer, and exclusion of solvent to hinder the water/proton-mediated mechanism
of inner-sphere electron transfer from the iron to the oxygen. These two conditions are
necessary and sufficient for extending the lifetime of oxy-ferrous life ≥10,000-fold from
the sub millisecond regime to tens of seconds, on par with those natural hexacoordinate
globins characterized.
It is possible that oxygen-binders with hexacoordinate hemes in the unoxygenated
state have a practical upper limit on oxyferrous lifetime, independent of solvent exposure,
having to do with the kinetics of the mobile histidine. In a binding mechanism that relies
on the detachment of an axial histidine under thermal equilibrium to accommodate oxygen
binding, the oxygen-bound state must compete with histidine reattachment, the octahedral
geometry of which favors the Fe3+ state and thus promotes transfer of an electron to the
oxygen molecule as it departs. This is essentially unavoidable in the absence of a largescale allosteric structural change upon oxygen binding that would put the histidine-heme
interaction out of sampling range at ambient temperatures. The notion of an ever-weaker
axial ligation of the heme in the unoxygenated state facilitating longer lived oxyferrous
lifetimes provides an intuitive evolutionary path from hexa-coordinate to penta-coordinate
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globins. Any mutation that changed the tertiary structure in such a way that the axial
histidine coordination became more strained could significantly improve the oxyferrous
lifetime of the protein, which could correspond directly to survival outcomes. The “distal
histidine” of pentacoordinate oxygen-binders reflects a natural trajectory along this
evolutionary coordinate, which eliminates histidine reattachment completely by placing it
just beyond coordination range. Hydrogen bonding between the distal histidine and bound
oxygen in proteins like myoglobin may not be a crucial part of the mechanism, like
previously thought, but only a serendipitous relic of the actually crucial process of
removing axial ligand competition. This is supported by the observation of a 38-hour
oxyferrous lifetime in the pentacoordinate scaffold with no hydrogen bond donors in range.
The basic requirements for heme binding and observable oxyferrous formation in proteins
are surprisingly simple, and stabilization of the oxyferrous state from the sub-millisecond
to the seconds regime can be accomplished by introducing very basic restrictions to protein
motion to improve solvent exclusion. However, boosting lifetime from seconds to days
requires finer tuning of the packing and protein dynamics that become relevant on the
longer timescales of interest. Of course, every oxygen binding protein has to balance
improved solvent exclusion with the need to allow oxygen into and back out of the active
site.

3.12 Future Work
The original design and crystallographic characterization of MZH3 demonstrated the
modular nature of the bundle design, with each “section” of the bundle preserving the
integrity of its original isolated cofactor binding domain. A next step in testing the limits
of solvent exclusion in a four-helix bundle would be to create an elongated MZH3-like
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structure with the heme site identical to that of MZH3 H110A at the center and well-coiled
segments of protein on either end (Figure 3.17). With this new scaffold in hand, both hisala combinations should be retested to see if oxyferrous lifetime improves for either relative
to the original MZH3 scaffold. This would provide information on whether a combination
of positioning the heme away from the bundle terminus as well as potentially improving
interfacial helical packing near the heme site will yield a longer oxyferrous lifetime vis-àvis better solvent exclusion. This can be compared with the properties of “DDH3 H78A”,
a protein analogous to DDH2a H78A except that, instead of using two phenylalanines to
“close off” the second site, the second half of the protein has been packed tightly with
hydrophobic residues according to the coiled-coil packing strategy expressed earlier
(Figure 3.18). This design would isolate any would-be observed differences in oxyferrous
lifetime relative to DDH2a H78A to changes in the degree of supercoiling/inter-helical
packing, as the solvent exposure via the bundle terminus would be identical to MZH3
H110A and DDH2a H78A. These two proteins combined might represent the limits of what
can be achieved in terms of solvent exclusion in a four-helix bundle scaffold.

Figure 3.17: Concept for a yet-to-be-synthesized protein, “MZHZM”, involving an antisymmetric reflection
of the diiron binding domain about the heme binding site to enforce maximal left-handed supercoiling of the
bundle about the heme site.
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Figure 3.18: Structural models of DDH3 bis-his (A) and DDH3 H78A (B). Panel C presents a schematic of
the sequence for the DDH3 scaffold, with red boxes indicated the a/d core layers and bolded residues
representing the changes made relative to the DDH2 scaffold.
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Chapter 4 Redox Modulation II:
Photoinduced Flavin Activation
4.1 Flavin Chemistry in Biology
Flavins play a lead role in a diverse array of biological processes, which is a
reflection of their structural and chemical versatility1–3 (Figure 4.1). Flavins can be found
as both free water-soluble electron carriers (as flavin adenine dinucleotide, FAD) as well
as both non-covalently bound cofactors (FAD and flavin mononucleotide, FMN) and
covalently linked prosthetic groups (including derivatives of FMN) . Flavin cofactors in
their myriad contexts rival hemes in the diversity of reactions they can catalyze, facilitating
many of the one-and two-electron oxidation/reduction reactions critical to the four major
energy metabolism systems (photosynthesis, aerobic respiration, denitrification, and sulfur
respiration)4.

Figure 4.1: The proton-coupled redox equilibria of flavin cofactor. The ability of the isoalloxazine ring gain
or lose a total of two electrons and two protons between its fully oxidized and fully reduced states, coupled
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with being a light-activated chromophore, allow it to play diverse roles in enzymatic catalysis and radical
pair chemistry. Figures adapted from 5,6.

Many flavoenzymes are capable of catalyzing oxygenation reactions, such as
Baeyer-Villiger oxidations and aromatic hydroxylations, which are crucial for soil
detoxification processes7. Flavin-dependent halogenases are required for the biosynthesis
of a variety of halogenated natural products, many of which have therapeutic
potential8.Flavins are also involved in the photo-repair of DNA damage and in the
regulation of caspase independent apoptosis9,10. In addition, they are important components
of the blue-light sensing photoreceptors (cryptochromes) involved in the regulation of
biological clocks and development and in the generation of light in bacterial
bioluminescence11–13.
Free radical formation is central to the reaction mechanism of most flavin enzymes.
In biology, free radicals form and decay through the transfer of single electrons between
redox cofactors (e.g. flavins14, tetrapyrroles15 or metal clusters16), amino acids (e.g. Trp,
Tyr or Cys)4 and various substrates (e.g. O217, NO18, ribonucleotides19). Light activation of
cofactors is an important means of creating radical pairs, and most of the light-dependent
reactions catalyzed by flavins begin with excitation of the flavin chromophore by blue
light.
The primary class of proteins that mediate flavin photoactivation are known as the
photolyase/cryptochrome blue-light photoreceptors, a phylogenetically old lineage
represented in all kingdoms of life. Photolyases repair UV-induced photoproducts in DNA,
and cryptochrome blue-light photoreceptors (often just referred to as “cryptochromes” and
abbreviated CRY) use the energy from blue light to regulate a variety of growth, circadian,
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and adaptive responses in organisms, ranging from prokaryotes to humans. Despite the
diverse in their downstream chemistry and signal transduction mechanisms, all these
enzymes initially depend on the photoexcitation of the flavin component of an FAD
cofactor, which subsequently oxidizes a chain of three tryptophans and results in a radical
pair across singly-reduced semiquinone flavin and an oxidized tryptophan residue20.

4.2 Cryptochromes, Flavin Activation, and Magnetic Sensing
Though quite diverse in their ultimate biological functions, all cryptochromes and
photolyases share a vital upstream mechanism whereby a blue photon excites a flavin
chromophore that then acts as an electron sink to draw electron flow away from a series of
aromatic amino acids. In particular, an evolutionarily conserved structure consisting of a
series of tryptophan residues is believed to be important in creating several spheres of
electron transfer, whereby direct electron transfer between the photoexcited flavin and the
closest tryptophan is followed by ET between the first and second closest tryptophan, and
then again between the second and the third (Figure 4.2). This is believed to be important
for increasing the lifetime of the charge-separated state long enough for the next phase of
the catalytic cycle to occur, by increasing the distance between the unpaired electrons and
creating an uphill energetic barrier to recombination.
Cryptochromes have garnered increased interest since they were first proposed to
be the basis for magnetic field sensing exhibited by some animals, notably birds. The
radical-pair hypothesis of magnetic sensing in animals proposes that this flavin-tryptophan
radical pair can undergo spin mixing effects under the influence of an external magnetic
field which would significantly alter the lifetime of radical pair. If structured in an
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anisotropic array and coupled to some as-of-yet unidentified downstream signaling
mechanism, the cryptochrome could provide the physical means through which an
organism can sense the orientation of a magnetic field as weak as Earth’s. A detailed
overview of the radical-pair hypothesis of magnetic sensing and proposed biological
implementations can be found here21.

Figure 4.2: Structural alignment of the conserved tryptophan cascade of members of the
cryptochrome/photolyase protein family. Shown are the structures of Escherichia coli CPD photolyase (blue)
(PDB entry: 1DNP), Thermus thermophilus CPD photolyase (red) (PDB entry: 1IQR), Drosophila
melanogaster (6-4) photolyase (gray) (PDB entry: 3CVU), Arabidopsis thaliana cryptochrome-1 (orange)
(PDB entry: 1U3D), Synechocystis sp. PCC 6803 Cry-DASH (yellow) (PDB entry: 1NP7), and A. thaliana
cry3 (Cry-DASH, brown) (PDB entry: 2J4D). For X. laevis CRYD, the conserved tryptophans are TrpA ≡
W400, TrpB ≡ W377, and TrpC ≡ W324.Adapted from 22.

More than just an isolated curiosity, exploring the basic mechanism of magnetic
field sensing and how it integrates up multiple scales of biological organization, and
developing the techniques and strategies necessary to do so, opens up completely new
territory in the life sciences and physical sciences alike. What follows is a bit of theory to
provide a basis for understanding the connection between magnetism and chemical
reactivity, and aid in the interpretation of the following experiments.
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4.3 Magnetism and the Electron: Radical Pairs and Spin Chemistry
The magnetism we observe in matter, from atomic nuclei to molecules and bulk
materials, arises from the fundamental physical property of elementary particles called
“spin”23,24. In the classical (though misleading) conceptualization of an electron as a
rotating charged sphere moving around a nucleus, spin corresponds to the rotational
angular momentum, distinct from the orbital angular momentum of its motion relative to
the nucleus. In reality, spin is an intrinsic property of a elementary particle, like charge and
mass, that is characteristic and invariant. Particle spin and its discrete nature was
experimentally demonstrated for electrons in 1922, in the famous Stern-Gerlach
Experiment. Here, a beam of paramagnetic silver atoms shot through a deflecting magnetic
field split the beam into exactly two trajectories25, demonstrating that the spatial orientation
of angular momentum for atomic matter was quantized.
The mathematics of the quantum field theory underlying the true reality of particle
spin is complicated, much of it with no satisfying physical conceptualization yet attached.
For the purposes of chemistry, however, a simple vector model will suffice. Spin can be
represented by the vector s associated with its quantum number s. For the fermionic
particles of ordinary matter26, which includes electrons, s = ½. The magnitude of s is
quantized and can be expressed as:
|𝑠| = √𝑠(𝑠 + 1)ħ

(𝐸𝑞. 4.1)

where ħ is the reduced Plank constant. For mathematical simplicity, s can be projected onto
an arbitrary axis z, representing an axis of measurement. Here, electron spin is represented
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by the spin projection quantum number, ms (-s, -s +1, …, s – 1, s ), where ms has 2s+1
allowed values. An electron with s = ½ can thus take on two values of ms relative to an
external magnetic field: +1/2 (“spin up” or ↑) when aligned with the field or -1/2 (“spin
down” or ↓) when aligned against it.
As a product of its intrinsic spin and charge, an electron also has an intrinsic
magnetic moment μs:
μ𝐬 =

g e μB 𝑠
ħ

(𝐸𝑞. 4.2)

where ge = 2.002319304 and is the dimensionless proportionality constant for a free
electron (or g-value), s is the spin quantum number, and μB is the Bohr magneton, the
natural unit for expressing an electron’s magnetic moment. The Bohr magneton is derived
as:
μB = −γe ħ =

𝑒ħ
2𝑚𝑒

(𝐸𝑞. 4.3)

Where -γe is the gyromagnetic ratio of an electron (the ratio of its magnetic moment to its
angular momentum), e is the elementary charge and me is the mass of an electron. The zcomponent of the electron’s magnetic moment is given by:
μz = g e μB 𝑚𝑠

(𝐸𝑞. 4.4)

Like ms, μz has two allowed values for an electron. If no external magnetic field is
present, the two states are “degenerate”, meaning they are equal in energy. However, when
an external magnetic field is present, the energy of the aligned spin state is lower than that
of the anti-aligned state, and the formerly degenerate energy level for the electron is “split”.
This magnetic field-induced energy level splitting is referred to as the Zeeman Effect.
In the classical treatment, the energy of this splitting depends on the magnetic
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moment (μ) and the external field (B):

E = −𝛍 ∙ 𝐁

(𝐸𝑞. 4.5)

The corresponding quantum mechanical treatment entails solving the Hamiltonian
(the energy operator) for the system:
Ĥ = −û ∙ 𝐁

(𝐸𝑞. 4.6)

Where û is the magnetic moment operator. In the specific case of the electron,
combining equations 4.2 and 4.3 yields:
Ĥ = −û𝐳 ∙ 𝐁 = −g e γe ŝ 𝐁

(𝐸𝑞. 4.7)

Where ŝ is the electron spin angular momentum operator. For the component of spin
projected along the z axis of interest:
Ĥ = −û𝐳 ∙ 𝐁 = −g e γe ŝ𝐳 𝐁

(𝐸𝑞. 4.8)

The solutions for ŝz (“eigenstates” in linear algebra parlance) are known to be ms ħ. The
energies of the states are thus:
Ems = −g e γe 𝑚𝑠 ħ𝐁 = −g e μB 𝐁

(𝐸𝑞. 4.9)

With the energies of the spin up and spin down states being:
E=±

1
g 𝛍 𝐁
2 e B

(𝐸𝑞. 4.10)

And the energetic difference between the two states being:
ΔE = g e 𝛍B 𝐁

(𝐸𝑞. 4.11)

The mathematical treatment so far is only complete for an isolated electron in
vacuum, experiencing only the applied magnetic field B. In matter, electrons exist in
atomic or molecular orbitals where additional magnetic fields arise from “motion” (i.e.,
possessing orbital angular momentum) relative to the nucleus and spin-spin interactions
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with other electrons. Both contribute to “local” Zeeman splittings of a particular electron’s
energy, which are difficult to compute and usually approximated by modifying the ge to
an effective value of geff.
In the simplest case of two unpaired electrons in an energy well (e.g., a neutral
helium atom with one excited electron), the total spin of the system (S) is given by the
vector sum of the individual electron spins:
𝐒 = 𝒔1 + 𝒔2

(𝐸𝑞. 4.12)

S = |𝑠1 − 𝑠2|

(𝐸𝑞. 4.13)

With allowed magnitudes of:

In this system, s1 = s2 = ± ½, so the possible values of S are 0 or 1. As in the single
electron case, the projection of S on to the z axis yields Ms (note the capitalization of “M”
to distinguish the spin of the system from the spin of the single electron). When S = 0,
Ms= 0; this system has one possible spin projection and is thus known as the “singlet state”.
If S = 1, Ms can take on values of -1, 0, and 1; this system has three possible spin
projections, and is accordingly known as the triplet state (Figure 4.3).

Figure 4.3: Two electrons, each of which has spins=12, can combine their spin angular momenta s1and s2 to
build a pair with total spin S= 0 or a pair with total spin S= 1. In the first case, the pair is in a spin-singlet
state (shown on the left).In the second case, the pair is in one of the three possible spin-triplet states: with
spin projection Sz= 0,±1(shown on the right). The pairs with Sz=±1 are called “equal-spin” pairs with respect
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to the spin quantization axis (here, the z-axis). The spin state |S,Sz〉is fully characterized by the two quantum
numbers Sand Sz. We use a spin-vector representation to visualize pair angular momenta, where the
expectation value of the cosine of the relative angle between the two spin vectors within a pair,〈
S,Sz|s1·s2|S,Sz〉/√s12s22, is−1 for singlet states, and 1/3 for triplet states. Thus, angular momenta can be
visualized as antiparallel for singlet pairs, whereas for triplet pairs they enclose in average a relative angle
of≈70.53° (even for “equal spin” pairs). Figure adapted from reference 27.

This method of treating an “electron system” works equally well for unpaired
electrons across two different molecules as it does for those within a single molecule or
atom. Such systems arise in redox chemistry involving organic molecules that generally
have no unpaired electrons in their ground state. When an acceptor molecule oxidizes the
donor molecule, each molecule becomes a radical (i.e., a species containing an unpaired
electron).
Since these two radicals are formed simultaneously, the spin of the system is
conserved and the radicals are spin-correlated. Again, this radical pair system can be in
either the singlet or the triplet state.
The allowed values of Ms (spin projections for the system) can be represented
through a vector model with a length of
3
2

ħ=√

(4.14)

(from substituting s = ½ into Equation 1.1). Each spin in the system is precessing along the
axis of magnetic field B (Fig. 1.2)28. The cone that is traced out represents the possible
states of the combined angular momenta. The rate of the precession (the Larmor Frequency,
ωL) is dependent on the energy gap of the Zeeman Interaction:

ΔE = ħ𝜔𝐿 = g e 𝛍B 𝐁
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(4.15)

𝜔𝐿 =

g e 𝛍B 𝐁
ħ

(4.16)

In the singlet (S) state, the two spins are antiparallel to each other and their resultant
angular momentum is zero. In the triplet (T0) state where Ms = 0 the spins are ~ 70.5
degrees to each other and their momenta still cancel out to zero. In the other triplet (T1 and
T-1) cases the vectors lie in the same directions and their resultant sums to 1. The two spins
in the system precess at slightly different rates, since the two electrons are in different
environments and thus each experience a different effective B. In general, the magnetic
environment of a particular electron is affected by magnetic interactions with other
electrons (termed “fine interactions” in spectroscopy) as well as interactions with nearby
magnetic atomic nuclei (termed “hyperfine interactions”)29. In radical pair systems, the
“dipolar interaction” is specifically used to describe magnetic dipole interactions between
the two unpaired electrons. In organic radical pair systems, the primary magnetic nuclei
(capable of contributing to hyperfine interactions) are 14N and 1H. Differential precession
of each electron ultimately allows for the singlet state of the system to transition to the
triplet state (as vice versa), as process known as intersystem crossing.
Another important piece of physics is the “exchange interaction” which, generally
applies to all pairs of identical particles encompassed by the total wavefunction of a system
(e.g., all electrons in a many-electron system). The exchange interaction is a quantum
mechanical phenomenon affecting all pairs of identical particles, and arises from the deep
algebraic properties of nature. In practical chemical terms, when two electrons have
parallel spin (triplet state) a node in the center of their joint probability distribution forms
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(making them less likely to be near each other in space), whereas when they have
antiparallel spin (singlet state) an anti-node in the center of their joint probability
distribution forms (making them more likely to be near each other in space). This difference
in spatial probability distribution doesn’t by itself entail a difference in energy. However,
the additional consideration that electrons are charged leads to two unpaired electrons in
the singlet state experiencing greater coulomb repulsion in the singlet state than in the
triplet state, lowering the energy curve for the triplet state. This means it is generally
energetically favorable for radical pairs, which are generally created in the singlet state, to
intersystem-cross to the triplet state if their lifetime allows for it.
The last bit of relevant theory is represented by spectroscopic selection rules, which
arise from applying the Born–Oppenheimer approximation and Fermi’s Golden Rule to the
simplification of the QED Hamiltonian. The spin selection rule dictates that electronic
transitions that would require a simultaneous change in multiplicity (to satisfy the Pauli
Exclusion principle) are “forbidden”. This means that relaxation of an excited triplet state
to a singlet ground state is many orders of magnitude slower (if observable at all) than the
relaxation of the corresponding excited singlet state to the singlet ground state.
We are now finally equipped to discuss the influence of external magnetic fields on
radical pair kinetics. In addition to the molecular magnetic fields experienced by the
unpaired electrons, an external magnetic field can interact with the spins of the T-1 and T1
states of the triplet system and alter their precession rates. This “lifts” the degeneracy of T1 and T1, changing their energy relative to S, and thus altering the probability of a spin flip
(Figure 4.4 A). In a low strength magnetic field situation, the T-1 and T1 states split
slightly, putting T1 in resonance with S (and T-1 further out of resonance) increasing the
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likelihood of a spin flip from singlet to triplet than in the absence of an external magnetic
field. This would lead to a radical pair to have a longer lifetime (Figure 4.4 B) as charge
recombination from the triplet state is forbidden. In order to recombine, the radical pair
would have to intersystem-cross back into the singlet state. This extension of lifetime is
referred to as the “low field effect”.
If a higher strength field is applied, the triplet T-1 and T1 states split even further
out of resonance with S, making a spin flip to T energetically unfavorable. Charge
recombination is then favored as spin multiplicity is conserved. This is referred to as the
“high field effect”.
The mechanism of magnetic field- mediated spin mixing depends on the strength of
the applied field (Figure 4.4 C). In a lower field regiment, the hyperfine mechanism
dominates, whereas at higher field strength the Δg mechanism is responsible. The hyperfine
mechanism is based on the differences in hyperfine interaction that each radical “feels”
from its molecule. The external field combines with these local fields and altering the rates
of precession on the spins resulting in a greater likelihood of spin flip. At a higher field
strength, the small, previously negligible, differences in the g values of each electron
(which are reflective of the local fields each electron feels from its spin orbit coupling and
or coupling to other electron spins) come into play and are able to alter electron precession
(ωL) and induce a spin flip:
∆𝜔𝐿 = ∆

g e 𝛍B 𝐁
ħ

(4.17)

These spin mixing effects have been observed in radical reactions since the late
1960’s30–32 and are of growing interest in contemporary chemical and material science
research33. Similar radical pair chemistry is currently believed to be the physical basis of
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biological magnetic sensing, in a signaling mechanism facilitated by cryptochrome
proteins14.

Figure 4.4: A general model of the radical pair mechanism between a donor (D) and acceptor (A). A) The
effect of the magnetic field upon the triplet states of a radical pair. If no magnetic field is present the three
triplet states are effectively degenerate. In a low field states T1 and T-1 are split, putting T1 in resonance
with S, allowing for more interaction and spin mixing, thereby effecting the charge recombination rate of the
radical pair. As the field increases, T1 and T-1 are further split becoming less in resonance with S than in the
presence of no field, this again affects spin mixing and radical pair lifetime. B) The photo-physical scheme
of the radical pair mechanism. The acceptor (or donor) becomes photo excited to the singlet state. It can
fluoresce (fl) back to the ground state or oxidize (ET) the donor (or acceptor) to form a spin correlated radical
pair with its partner in the singlet state. The singlet radical pair will then mix to the triplet state with some
efficiency. The rate of this spin mixing (SM) can be affected by an external magnetic field. The singlet can
decay to ground state via charge recombination (CR), while the triplet cannot as it is “spin forbidden”. Since
the external magnetic field will alter the single-triplet population, it can affect the lifetime of the radical pair.
Also the radical pair can eventually lose spin correlation (DP) and the individual radicals can decay or react
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separately (E CR). C) A depiction of the magnetic field effect as a function of field strength. The magnetic
field strengths at which the low and high field effects occur are highlighted. At ~mT fields the effect is
facilitated by the Hyperfine Interaction, at ~T strengths the Δg mechanism dominates. Interconversion of the
singlet and triplet states of a simple radical pair. The fraction of radical pairs in thesinglet state is plotted as
a function of time (0 ≤ t ≤ 2 μs) starting with a singlet state at t=0.

4.4 Standing Questions Regarding the Radical Pair Mechanism
The singlet/triplet spin dynamics of the FAD•- /Trp•+ radical pair are frequently
proposed as the source of cryptochrome magnetic sensitivity. Experiments with natural
cryptochromes and photolyases have shown a magnetic field dependence for the lifetime
of the flavin semiquinone state, but only ever under cryogenic conditions (-15C and %50
glycerol). Despite the interest in flavin-based radical chemistry of the cryptochrome family,
however, it remains difficult to provide experimental confirmation of the myriad associated
hypotheses. This stems from the complexity and marginal stability of wild-type
cryptochrome proteins. It is often difficult to express and purify the fragile proteins in
quantities adequate for most experimental techniques, and even so generally lack the
necessary stability to maintain structural integrity under ambient aqueous conditions. It is
even more difficult to make extensive mutations to the active site without disrupting the
protein fold, which complicates analysis since there are many redox-capable organic
groups near the active site that may compete with tryptophan in electron transfer.
There are thus several basic chemistry question, currently unanswered, that could be
addressed in a minimally designed system:
Is it possible to observe a magnetic field effect in a flavin protein at ambient
conditions (room temperature in aqueous solution)?
In a flavin protein, is a single tryptophan as the only nearby redox-active center
sufficient to form an observable radical pair with the flavin upon photoexcitation?
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If so, is it the kinetics of radical pair formation and decay that is sensitive to the
applied magnetic field?
If so, how does the magnitude of the MFE of this minimal system compare to that
observed for natural cryptochromes?
In this project, we set out to create a minimal “cryptochrome” in a four-helix bundle
scaffold to address these initial questions and create a experimental platform for further
exploration (Figure 4.5).

Figure 4.5: A: Drosophila melanogaster cryptochrome vs B: minimal cryptochrome model in the parallelantiparallel bundle.

4.5 Cryptochrome Functionality in a Parallel-Antiparallel Bundle
To take advantage of the existing characterization of the parallel-antiparallel
bundles in the heme binding work, the basic sequence of the flavin binding bundle was
kept as similar to HM-1 as possible (Figure 4.6).
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Figure 4.6: Repurposing the HM-1 scaffold for flavin binding. Amino acid changes are shown in bold in the
SHF sequence.

The design changes included switching out the tryptophans at the 3rd position of
each helix with glutamines, and replacing the histidines at the 6th position of each helix
with core-packing phenylalanines. The interior alanine at the 9th position of helix 2 was
substituted with a cysteine, to which a flavin derivative could be coupled. The final product
constituted the control protein, which could covalently bind a flavin but lacked any
potential redox partners. The first three variants of this design had the core-facing residue
one, two, or three heptads away from the cysteine mutated to a tryptophan to serve as the
sole redox partner for the photoactivated flavin. These variants were termed W13, W16,
and W20 based on their residue position on the second helix of the protein (Figure 4.7).
After attachment of the flavin, the protein molecular weight was ca. 15 kDa, the exterior
charge was −12 at pH 7.5, and the pI was 4.22. Genes encoding for these sequences were
synthesized and recombinantly expressed in E. Coli. All proteins were soluble and
expressed in similarly high yield.
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Figure 4.7: Design of the parallel-antiparallel flavin-binding scaffold SHF. A: Axial schematic view of the
de novo flavin protein with a flavin (orange) and a tryptophan residue (green) positioned in the core of the
four-helix bundle: B: Sequential core positions adjacent to the site of flavin attachment available for mutation
to a tryptophan residue, located one(0.56 nm, W13), two (1.12 nm, W16), or three (1.68 nm, W20) helical
turns away from the flavin. C: Modeled structure for the flavin-only control protein, D: W13, E: W16, and
F: W20.

Building a binding site into a protein for a flavin is not as straight-forward as it is
for heme. Natural flavin enzymes that non-covalently bind FAD as their cofactor often do
so via a Rossman or “Rossmanoid” fold, which binds the nucleotide portion of the molecule
rather than the isoalloxazine ring. However, roughly 10% of naturally occurring flavin
enzymes do make use of a covalent linkage between the flavin-containing cofactor and the
protein, some directly between an amino acid side chain and an adduct of the isoalloxazine
ring. In earlier studies with the dimeric bundle assemblies, Sharp et al successfully reacted
an N-acetyl-flavin derivative with a cysteine’s thiol group to covalently bond it to the
peptide. For the sake of simplicity and minimizing steric bulk in the protein interior, it was
desired to minimize the presence of additional functional groups (like adenine in FAD). In
addition, a shorter covalent linker than the N-acetyl group was desired the limit the range
of motion of the flavin within the protein. For this project, we used 8C-bromoriboflavin,
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which can be attached to a protein via a straight-forward nucleophilic substitution reaction
(Figure 4.8).

Figure 4.8: Reaction conditions for the covalent coupling of the riboflavin derivation to the protein. 5-fold
molar excess of the flavin was mixed with apo protein with 6M guanidinium HCl and 1mM TCEP, pH
adjusted to 9.0. Incubating in the dark at 55 C overnight with gentle stirring was sufficient for ≥90% flavin
incorporation. The flavoprotein product was purified from unreacted flavin and apo protein via HPLC.

UV-Vis spectroscopy was used to validate designs. Before flavination, a typical
feature of the W series proteins was the tryptophan absorption at 280nm. Having the
cysteine coupled directly to the ring system of the flavin at the 8-position shifted the
electronic properties of the oxidized form of the flavin compared to free 8-halogenated
riboflavin or non-covalently attached flavins (e.g., riboflavin or FAD), with the fully
reduced spectrum remaining essentially unchanged. Significant band shifts included the
S0→S1 transition (444 nm to 475 nm) and the depletion of the S1→S2 361nm feature. The
attachment to the cysteine also increased the extinction coefficient of the S0→S1 transition
from 11,300 M-1cm-1 to 24,640 M-1cm-1, in line with what has been observed for 8mercapto coupled flavins (Figure 4.9)34.

4.6 Characterization and Quality Control
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Figure 4.9: Absorption spectra of the apo-protein (gray), the oxidized “ground state” of 8-bromo-riboflavin
precursor (black), and oxidized (blue) and fully reduced (orange) control holo-protein.. Normalized emission
spectra of the same control flavoprotein (green, fluorescence; red, phosphorescence) are also shown.

Circular dichroism measurements confirmed the thermal stability and secondary
structure of the four designs, which were similar to previously characterized parallelantiparallel bundles. UV-vis HPLC traces and MALDI mass spectrometry confirmed the
covalent incorporation of the flavin. The fluorescence of the covalently-bound flavin
showed no solvatochromic shift in different protein designs, suggesting that the cofactor
experiences similar environments (Figure 4.20). Additionally, the tryptophan fluorescence
maxima are blue-shifted relative to the free amino acid, implying that the tryptophan
residues are located well within the hydrophobic core of the protein. The redox potentials
of the flavin and tryptophan indicate a favorable driving force for light-activated electron
transfer in the protein. The fluorescence quantum yield is greatest for the tryptophan -free
control and W20 and decreases with decreasing distance between the chromophore and the
115

Trp. This is consistent with time-correlated single photon counting measurements: the
initial fluorescence intensity was comparable in all designs, but the fluorescence lifetimes
decreased with decreasing flavin- tryptophan separation. This indicates distance-dependent
quenching of the flavin fluorescence in the presence of tryptophan, consistent with electron
transfer involving the excited singlet state of the flavin.

4.7 Examining Radical Pair Kinetics with Transient Absorption
Spectroscopy
The photochemistry of the proteins was investigated further by nanosecond
transient absorption (TA) spectroscopy (Figure 4.10 A). There is a broad ground state
bleach in the range 400−500 nm and a strong excited state absorption at 500−650 nm
consistent with the rapid formation (≪1 μs), by photoinduced electron transfer, of a [F•−
TrpH•+] RP35, in which the F•− radical is covalently bound to a protein at the 8-position
of the flavin ring system36. In the control protein and in W20, only a weak absorption band
was observed at 500−800 nm with a lifetime of 17 μs, assigned to the triplet excited state
of the flavin37. Formation of the RP should be possible in W20; however, intra-protein
electron tunneling rates usually drop by a factor of approximately 2300 for every 0.56 nm
added by the turn of the α-helix. Electron transfer in W20 (estimated in Table 1 for a
donor−acceptor separation of 3 α-helical turns) is unlikely to compete with other excited
state deactivation pathways, and was not observed. The flavin radical dominates the
transient spectra of W13 and W16 because the extinction coefficients of Cys-bound flavins
are substantially higher than those for free flavins. From a comparison with electronically
similar flavins, the spectrum in Figure 3A appears to be the result of partial protonation of
the flavin radical to form the neutral FH• species around pH 7. The absorption of the Trp
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radicals occurs at very similar wavelengths and cannot be resolved independently.
However, based on the pKa for TrpH•+ (4.3)38, deprotonation is expected to form the
neutral Trp• radical. Both W13 and W16 have similar lifetimes for the RP, on the order of
several microseconds. This is shorter than observed in Cry proteins39, but sufficiently long
that MFEs can be generated and observed.

Figure 4.10: Simplified schematic of a transient absorption spectrometer. A temperature controlled, stirred,
sample is excited by a blue laser. At some delay after laser excitation, a light source is fired and the resulting.
UV Vis spectra is recorded at a detector. A non-laser excited spectrum is then subtracted from the laser
excited spectrum showing the difference spectrum. Schematic of the CRDS apparatus used to measure MFEs
asa function of PPD time (t), probe wavelength (λ), and magnetic field strength (B). The differential
absorbance (ΔA) is determined as a function of the ring-down times measured with (τ) and without (τ0)
photoexcitation. The timing of the system is computer controlled using a delay generator.

4.8 Measuring Magnetic Field Effects
To measure the MFE, TA spectra were taken in the presence and absence of a 20
mT magnetic field at 298 K. The action spectra [ΔΔA = ΔA(20 mT) − ΔA(0)] of W16 and
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W13 match the spectral shape of the excited state absorption between 500 and 650 nm. The
negative field effect observed in the ground state bleach and positive effect in the excited
state absorption are expected if the RP forms via the triplet excited state of the flavin. No
MFE was observed for W20, consistent with the absence of RP signals in the TA spectrum.
Likewise, the control protein showed no measurable MFE, further supporting the view that
there is no magnetically sensitive intra- or intermolecular chemistry in the absence of a
tryptophan residue. After excitation, a fraction of the excited flavin (1F*) undergoes
intersystem crossing (ISC) to form the excited triplet state (3F*). The primary spincorrelated RP, denoted RP1, is formed as a triplet by electron transfer from the Trp to the
excited triplet flavin. RP1 can undergo S−T interconversion induced by electron−nuclear
hyperfine interactions. In the presence of a strong field, the Zeeman interaction removes
the degeneracy of the triplet RP energy levels, reduces the efficiency of spin-mixing, and
leads to an MFE. Protonation of the flavin radical or deprotonation of the Trp radical
creates the secondary radical pair, RP2, observed in our TA measurements, which
eventually returns to the ground state. The fractional MFEs [(ΔA(20 mT) − ΔA(0))/ΔA(0)]
for W13 and W16 are comparable, but the absolute magnitude [ΔA(20 mT) − ΔA(0)] is
smaller for W13. This probably results from competition between singlet- and triplet-born
RP formation in W13, where the smaller flavin-tryptophan distance leads to a faster
forward electron transfer that competes with ISC. Rapid formation of a singlet-born RP is
consistent with the increased quenching and shorter fluorescence lifetimes observed by
TCSPC. However, the positive MFE indicates that formation of the RP must also occur via
the triplet route. Singlet photochemistry is not observed on the microsecond time scale
because charge recombination rapidly returns the singlet RPs to the ground state. Charge
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recombination is initially spin-forbidden for triplet-born RPs which, therefore, have a
longer lifetime and contribute more strongly to the MFE. The Triplet-dominated
photochemistry in these proteins is in direct contrast to Cry, which forms an RP from the
singlet excited state. This is not surprising: ISC is certainly faster in flavoproteins than in
Cry because of increased spin−orbit coupling due to the cysteine’s sulfur atom being
directly attached to the flavin ring system. Additionally, for W16 and W20, electron
transfer rates are probably slower than those observed in Cry.

Figure 4.11: Kinetic traces obtained from TA experiments on SHF W16 at 520 nm demonstrating the
difference (blue) between measurements with the field on (red) and field off (black).

However, the difference in the spin state of the excited flavin leading to the RP does
not affect the ability of the proteins to serve as a model for elucidating the principles of
efficient protein-based sensing of magnetic fields. In fact, triplet-born photochemistry is
arguably advantageous for such a simple model system. Given the short distances and large
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driving force in W13 and W16, the singlet RP is expected to undergo rapid charge
recombination. The triplet spin state stabilizes the RP in the proteins, while natural proteins
must rely on physical separation of the charges using an electron transfer chain or
conformational changes to achieve the same end. The extension of the RP lifetime in the
proteins due to its triplet spin state allows the observation of a room temperature (298 K)
MFE of ∼16% at 20 mT on a microsecond time scale (Figure 4.11), comparable in
magnitude to that of Arabidopsis thaliana Cry-1 or E. coli photolyase (12−17% at 28 mT)39.
Such large MFEs in natural systems are only observed at reduced temperatures (-15 °C and
below) and in the presence of large amounts of glycerol.
Low field effects in the milliTesla regime and below are dominated by hyperfine
interactions to the point of the ΔG mechanism (arising from differences in spin-spin and
spin-orbit coupling) being negligible (Figure 4.4 C). As a result, Earth-strength magnetic
fields cannot significantly affect a radical-pair reaction if there are no hyperfine
interactions in either radical. Conversely, the nuclear magnetic environment of the radical
pair defines the spin mixing properties of the system as a whole. Since EPR measures the
energy gap between spin states in systems with one or more unpaired electron (i.e., the
degree of Zeeman splitting), which are in turn affected by hyperfine interactions, EPR
spectra can serve as “fingerprints” for the chemical identity of a radical or radical pair.
Figure 4.12B shows the EPR signal (averaged over 10 µs post-excitation) for SHF W13,

which corresponds to the Flavin •- /W •+ radical. This is virtually the same as the trEPR
spectrum collected for the DmCry protein (Figure 4.12A), which confirms the chemical
identity of the functional radical pair in natural cryptochromes as the flavin-tryptophan
pair (as opposed to nearby adenine, tyrosine, and histidine groups that potentially offer
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competing electron pair pathways). Furthermore, the EPR data confirm that the key
magnetic properties of the radical pair in cryptochromes are preserved in our model
system, despite the sulfur in the covalent linkage lowering the energy of the primary
electronic transition.

Figure 4.12: A: transient EPR experimental data (red trace) of DmCry WT, with overlaid simulated spectrum
(black trace). Adapted from 40. B: transient EPR experimental data (black trace) of SHF W13. Spectra were
recorded at 274 K at a microwave frequency of 9.67 GHz.

4.9 Ultrafast Kinetic Analysis of single-W Series
The TA experiments that confirmed the magnetic field effect in the single
tryptophan bundles were limited to a microsecond resolution. While microsecond transient
absorption studies confirmed magnetic field sensitivity characteristic of a triplet-borne
radical pair, fluorescence quenching was inversely proportional to flavin-tryptophan
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separation, and it was proposed that the quenching
mechanism was electron transfer from the flavin singlet
state. It was an open question as to why, even in the
shortest flavin tryptophan spacing with the highest
degree of quenching (the W13 protein), the radical pair
lifetime was observed as long as a microsecond,
especially

given

the

large

driving

force

to

recombination. Ultrafast studies were needed to resolve
the excited-state quenching mechanism as well as the
potentially different roles played by possible singlet and
triplet-borne radical pairs.
To this end, protein samples were pumped at 420
nm and the transient spectra recorded between 425 nm
and 715 nm at delay times of 0.2 ps to ~3.5 ns at 25 oC
(Figure 4.13). In all designs, the absorption spectra were
dominated by two negative transients (450 nm and 560
nm) and three positive transients (500 nm, 525 nm, and
700 nm). Assignment of these transients to excited
electronic states of the Cys ligated RFL begins with the
simpler control protein. Because this report is the first
Figure 4.13: The time resolved transient absorption spectra of the flavoproteins. The flavin in the protein samples
was excited at 420 nm using a fs Ti:sapphire laser. Each trace represents the spectra observed at the delay time
after excitation indicated in the inset. The four panels from the top describe W13, W16, W20 and control,
respectively. The bottom panel shows the steady state absorption and fluorescence of the control protein.
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ultra-fast study on 8-Cys coupled RFL, ultrafast spectra of FMN9,10, FAD11 and
cryptochrome12 provided useful proxies for assignment of spectral features. The persistent,
negative signal about 450 nm, was attributed to the ground state bleach (GSB). At earlier
time points this bleach band appears narrowed by some positive singlet-excited-state
absorption (ESA). At 560 nm a negative signal was observed that red shifted after ~10 ps
and eventually crossed zero between 0.5-1 ns. Transients in this region include both singlet
stimulated emission (SE) and triplet absorption. The broad absorbance feature at 700 nm,
clearest at ~3.2 ns, was attributed to the RFL triplet13.
Although these transient absorption features were observed at similar wavelengths
in all four designs, their time evolution varied significantly. The simplest kinetic analysis
involves selecting wavelengths that are dominated by the major difference absorbance
features. The absorbance changes at 450 nm monitored the flavin GSB (Figure 4.14A).
Excited singlet SE was examined at 560 nm. To remove interfering absorption from triplet
dynamics, a suitable reference wavelength at 500 nm with comparable triplet absorption is
subtracted (Figure 4.14B). The excited triplet absorbance was monitored at 700 nm,
subtracting a reference wavelength of 500 nm where both singlet and triplet difference
spectra undergo little change (Figure 4.14C).
In the control, and in W20, little GSB recovery was observed in the first 50 ps
(<10%, Figure 4.14A). The broadening and redshift of this bleach signal is attributed to
the decay of excited singlet state absorption (Figure 4.13). In W16, the GSB had a similar
broadening and red shift along with a ~25% single exponential recovery (τ = 5 ps) that
remained stable after ~30 ps. In W13, the GSB was the broadest and resembled the steady
state absorbance the most. The GSB recovered ~75% as a double exponential (τ1 = 5 ps
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relative amplitude = 0.42, τ2 = 60 ps relative amplitude = 0.58) that remained stable after
~200 ps.
The SE feature underwent a 5 nm redshift from 555 nm to 560 nm in the first 10 ps
(Figure 4.13). The redshift was most obvious in the control and W20, but still observable
in W16 and W13. 420 nm laser excitation is about 50 nm blue of the flavin S0→S1
absorption maxima (Figure 4.13, bottom panel) and appears to create a hot singlet state that
vibrationally relaxes on this timescale. The SE transient, a proxy for singlet decay, was
slowest in the control (τ = 840 ps), followed by W20 (τ = 800 ps), W16 (τ = 615 ps) and
fastest in W13 (τ = 140 ps, Figure 4.14B). SE decay in W13 can be explained equally well
by a double exponential (τ1 = 30 ps relative amplitude = 0.57, τ2 = 260 ps relative amplitude
= 0.43).
The triplet transient formation roughly mirrored the singlet decay (Figure 4.14C).
Formation was slowest in the control (τ = 1300 ps), followed by W20 (τ = 890 ps), and
fastest in W16 (τ = 730 ps). The low signal amplitude and triplet yield in W13 prevented a
fitting. A summary of the kinetic data is given in Table 4.1.

Figure 4.14: The time evolution of spectroscopic states of the four flavin proteins: W13 (red), W16 (green),
W20 (blue) and the control (black). The fitting parameters are summarized in table 1.A: Ground state bleach
of flavin cofactor. Time points were taken from 1 ps to ~3.2 ns in a 20 nm window about 450 nm (440-460
nm). W13 was fit with a double exponential while W16 was fit with a single exponential. W20 and the control
could not be reliably fit with either function B: Stimulated Emission of the flavin cofactor. Time points were
taken from 25 ps to ~3.2 ns in a 20 nm window about 560 nm (550-570 nm) and referenced to a 20 nm
window about 500 nm (510-490 nm). All series were fit with single exponentials (solid line). W13 was also
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fit with a double exponential (dashed red line). C: flavin cofactor triplet feature. Time points were taken
from 25 ps to ~3.2 ns in a 20 nm window about 700 nm (710-690 nm) and referenced to a 20 nm window
about 500 nm (510-490 nm). W16, W20 and the control were fit with single exponentials. W13 noise levels
are too large for an accurate fit.

Table 4.1: The kinetic parameters of the single wavelength fits of the bleach and or dual wavelength fits of
the triplet and stimulated emission in the flavin proteins. Each column contains the 1/e time (τ) of the fit
and the r2 coefficient to assess quality of fit.
Design

Bleach
450 nm
τ / ps

r2

Control
W 20
W 16
W 13

No Fit
No Fit
5±1
5 ± 2 (0.48)
60 ± 10 (0.52)

N/A
N/A
0.89
0.99

Stimulated
Emission
560 nm – 500 nm
τ / ps
840 ± 35
800 ± 10
610 ± 40
140 ± 20
30 ± 40 (0.57),
260 ± 35 (0.43)

r2

Triplet
700 nm - 500 nm
τ / ps

r2

0.99
0.99
0.99
0.97

1300 ± 470
890 ± 45
730 ± 50
No Fit

0.93
0.99
0.99
N/A

0.99

4.10 Global Analysis and Fitting of Spectra
To complement the analysis of individual wavelengths and resolve the multiple
spectrally overlapping components, full data sets (intensities over all times and
wavelengths) were fit using a global SVD analysis. The magnitude of the SVD singular
values indicate 3-4 spectrally and kinetically distinct components above the background
noise (Figure 4.15). Fitting of the dimensionally reduced data to a four-state sequential
kinetics model show that the first state transitioned rapidly (τ <10 ps) to the second state,
and the second state to the third state (τ ≈ 0.8 ns; Figures 7-10). Relaxations between any
of the three states to a spectrally silent fourth state required fitting to τ’s outside of the
experimental window (~3.2 ns) of the instrument. The four components were assigned to
the following species; vibrationally hot flavin singlet (1F*hot), vibrationally relaxed flavin
singlet (1F*cool), flavin triplet (3F*), and ground state (F). Oxidized tryptophan will have
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relatively small difference spectrum changes relative to the flavin.

Figure 4.15: Global analysis fit to a four-state sequential model for A) the flavin-only control, B) W20, and
C) W16. The four-state sequential model fails to adequately describe W13. Upper panels: The sequential
kinetics model with fit time kinetic time constants. Fluorescence and phosphorescence rates are not well
defined on this timescale. Lower Panels: Time course of the model populations.

The homogeneous four-state sequential kinetic model was adequate to describe the
data in the Control, W20 and W16. However, it fails to fit the third SVD component of
W13. To simplify consideration of more complex kinetic models, we restricted kinetic
model fitting to times longer than 8 ps, so as to remove the initial hot flavin singlet. In this
analysis, SVD also revealed three components, albeit with different spectra and time
evolutions. Band shifts in the 470 nm region around 100 ps could plausibly arise from
either a heterogeneous branched or parallel kinetic model.
In a branched model (Figure 4.16A), the vibrationally-cooled excited flavin
branches into two populations: flavin triplet, and observable flavin/Trp radicals. The triplet
persists beyond the experimental window, while the radical pair recombines to ground state
in ns.
In a parallel model (Figure 4.16B), there are two discrete populations of
vibrationally-cool excited flavin. One population is able to participate in transfer with
126

tryptophan (1Fa*) while the other is not (1Fi*). The electron-transfer competent population
transiently populates a charge-separated state (Fa•−) that does not persist but rapidly relaxes
to the ground state (F). The electron-transfer incompetent population proceeds to the flavin
triplet (3Fi*) that persists beyond the experimental window, eventually relaxing to the
ground state.

Figure 4.16: A: In the branched kinetic model for W13, the vibrationally relaxed flavin singlet (1F*) branches
into a semiquinone flavin (F•−) and then to ground (F), or to the triplet (3F*) and then to ground. Fit log rates
and branching ratios indicated. B: In the parallel kinetic model for W13, two excited singlet state populations
(1Fa* and 1Fi*) evolve separately: one to a short-lived semiquinone flavin (F•−) and then to the ground state
(F); another to the triplet (3Fi*) and then to ground. Fit log rates and population ratios indicated. Lower
Panels: Population of the four states for the respective models in log time. Log times of transitions and
populations are indicated in the top panel.

A global fit of the broad spectral changes of the flavin-only control protein to a
homogenous -four state kinetic model corroborates the single or dual wavelength analysis
and describes the evolution of three visible states. The first state, identified as a hot excited
singlet rapidly relaxes (τ = 7 ± 2 ps) to a second state, identified as a red-shifted and
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vibrationally-cooled singlet. This evolution shows a similar extent and timescale to other
flavin systems41,42. The expected transition to a third state, the triplet, at 1.0 ± 0.3 ns is
faster than the ~6 ns intersystem crossing (ISC) rate of non-covalently bound FMN43. The
faster ISC is similar to that of flavins found in LOV domains44,45. In both cases the spinorbit coupling between the flavin’s ring system and a nearby or attached cysteine sulfur
(heavy atom effect) is believed to accelerate the ISC46.
As expected, W20, with the greatest flavin-tryptophan separation resembled the
flavin-only control protein both in the single/dual wavelength kinetic analysis and during
the global fitting. With a donor/acceptor distance close to the Cβ separation of ~16.8 Å and
a driving force of ~1.2 eV (vs. SHE at pH 7.5), electron tunneling between the cofactors is
expected to be on the microseconds timescale (Figure 12), too slow to be observed in these
measurements.
W16 on the other hand, displays radical pair kinetics on the ultrafast timescale.
Electron transfer is the most plausible mechanism to explain the ~25% recovery of the
GSB, given the near identical biophysical properties across all designs, save the
tryptophan-RFL proximity. However, the 11.2 Å distance between Cβ anchoring the RFL
and tryptophan, is predicted to result in electron transfer outside the 3.5 ns window of this
experiment21.

4.11 Conclusions for the Single-W Variants
In accordance with the transient spectroscopy performed on slower timescales, we
propose that protein fluctuations slower than 100 ns leads to dynamic changes in the
distance between the redox centers. Considerable protein motions, (especially of Trp
residues) are known to affect electron-transfer rates in flavoprotein BLUF domains47.
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Molecular dynamics simulations predict similar motion in Arabadopsis cryptochrome48.
With long axis redox center dimensions of 8 and 5 Å for the RFL and tryptophan
respectively, the donor and acceptor could in principle sample edge-to-edge distances from
van der Waals contact to ~17 Å (Figure 4.17). Even a 5 Å change in distance between
flavin and tryptophan would lead to a 1000-fold change in electron-tunneling rates.
Rotations about Cβ of both the flavin and the tryptophan could be responsible for the
cofactors assuming a number of different conformations relative to each other, only a
portion of which are in electron-transfer position. Therefore, upon light activation, a
population of cofactors in proper position would be able to transfer electrons from the
singlet state on the ultrafast timescale. Subsequent charge recombination over the same
distance with a similar driving force will be rapid with little accumulation of this
intermediate. The remaining cofactors would evolve unperturbed to the triplet state. All of
these observations are consistent with a homogenous four state model of the kinetics in
W16.

Figure 4.17: Proposed rotation-induced differences in the flavin tryptophan distance in the flavin proteins.
In this example, W16 has an 11.2 Å, estimated distance between the Cβ of the riboflavin-ligating cysteine
and the tryptophan. However, since the redox-center dimensions of ~8 and ~5 Å for riboflavin and
tryptophan, respectively, are comparable to Cβ anchor-point separation, it is plausible to adopt conformations
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from Van der Waal’s contact to 17 Å edge-to-edge distance.

Analogous conformations are apparent with W13. Here, the closer proximity of
flavin and tryptophan permits ~70% of the electron transfer to occur from the singlet state,
consistent with observed GSB recovery. The faster kinetics requires a more complex model
than the sequential four-state model used for other designs. Two heterogeneous branched
and parallel models were tested, with the parallel model deemed superior for three reasons:
1) the indicated spectra of the charge-separated state produced in the branched model did
not resemble any known flavin or tryptophan radical spectra; 2) the driving force for radical
pair formation and recombination was the same in W13 as the other designs, and should
not lead to appreciable accumulation of charge separated state; and 3) the spectral
differences between electron-transfer competent and incompetent excited singlet flavin in
the parallel model are consistent with different flavin environments and provide a plausible
explanation for the different kinetic pathways. The red-shifted excited singlet flavin may
be more exposed to water49 and extend away from the tryptophan, which would lead to
slower electron tunneling and support more ISC to the triplet state. From the triplet state,
it can form a magnetically sensitive radical pair. At longer times, the radical pair can
recombine in competition with triplet phosphoresce. This photochemistry scheme is
summarized in Figure 4.18.
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Figure 4.18: A kinetic model of the dynamics and electron transfer in the flavin proteins. The flavin absorbs
a photon to a hot excited singlet state that cools in ps. Depending on the separation between flavin and
tryptophan, the singlet may undergo electron transfer to create a singlet-borne radical pair or undergo
intersystem crossing in less than 1 ns to the triplet with a concomitant loss of fluorescence. The triplet-excited
flavin may form a triplet-borne radical pair or phosphoresce if the tryptophan is too distant. Triplet-borne
radical pair can interconvert between the singlet and triplet state in a magnetic field-dependent fashion.
Singlet radical pairs can charge recombine, while triplet radical pairs may persist long enough for
microsecond protonation.

This work validated the feasibility of four-helix bundle flavin proteins as a robust
and adaptable testbed for manipulating radical pair lifetimes and increasing the magnetic
field sensitivity and directional sensing. Moving forward, designs placing two tryptophans
at close and intermediate positions should facilitate conversion of the triplet-borne radical
pair to a longer-lived singlet-borne radical pair. Moreover, this should be facilitated by an
advantageous redox-potential gradient introduced by varying the solvent exposure of the
tryptophans, similar to that seen in natural cryptochrome chains. In addition, it is
reasonable to substitute non-tryptophan electron donors with smaller or larger hyperfine
interactions to test predicted changes in magnetic field sensitivity48. This includes
flavin/tyrosine radical pairs invoked in some natural proteins50.
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4.12 Extended Variants of the SHF Scaffold
In order to test these hypotheses, a series of new variants of the SHF scaffold were
made (summarized in Figure 4.19), with placement of the new and additional redox active
amino acids based on the original three positions on helix 2 (13,16, and 20). The “two
tryptophan” designs had the first tryptophan at the 13 or 16 position with the second
tryptophan at the 16 or 20 positions, yielding, W13W16, W13W20, and W16W20. The
single-tyrosine mutants placed an individual tyrosine at each of the original tryptophan
positions, yielding Y13, Y16, and Y20. The possibility of a tyrosine being able to act as a
terminal-donor of an electron transport chain was also explored, with tryptophan proximal
to the flavin at either position 13 or 16 and tyrosine at a distal position of either 16 or 20
(yielding W13Y16, W13Y20, and W16Y20).
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Figure 4.19: New variants of the flavin-binding SHF bundle designed to probe tyrosine reactivity and electron
transport chain functionality. The original three single-W variants (top left), with well-characterized positions
and environments relative to the flavin, provide a good starting point for new designs as they provide a direct
point of comparison for future characterization.

It was furthermore of interest to move beyond the “core” positions of the scaffold
and explore the extent to which the solvent exposure of the tryptophan could be varies. To
this end, additional single-tryptophan variants were made, along the section of helix 2
flanked by the W13 and W20 positions, that together placed tryptophan at every possible
position in the heptad. Tryptophan is a fluorescent molecule, the emission spectrum of
which can be shifted by its environment/chemical neighbors if it provides variable
pathways for vibrational relaxation post-excitation and pre-emission. This notion of
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chemical environment extends to solvent as well, for which the general ability of solvent
to affect the UV-vis spectra of dyes or fluorophores is termed the “solvatochromic effect”.
Free tryptophan dissolved in water or aqueous buffer has a peak emission at 357 nm after
excitation at 280 nm, whereas when dissolved in dioxane (an organic solvent with a very
similar polarization to the bulk protein medium) the peak emission is at 331 nm (a 26 nm
shift). Peak emission can thus be used as a proxy for the degree of solvent exposure of a
tryptophan in a protein. Figure 4.20 shows the results of the fluorescence experiments for
each of the apo single-W variants. The results are in agreement with the general design of
the bundle, with “core” residues at the a and d positions in the helix having peaks very
similar to that of monomeric tryptophan in dioxane, whereas the intervening residues that
rotate out towards the bundle exterior exhibit peaks similar to monomeric tryptophan in
water.
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Figure 4.20: The “tryptophan-scanning” experiment in the SHF scaffold. Left vertical panel shows the
location of the tryptophan at each position relative to the flavin-linking cysteine residue. The graph displays
the peak emission wavelength (after excitation at 280nm) for the tryptophan of each variant as a proxy for
solvent exposure, relative to that of free (monomeric) tryptophan in solutions of dioxane and water. Yellow
shading indicates a water excluded environment, blue indicates a water exposed environment, and green
indicates an interfacial environment, or a time-averaged sampling across both water-excluded and waterexposed environments.

This prompted the design of two additional two-tryptophan variants: W13W18 and
W16W18. Each of these designs started with W13 and W16, whose magnetically sensitive
radical pair forming chemistry was previously validated, and then added a tryptophan at
the 18 position, which solvatochromism confirmed to be one of the most solvent exposed
positions. Figure 4.21 shows the results of the solvatochromism assay for these two
proteins alongside the previous three two-tryptophan designs (with both residues in corefacing positions). Both W13W16 and W13W20 retain the solvent excluded environment
for both of their tryptophans, whereas W16W20 exhibits some increase in average solvent
exposure. Both W13W18 and W16W18 display an average peak emission between the
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values obtained for W13/W16 or W18 alone, indicating that the SHF scaffold tolerates
having two tryptophan mutations.

Figure 4.21: Tryptophan solvatochromism experiments of the double-tryptophan mutants compared to the
single-tryptophan proteins.

W13W18 and W16W18 (in addition to all the designs described in Figure 4.19) were
flavinated and analyzed via pump-probe transient absorption spectroscopy, as previously
described for W13, W16, and W20. Detailed kinetic analyses of the data and comparison
of the variants are yet forthcoming; however, all five of the double-tryptophan designs
exhibit radical pair formation and display a magnetic field effect. Of particular interest is
the differential behavior of W1318 and W16W18. W13-W18 shows a loss of the
percentage MFE consistent with a loss of the species carrying the magnetically sensitive
signal (Figure 4.22). The overall percentage MFE for W16-W18 remains constant (or even
potentially continues to grow) over this same timescale.
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Figure 4.22: A: MFE transient absorption measurements of W13W18 and W1618, with a magnetic field of
25 mT. A: W16-W18 exhibits an MFE of 14.7% at a 1.1 us delay time measured at 470 nm and 19.1%
averaged from 7-8.7 us. B: W13-W18 exhibits an MFE of 18.8 % at a 1.1 us delay time measured at 470 nm,
or 8.45% averaged from 6.6-8.7 us. C: W13-W16 reaches the maximum of the MFE ddA in the ground state
bleach at an earlier time, and decays away faster than W16-W18. D: W16-W18 and W13-W18 exhibit
qualitatively different behaviour in their percentage MFE over time. W13-W18 shows a loss of the percentage
MFE consistent with a loss of the species carrying the magnetically sensitive signal. The overall percentage
MFE for W16-W18 remains constant (or even potentially continues to grow) over this same timescale.

The series of flavin-tyrosine bundles were made in the interest of exploring tyrosine radical
chemistry and electron transfer, as tyrosine may contribute to competing electron transfer reactions
(alongside adenine and histidine) in natural cryptochromes/photolyases, or play an important role
as a terminal electron donor in the cryptochrome mechanism. All six tyrosine-containing constructs
illustrated in Figure 4.19 express well as highly alpha helical proteins. Detailed spectroscopic and
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kinetic analyses of these constructs are forthcoming; however, initial comparisons of the ultrafast
TA and MFE data between the Y16 protein and the original W16 protein already provide useful
insight into the relative behavior of the two amino acids. Qualitatively, the kinetics of radical pair
formation in W16 and Y16 are very similar (Figure 4.23B and D). For Y16, there was a less

pronounced difference between the Bon and Boff cases in terms of the observation of the
protonation step, and a smaller magnetic field effect of approximately 10% of that seen for
W16. This could be due to intrinsic differences between the radical pair identities, or a
result of decreased competition between the protonation step and back electron transfer in
the Y16 protein.

Figure 4.23: Comparative behavior of the SHF Y16 and W16 constructs. B and D show the UV-vis difference
spectra after flavin excitation at 450nm for Y16 and W16, respectively. A and C show the ΔA at 587nm
(corresponding to flavin radical species) over time.

4.13 Creation of coiled coil flavin binding protein
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As illustrated in Figure 4.17, the uncertainties in cofactor conformation and edgeto-edge distance inherent to the structurally dynamic scaffold naturally lend to the aim
creating a well-structured flavin-binding analog of the SHF bundle. The goal was to create
a coiled-coil bundle with a flavin binding pocket near the bundle terminus that would
restrict the possible conformations of the cofactor once covalently linked to the protein via
the cysteine.

To do so, design inspiration was taken from the success of creating

DDH2/DDH3 from the MZH3 scaffold, and the resulting molecule was called FMK3.

Figure 4.24: The design of the FMK3 scaffold. A: “Snaked” schematic diagram of the protein sequence, with
red outlines indicating and a-d core layer and bolded residues showing mutations made relative to the DDH2
scaffold. B: Modeled structure of the holo form of the FMK3 flavin-only control protein. C: Modeled
structure of the holo form of the FMK3 F17W I85A single-tryptophan protein.
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The basic design of FMK3 with respect to bundle length and loop design was kept
similar to DDH2 (Figure 4.24). The changes consisted of the second “half” of the bundle
(the side of the protein opposite the peptide termini) being tightly packed with size
complementary hydrophobic residues (leucine, isoleucine, and valine) according to the
coiled-coil packing strategy discussed in chapters 2 and 3. Particularly in the second layer
from the left (Figure 4.24A) the histidines where replaced with leucines, and residue 128
was changed to a cysteine for flavin incorporation. Finally, the tryptophans at positions 63
and 132 were replaced with glutamines. FMK3 is 135 amino acids long with a molecular
weight of 15.05 kDa in the apo-state and a theoretical isoelectric point of 5.19, estimated
using the ExPASy ProtParam server51.
Two versions of this construct were initially created, one with the cysteine only and
another with an interior tryptophan at position 17 (replacing a previously existing
phenylalanine) at the isoleucine at position 85 replaced with an alanine to complement the
size of the tryptophan. Position 17 was chosen for the tryptophan due to steric similarities
of phenylalanine and tryptophan, which should minimize potential folding differences
between it and the cysteine-only control. The expressed protein is soluble, reacts with
flavin under the same conditions as SHF, and retains the flavin following HPLC
purification. Circular dichroism confirms a highly alpha helical structure similar to DDH2.
Tryptophan quenching of flavin fluorescence indicates tryptophan is within range of flavin,
and provides a strong constraint for the flavin being anywhere other than the intended
pocket (i.e., not facing out towards solution or sitting between a helical interface)(Figure
4.25).
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Figure 4.25: Comparison of the quenching of flavin fluorescence by tryptophan between the SHF and FMK3
scaffolds. FMK3-W17 shows a degree of quenching intermediate to that of SHF-W16 and SHF-W20.

Following confirmation of the design, and series of single-tryptophan mutants
spanning the length of a heptad (and centered on the W17 variant) were generated and
expressed, analogous to the tryptophan-scanning experiment described for the SHF
scaffold. This was followed by similar fluorescence solvatochromism measurements to
assess whether single tryptophan mutations at various positions affected the
structure/orientation of the helices. In short, the peak emissions of the single tryptophan
mutants relative to each other are as expected. W17 (the initial tryptophan-containing
protein) as well as W20 (the next core position along the same helix) are in solventexcluded environments (Figure 4.26). W14, W15, W18, and W19, each of which are in
interfacial or solvent-facing positions in the design, accordingly display redshifted
emission peaks. “Close W”, or W124, is on the same helix as the flavin-attaching cysteine
in the next a-d core position towards the center of the helix, and as expected occupies a
solvent excluded environment. It is interesting to note that, in the FMK3 designs, the coreposition tryptophans possess fluorescences that are blue shifted even relative to the dioxane
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control (relative to SHF, where core tryptophans had peak emissions near or slightly to the
red of the dioxane control). This may reflective of a more rigid tertiary structure where,
beyond good solvent exclusion, modes of vibrational relaxation involving through-bond
motion and torsion may be restricted (relative to SHF).

Figure 4.26: The “tryptophan-scanning” experiment in the FMK3 scaffold. The graph displays the peak
emission wavelength (after excitation at 280nm) for the tryptophan of each variant as a proxy for solvent
exposure, relative to that of free (monomeric) tryptophan in solutions of dioxane and water. Yellow shading
indicates a water excluded environment, blue indicates a water exposed environment, and green indicates an
interfacial environment, or a time-averaged sampling across both water-excluded and water-exposed
environments.

4.14 Conclusions
These protein constructs suggest that there is greater latitude for the design of
magneto-sensitive flavin-tryptophan radical pairs than observed in currently characterized
cryptochromes. This work has addressed the initial hypotheses surrounding cryptochrome
chemistry:
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•

It is possible to observe a flavoprotein-born magnetic field effect under ambient
conditions.

•

A single tryptophan is sufficient as an electron donor for forming a cryptochromelike magnetically sensitive radical pair (as characterized by EPR).

•

The magnitude of the MFE in the single-tryptophan constructs is comparable to that
observed in natural cryptochromes.
To date, all magneto-sensitive radical pairs in obtained in cryptochromes contain

singlet-borne radical pairs21. Chemically synthesized systems often show magnetically
sensitive triplet-borne radical pairs52,53. The dominance of singlet-borne cryptochrome
radical pairs may reflect an evolutionary legacy from photolyase-like precursor designs54,
reinforced by the reliance on FAD as the light-activated cofactor. FAD carries the inherent
“threat” of unproductive electron transfer from the adenine ring to the excited flavin
nucleus when in the “stacked” conformation55. Minimizing this side reaction would put
selective pressure to maintain a tryptophan residue in near contact with the flavin nucleus
resulting in rapid electron transfer from the excited flavin singlet state.
Slower electron transfer from a more distant tryptophan to an excited flavin triplet
would not be protected from adenine electron transfer thereby effectively quenching flavin/
tryptophan radical pair formation. This is not an issue for the adenine-free FMN in natural
flavoproteins containing LOV domains, nor for the riboflavin derivative used in the SHF
scaffold. Since these proteins demonstrate the practicality of triplet-borne radical pair
activity and magnetic sensitivity, a search among natural FMN-binding proteins may
uncover unsuspected triplet-borne radical pair dynamics in natural systems Additionally,
triplet-borne radical pairs may shed some light on the proposed function of superoxide
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generation in magnetic sensing56; the positive or negative effect of which is yet to be
determined.

4.15 Future Work
The studies performed to date on cryptochrome MFEs, both in natural proteins and
designed constructs described here, have all relied on “isotropic” experiments. That is, the
samples for the various spectroscopy experiments described have consisted of randomly
oriented proteins in solution. MFE measurements made in this manner are inherently low
signal-to-noise, for two reasons. The first is that only flavin molecules whose excitation
dipole is lined up with the polarization of the incoming photon will absorb effectively,
meaning there’s a distribution of absorbing proteins among the total in solution that will
interact with the directionally incident light. Furthermore, the radical pair mechanism is
dependent on the angle of the incident magnetic field (both in theory and in experiments
of animal behavior. Thus, in an isotropic experiment, only a further subset of the
photoactivated flavin centers experience a maximum effect on their spin mixing rates when
an external field is applied. This poses problems for further experiments on might want to
perform of a cryptochrome model, related to how the full biological sensing mechanism
involving the proteins might actually work. Nearly any conceivable magnetic sensing
structure would have to involve a strong ordering of the cryptochrome centers along at least
one spatial dimension, in order for the organism to gain sensitivity down to the 50 µT of
Earth’s magnetic field and for the associated neural pathways to be able to calculate the
field inclination. Figure 4.27 illustrates one of many hypothetical schemes by which
cryptochrome proteins (which have been found to be expressed in the avian retina) could
be structured as part of a larger magnetic sensing organ.
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Figure 4.27: Hypothetical illustration suggesting how the avian double cones could be responsible for lightdependent magnetoreception. (a) Double cones consist of two closely attached cone cells. (b) It is possible
that the opsins in the outer segments of the photoreceptor cells are arranged in parallel rows of dimers at
night (but not during the day) like those recently found in mouse rod cells under low-light conditions57. If the
cryptochromes were attached to such dimer tracks, they could be highly oriented within the disk membranes
and therefore respond in unison to the direction of the magnetic field. If these tracks were oriented at 90° to
each other in the two halves of any given double cone, this could form the basis for an opponent processing
pathway similar to the ones known for color vision in vertebrates and polarization vision in insects 58,59. For
instance, a 0° “off ” bipolar cell could receive input from a number of 0° members of the double cones,
whereas a 90° “on” bipolar cell could receive input from a matching number of 90° members of the same
double cones. These bipolar cells could project onto a bistratified compass ganglion cell, which would then
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send the information to the rest of the brain for further processing. There are many other processing designs,
which could for instance involve two “on” bipolar cell types and one inhibitory amacrine cell type, which
could lead to the same opponent processing function. (c) As an alternative to a location between the outer
segment disks, the cryptochromes could also be associated with the highly directed inner segment
membranes. This would have the advantage that the cryptochromes would not have to compete with opsins
for the incoming photons. Adapted from reference21.

The desired capacity for oriented experiments with cryptochrome centers has not
been feasible in the past; due to fragile nature of natural cryptochromes (even in vitro under
ambient conditions) being incompatible with the modifications and conditions necessary
to make a practical oriented protein assembly. However, now that the essential physical
chemistry of the cryptochrome reaction center has been reproduced in stable four-helix
bundle constructs, which have been demonstrated to be conducive to layer formation, it
should now be possible to create ordered “cryptochrome” arrays and proceed with
informative anisotropic experiments.
The follow set of experiments are thus proposed as a possible strategy (illustrated in Figure
4.28):

Figure 4.28: Proposed scheme for oriented MFE measurements.
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1. Take one of the MFE-validated bundle constructs, or another design yet to be
characterized, and orient the proteins using the Langmuir-Blodgett technique to create
multilayers on quartz slides (approximately 12.5 mm by 25 mm dimension). Make slides
with 5, 10 and 20 multilayers to see which dimensions give the best compromise between
thickness and structural integrity.
2. Check for linear dichroism of the flavin’s blue and near-UV absorption bands using a
cube polarizer in a spectrometer.
3. at the same time, use a linear dichroism-enabled spectrometer for more refined spectral
dichroism measurements as a function of the angle between the probe beam and quartz
substrate, and then correlate this angle dependence with the flavin transition dipoles and
estimate the orientation of the flavin transition dipole with respect to the quartz substrate.
In the past, the helical axis of the bundles had been nearly, but not exactly, normal to the
substrate when LB films are deposited at high surface pressure.
4. See if can modulate the absorption (or emission) of the flavin with applied magnetic
field. Use a lock-in amplifier reference frequency connected to an amplifier to apply a
sine-wave modulation of Helmholtz coil magnetic field. Feed back the output of a PMT
or diode detector to the lock in amplifier. See if there is any modulation of the absorption
or emission signal at the reference frequency that can be correlated with greater or lesser
interconversion between singlet and triplet states with magnetic field. There are two angles
to be changed: the angle between the probe beam and the substrate & the angle between
the magnetic field and the substrate. It would likely be valuable to vary both of these, as
well as the amplitude of the applied magnetic field.
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Chapter 5 Modularity Scalability, and
Biocompatibility
5.1 Transitioning to Synthetic Biology: Interfacing Natural and Nonnatural Proteins
Synthetic biology is a new, rapidly growing field that has emerged as a crossdisciplinary effort among life scientists, physical scientists, and engineers. Broadly, the
field has two complementary goals, reminiscent of other disciplines as they began to
mature from discovery-focused practices into their respective applied sciences: To improve
understanding of biological systems through mimicry and recapitulation of natural
structure and function, and to apply that knowledge to produce new bio-orthogonal systems
with novel functionality. As was the case with naturally evolved protein sequences at the
biochemical level, complexity in nature at the cell and cellular component level is
astounding. This complexity stems from a hierarchical organization of biomolecular
components with multiple layers of interactions between them, with each layer subject to
its own versions of Muller’s Ratchet, Darwinian multiple utility, and marginal stability.
Fortunately, many aspects of both the components and their interactions are becoming
increasingly understood as their corresponding scientific fields continue to rapidly
advance.
Synthetic biology efforts vary in both the level of organizational hierarchy they
tackle as well as how much they deviate from what exists in nature (Figure 5.1); these two
parameters can be thought of as mapping out a “synthetic biology space” in which
developments from various traditional disciplines can be plotted. For example, at the high153

complexity nature-based level, geneticists might try to construct a “minimal genome” out
for a self-replicating cell from existing natural genes, whereas at the low-complexity
highly synthetic level, chemical biologists and organic chemists may make characterize
biomimetic polymers using non-naturally occurring monomers. The fields of protein
biochemistry and protein engineering fall under intermediate values for both dimensions,
encompassing “tecton design” with the basic principles of secondary and tertiary structure
formation and leading up to correctly folded functional holoproteins.

Figure 5.1: An outline of synthetic-biology space. A few of the routes currently being explored are mapped
according to the position in the natural hierarchy from which the work stems and the level of divergence from
nature that is being attempted. The fields of protein biochemistry and protein engineering are outlined within
the dotted boundary. In combination with novel enzymes and an encapsulation mechanism, a complete path
from basic natural building units all the way to synthetic, functional cell-like entities may be charted.
Adapted from reference191.

The framework outlined in Figure 5.1 is useful in two respects: First, it frames the
ultimate goal of synthetic biology of creating multi-component, encapsulated, functional
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systems. Second, it highlights how a variety of seemingly uncoordinated efforts from
different traditional disciplines at different levels of hierarchy can actually be grouped into
a small number of general approaches, and how successes in one “allied field” become
enabling for more advanced research in others.
For protein engineers, the design of stand-alone, aqueous proteins that fold and
function as intended can thus be considered the first milestone in a greater journey of
biomolecular design towards the goal of being able to engineer large-scale,
multicomponent, and functional biomolecular assemblies. The forthcoming design targets
include inter-protein and inter-macromolecular interactions (beyond the “self-interaction”
of homo-oligomers), the formation of protein complexes/supramolecular assemblies, the
reliable folding and integration of membrane proteins, and ultimately control over
interaction and signaling networks that incorporate all of these elements.
In order for design at the biomolecular level to ultimately integrate with synthetic
biology efforts starting at different levels hierarchy and nature-divergence, it is necessary
to investigate how engineered proteins, particularly de novo-designed constructs, interact
with the pre-existing cellular machinery. The following studies apply variants of the
unstructured single-chain heme-binding scaffold (introduced as HM-1/BT6 in chapters 2
and 3) to probe the interactions of this class of minimally-designed four helix bundles with
three different bacterial membrane complexes: The twin-arginine translocase (Tat) system,
the general type II secretion system (Sec), and the cytochrome c maturation complex
(Ccm).

5.2 The Tat Transporter System
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Figure 5.2: Prokaryotic quality control of a nascent polypeptide during its voyage to one of two primary
translocons, Sec and Tat. SecA maintains quality control by assisting the cytoplasmic folding of
nontransported polypeptides. Sec substrates that retain an extended conformation, such as through interaction
with SecB (d), are efficiently transported. However, if prefolding of a Sec substrate occurs (e), the protein is
degraded in the cytoplasm or else can become jammed in the translocon. For a subset of preproteins destined
to the Tat translocon, association with a chaperone (f), such as DnaK or other Tat-specific factor, likely
shields the signal sequence until folding is completed. This same factor or an additional factor may also
promote correct folding and serve as a first layer of proofreading prior to translocation. Tat transport proceeds
only if the Tat substrate is correctly folded; otherwise transport is aborted, and the substrate is degraded by
proteolytic machinery (g). Figure adapted from reference192.

The transport of proteins across membranes is one of the great challenges faced by
the cell and the synthetic biologist alike. In prokaryotes, two major pathways are used to
achieve protein translocation across the cytoplasmic (inner) membrane (Figure 5.2). The
Sec system transports proteins in an unfolded configuration using energy provided by both
ATP hydrolysis and the transmembrane proton gradient193. In contrast, the twin-arginine
translocase (Tat) system transports fully folded proteins194,195 and is energized solely by
the transmembrane proton gradient. The majority of Tat substrates are cofactor-containing
proteins that require assembly in the cytoplasm196–198 including those that fold too quickly
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for Sec transport199 and those that assemble into oligomeric complexes200. Proteins
translocated by the Tat pathway have an N-terminal signal sequence characterized by a
twin-arginine (RR) motif201; the signal sequence is cleaved from the precursor protein
during or immediately after translocation, releasing the mature protein into the periplasm.
How components of the Tat machinery assess the folding state of a protein substrate
remains poorly understood198,202,203. A quality control or proofreading mechanism could
exist to prevent futile export of misfolded or misassembled proteins204–206. In E. coli, the
Tat apparatus comprises TatA/B family proteins and the TatC protein (Figure 5.3). Single
point mutations in either TatA or TatC were identified that allow both TatB and TatC
enabled export of a broader range of unfolded substrates, suggesting that the TatABC
subunits cooperatively assess the folding state of proteins independently of protein
translocation

207

. Richter et al.208 showed that small, unstructured hydrophilic FG repeat

proteins could be exported by the Tat system, and that the presence of hydrophobic surface
patches was sufficient to abort transport, raising the possibility that the Tat system screens
proteins based on their surface hydrophobicity. It has been reported that the length of the
unstructured FG repeat polypeptide dramatically affects Tat export, with longer regions
abolishing Tat export altogether

209

. Conversely, Jones et al.210 recently reported that the

Tat system was surprisingly tolerant of hydrophobic patches on the surface of structured
single-chain variable fragment proteins, and export efficiency was increased with greater
structural rigidity. Chaperones may also prevent export of a protein until cofactor insertion
has taken place211–213, and mutants incapable of cofactor binding are rapidly degraded once
in contact with the Tat machinery214.
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Figure 5.3: Working model for Tat transport of folded proteins. Following preprotein folding in the cytoplasm
(a and b), Tat substrates (S) are recognized by the translocon (c) in a process that likely involves TatB, TatC,
and the leader peptide. According to the cyclical assembly model215, preprotein binding to the TatB-TatC
complex triggers assembly of multiple TatA monomers that likely form a translocation pore (d) through
which a folded substrate is able to pass (e). Following successful transport, the TatABC complex
disassembles. This model of assembly-disassembly may explain how the translocon can accommodate
proteins of various sizes and how the Tat system can be present within membranes without compromising
permeability to ions and protons. Adapted from reference192.

To further investigate the Tat quality-control mechanism, we used mutants of the
BT6 scaffold. Here, three different variants were utilized, each with a different heme b
binding capacity (Figure 5.4). Using nuclear magnetic resonance (NMR) and circular
dichroism (CD) spectroscopy, we show that binding two, one, or no hemes (Figure 5.4)
imparts changes in the extent of folding of the protein variants. The archetypal
trimethylamine-N-oxide reductase (TorA) Tat signal peptide was fused to the N terminus
of the three proteins (Table 5.1), and the E. coli Tat machinery was challenged to
differentiate between the folding variants. We show that the Tat apparatus is able to sense
the conformational flexibility of the different BT6 substrates, and that increasingly wellstructured four helix bundles are exported with enhanced efficiency.
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Table 5.1: Amino acid sequences of proteins and signal peptides used in this study

Figure 5.4: Structural models of the BT6 variants used in this study. A, BT6 coordinates two heme b
molecules (red) using four histidine ligands (white). B, in BT6M1 the H53A substitution means the protein
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can only coordinate one heme b. C, in BT6M0 the double H53A/H88A substitution prevents heme binding.
All images were taken from 50-ns trajectories.

The aim of this study was to test whether the E. coli Tat system could recognize
and export a de novo–designed di-heme protein, and then to use variants of this protein
with experimentally confirmed differences in conformational flexibility to test if the Tat
apparatus selectively processes the more structured proteins. As described above and
depicted in the modeled structures presented in Figure 5.4, three variants of the BT6 protein
were produced, facilitating the incorporation of two (BT6), one (BT6M1), or zero
(BT6M0) heme b cofactors. The requirement for bis-histidine ligation of heme b in this
scaffold enabled the generation of the one and no heme-binding variants through H53A,
and H53A/H88A, respectively (Table 5.1, Figure 5.4). Heme-binding bundles are typically
expressed in E. coli in large amounts, with bound heme largely absent following lysis and
purification, because the native tetrapyrrole biosynthetic pathway cannot keep up with the
induced synthesis of recombinant protein. Apoproteins were reconstituted in vitro with an
excess of heme and unbound pigment was removed by anion exchange chromatography.
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Figure 5.5: Spectroscopic analysis of apo- and heme-reconstituted proteins. A, UV-visible absorption spectra
of heme-reconstituted protein samples normalized to absorbance at 280 nm. B–D, normalized melting
(yellow) and refolding (green) of secondary structure measured as the reduction in CD ellipticity at 222 nm
across a temperature gradient in the absence (open markers) or presence (solid markers) of heme. Ellipticity
was recorded every 1 °C, but only every third data point is shown for clarity. Lines are theoretical and
described by a Boltzmann distribution (see “Experimental procedures”). Melting (Tm) and refolding (Tf)
temperatures are reported in Table 5.2.

The Soret absorption bands for the BT6, BT6M1, and BT6M0 proteins were
normalized for protein concentration (absorbance at 280 nm) and had maxima at 413, 412,
and 396 nm, respectively, with the amplitudes corresponding to binding two, one, and no
hemes, respectively. The weak, blue-shifted absorption of BT6M0 suggested a low level
of adventitiously bound heme. We compared heme absorption in the protein-bound, and
solvated (buffer or DMSO) states, which had respective maxima at 413, 404, and 384 nm.
The blue-shifted absorption maxima for solvated heme are consistent with the weak, blueshifted absorption for BT6M0 (Figure 5.5A) arising from residual, weakly bound heme;
ligation into the internal cavity of BT6 and BT6M1 causes a red-shift absorption of the
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heme. Temperature-dependent CD spectroscopy was performed to assess the effect of
heme ligation on the thermal stability of each scaffold. At 15 °C the CD spectra of all three
variants, with or without bound heme, were typical of alpha-helical structures/ Likewise,
irrespective of heme binding heating to 80 °C resulted in spectra typical of that of a
denatured protein216. Ellipticity at 222 nm was monitored during temperature cycling from
15 to 80 to 15 °C to observe denaturing and subsequent re-folding of protein (Figure 5.5,
B–D). For BT6, heme incorporation displaced the midpoint of the melting curve from 22
to 56 °C, the 34 °C difference indicating increased stabilization following heme binding.
The same procedure with BT6M1 increased stabilization by only 16 °C (25 to 41 °C), and
had very little effect on the BT6M0 scaffold (32 to 35 °C) (Table 5.2). Thus, bis-histidine
ligation of two hemes within the cavity of BT6 significantly stabilizes the four-helix bundle
structure, and there is a smaller effect with only one bis-histidine ligation in BT6M1. In
the case of BT6M0, where heme ligation is not possible, there is correspondingly no
significant stabilization of protein structure in the presence of heme.
Table 5.2: Melting temperatures (Tm) and folding temperatures (Tf) of proteins in the absence (apo) or
presence of heme.

One-dimensional proton (1H) NMR spectroscopy was used to assess
conformational changes in tertiary structure upon heme binding to the BT6 scaffolds. A
1H NMR spectrum characteristic of a protein with limited tertiary structure was observed
for all scaffolds in the absence of heme (Figure 5.6A). Addition of heme to BT6 showed
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greater dispersion of resonances in the amide proton region, with a notable increase in the
number of peaks at around 10 ppm, suggesting that the heme is binding to the scaffold and
stabilizing the protein tertiary structure (Figure 5.6B). BT6M1 showed a small increase in
resonance dispersion following heme addition (Figure 5.6C), whereas BT6M0 showed no
significant change in amide proton dispersion (Figure 5.6D). The increase in the chemical
shift dispersion observed in the methyl proton region (at around 1.0–0.0 ppm) for BT6,
BT6M1, and BT6M0 mirrored the behavior observed for the amide proton resonances.
Together, the increase in 1H NMR dispersion in both backbone amide and methyl regions
confirm the ligation of heme into the BT6 and BT6M1 variants and indicate an increase in
protein folding upon ligation. These results are consistent with previous NMR data that
showed poor dispersion for a related BT6 variant in the apo form and progressive
structuring of the protein when one and then two equivalents of heme were added78.
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Figure 5.6: Proton NMR resonances of proteins with and without heme cofactor. A–D, the amide proton
region for apo-BT6 (red), apo-BT6M1 (blue), and apo-BT6M0 (black) (A), and comparisons in the absence
(solid line) and presence (dashed line) of heme for BT6 (B), BT6M1 (C), and BT6M0 (D). For BT6 and
BT6M1, the presence of heme induces changes in the amide proton resonance dispersion, whereas for
BT6M0 negligible changes are observed. These chemical shift changes are consistent with a heme binding
event coupled with a change in protein conformation.

5.3 In vivo Tat export assays
The E. coli TorA signal peptide is sufficient to direct green fluorescent protein (GFP) to
the E. coli periplasm via the Tat system205. Constructs in which the sequence encoding the
TorA signal peptide (residues 1–39) and first 4 amino acids of the mature TorA protein
(residues 40–43) were added in-frame to the 5’ termini of the genes encoding the BT6
protein variants followed by a C-terminal His6 tag were synthesized and cloned into the
pEXT22 vector. In the TorA–BT6 variants residues His-95 and His-130 correspond to His53 and His-88 in the protein scaffolds presented in Fig. 5.4. The resulting plasmids were
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co-transformed into E. coli BL21(DE3) along with empty pET-21a(-). The pEXT22 vector
was used as it allows isopropyl _-D-1-thiogalactopyranoside (IPTG)-inducible expression
of the synthetic gene under the control of a tightly regulated tac promoter. The low copy
number of pEXT22 (R100 origin of replication, 1–1.5 copies per chromosome) limits
production of recombinant protein, to avoid overwhelming the E. coli Tat apparatus with
substrate. Following growth and protein production, periplasmic fractions were prepared
from harvested cells as described under “Experimental procedures” and analyzed alongside
cell-free extracts prepared from identically grown cells. The C-terminal His6 tag allows
immunodetection of the recombinant protein; the predicted molecular mass of the
unprocessed precursor protein is_21 kDa, whereas the Tat-processed mature protein is 17
kDa. Anti-GroEL was used to probe the degree of cytoplasmic contamination in the
periplasmic preparations (Figure 5.7A); for all samples, only a faint signal was detectable
in the periplasm compared with that detected in cell-free extracts, indicating the level of
contamination was very low.
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Figure 5.7: Differential export of BT6 variants by the Tat system determined by immunoblotting. B: GroEL
was used as a cytoplasmic marker to confirm only very minor cytoplasmic contamination of periplasmic
preparations. B, -lactamase was used to confirm equal loadings of cell-free extracts or periplasm samples. C,
the C-terminal His tag on the BT6 proteins was used to determine the degree of Tat-dependent periplasmic
localization and the level of the unprocessed precursor proteins in cell-free extracts. For all panels the
positions of molecular weight markers and the expected size of proteins are indicated alongside the blots.
Each blot is representative of at least three independent experiments.

The Tat export assays were performed in cells that also maintained the pET-21a(+)
vector, allowing immunoblot signals to be normalized by immunodetection of β-lactamase
(Figure 5.7B), allowing direct comparison of the degree of Tat transport between samples.
For TorA–BT6, a 17-kDa signal was present for both periplasmic and cell-free extract
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(Figure 5.7C) preparations with no signal detected at 21 kDa, indicating complete
processing and export of TorA–BT6. To confirm the periplasmic localization was Tatdependent, a R12K/R13K (KK) variant of the TorA signal peptide was generated and fused
to BT6 (Table 5.1); it has previously been demonstrated that the KK motif completely
abolishes Tat-transport

204,217

. When this construct was tested, a 21-kDa signal

corresponding to the unprocessed apoprotein is observed in blots of total lysates and no
processed protein was detectable in the periplasm (Figure 5.7C). Together these data
indicate that the BT6 scaffold is able to acquire heme from the native biosynthetic pathway
and fold in vivo, and that this folding event can be detected by the Tat system, with the
TorA signal peptide sufficient for Tat-mediated recognition and transport of heme-loaded
BT6 to the E. coli periplasm (Figure 5.8).

Figure 5.8: The Tat complex is capable of recognizing and transporting heme-loaded BT6 relative to the
heme-binding knockout.

To probe the proofreading ability of the Tat machinery to recognize and efficiently
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export only folded proteins, similar constructs were generated in which the TorA signal
peptide was fused to the BT6M1 and BT6M0 proteins, which, in the presence of heme, are
either partially folded (BT6M1) or unfolded (BT6M0) relative to BT6. Compared with
BT6, considerably less protein was found in the periplasm for BT6M1, and almost none
for BT6M0 (Figure 5.7C). Conversely, blots of cell-free extracts of the same strains reveal
a significant signal for the unprocessed proteins for BT6M0, and to a lesser extent BT6M1,
as observed for the TorA–KK–BT6 control, showing that the preprotein accumulates in the
cytoplasm when it is less well folded (Figure 5.7B). The cellular levels of protein variants
should be very similar as all the proteins are identical (apart from one or two point
mutations) and were expressed from the same plasmid in the same cell line under the same
conditions. Indeed, the data presented in Figure 5.7C shows that the total signal (preprotein
plus exported protein where relevant) for all three proteins is similar. However, to further
confirm that the differential periplasmic targeting of the three BT6 variants by the Tat
system was due to differences in their heme loading and associated folding and not in
expression, synthesis, or stability, we performed two additional control experiments. First
we produced each protein under the same conditions as for the Tat export assays but
without the TorA signal peptide, and immunoblotting confirmed approximately equal
levels of each, ruling out the possibility that BT6M1 and BT6M0 are either expressed at
lower levels or are more rapidly degraded in the cytoplasm than BT6. We also performed
Sec system-mediated export assays of BT6, BT6M1, and BT6M0. As the Sec system
transports unfolded proteins across the cytoplasmic membrane, differences in folding,
mediated in the case of BT6 by heme binding, will not affect transport. Genes were cloned
into the pET-22b(-) vector in-frame with an N-terminal PelB (Erwinia carotovora pectate
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lyase B) Sec leader peptide (22 amino acids)218,219 (Table 5.1). Stop codons were omitted
so proteins had a C-terminal His6 tag for immunodetection; the unprocessed proteins have
a predicted molecular mass of ~19 kDa and the mature proteins would be ~17 kDa
following cleavage of the PelB signal sequence. Normalized loadings of cell lysates yield
single, similarly intense signals for BT6, BT6M1, and BT6M0, indicating all three apoproteins are equally synthesized and transported to the periplasm when directed through
the Sec system.

Figure 5.9: Spectroscopic analysis of purified protein proteins. UV-visible absorption spectra of proteins
purified from the periplasm of E. coli (BT6, red line; BT6M1, blue line; BT6M0, black line) compared with
BT6 reconstituted with heme in vitro (red dashed line). Spectra are normalized to absorbance at 280 nm. Inset
panels show the purified proteins.
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5.4 Purification of proteins from the periplasm
To demonstrate that heme ligation into BT6 was responsible for its Tat-dependent
localization in the periplasm, production of His-tagged proteins was performed on a larger
scale using the recently described E. coli W3110-TatExpress cell line. Cells were
fractionated and protein proteins were purified from the periplasmic fraction by
immobilized metal affinity chromatography. Eluates were concentrated and striking
differences in pigmentation between the protein variants were observed, with a deep red
color for BT6, weaker pigmentation for BT6M1, and no visible color for BT6M0 (Figure
5.9, inset panels). SDS-PAGE of the concentrated eluates revealed the same pattern as the
Tat exports presented in Figure 5.7, with more BT6 than BT6M1 and only a trace amount
of BT6M0. This also ruled out any leakage of unprocessed protein across the cytoplasmic
membrane as the larger precursor species were not purified. The absorbance spectra of Tatexported BT6, BT6M1, and BT6M0 samples normalized at 280 nm are shown in Figure
5.9, along with in vitro heme-reconstituted BT6. There is a close match between the spectra
of the Tat-exported heme-loaded BT6 purified from the periplasm and the reconstituted
BT6 sample (Figure 5.9, solid red versus dashed red lines). The high affinity of BT6 for
heme78 ensures full occupancy of the two heme-binding sites, so the Tat-transported BT6
purified from the periplasm is also fully heme bound. These data, alongside the export
assays shown in Figure 5.7, reveal that the TorA–BT6 protein is able to sequester heme b
from the native E. coli biosynthetic pathway, correctly fold around its substrate, and retain
the pigment following export by the Tat-apparatus.

5.5 Discussion of Tat
The Tat pathway is present in the cytoplasmic membranes of most prokaryotic
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organisms and is evolutionarily conserved in the thylakoids of plant chloroplasts and some
mitochondrial membranes195,199. In addition to playing a biosynthetic role in numerous
important cellular processes, the Tat pathway is required for colonization and virulence of
globally significant human pathogens220,221 The Tat system differs from the universally
conserved Sec pathway, which transports unstructured polypeptides, as it transports folded,
typically cofactor-containing proteins. How the Tat apparatus is able to determine that a
protein is folded, cofactor loaded, and suitable for export is not understood. Here, we have
used artificial heme protein proteins to investigate the ability of the archetypal E. coli Tat
machinery to discriminate between folding states of protein substrates. The proteins used
in this study are four-helix bundle proteins enclosing a hydrophobic cavity that can
accommodate heme cofactors ligated by histidine residues. Point mutations to the BT6
protein, affecting only single histidine ligands, generated the BT6M1 and BT6M0 proteins,
and were sufficient to reduce the number of bound hemes, verified by absorption
spectroscopy. The number of bound hemes therefore provides a simple, well-defined
method to alter the stability of a protein substrate. The consequent effects of heme content
on the thermostability and folding of each protein were measured using temperaturedependent CD spectroscopy and 1H-NMR. When directed for export through the Tat
export machinery, there were clear differences in the extent of translocation for BT6,
BT6M1, and BT6M0 proteins that correlate with the in vitro stability and folding
experiments for heme-bound constructs. Export efficiency decreased with increasing
conformational flexibility; the unstructured BT6M0 protein is largely rejected for export,
whereas limited export was observed in the intermediate case of the single-heme-binding
BT6M1 protein. The export data shown would only be obtained if the BT6 proteins were
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able to ligate heme, in vivo, as heme coordination is a pre-requisite for protein stability and
folding. Evidence for in vivo heme ligation was shown with the purification of hemecontaining proteins from the periplasmic fraction of E. coli, the spectra of which strongly
resemble those of heme proteins generated in vitro. Although the native E. coli Tat
translocase will never have encountered the artificial protein substrates described here, our
data show that it is able to recognize and distinguish between them, even to the extent of
processing the intermediate state of BT6M1 differently from the folded BT6 and the least
structured BT6M0. Thus, the Tat proofreading process must involve a generic form of
discrimination; the correlation between the structural flexibility of the Tat substrate and its
suitability for export suggests that there are initial encounters between Tat components and
the substrate at the membrane surface. Such interactions might sense flexible motions of
the substrate that are transmitted to other components of the Tat machinery, preventing
transport across the membrane. This proof-of-concept study shows that an artificial protein,
engineered to bind heme b from a native biosynthetic pathway, can be exported from the
cell in its correctly folded state. Development of this concept may contribute a significant
advance in biotechnology, where the principle could be applied to other organisms and to
important biomolecules and protein-cofactor complexes, particularly those that may cause
toxicity to the host.

5.6 The Sec Translocon and the Ccm complex
Synthetic biological systems require that the designed biomolecules they
incorporate interact productively with natural proteins and substrates. Many design efforts
for cofactor-binding proteins involve recombinantly expressing and purifying the apo
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scaffold and then performing an in vitro titration/coupling reaction to create the final holo
protein for downstream analysis. However, holoenzymes that are expected to function in a
biological context must also be able to functionally assemble their cofactor(s) in vivo.
It is thus of interest to explore the capacity of de novo designed redox scaffolds to
interact with natural cofactor maturation machinery. Here we test the ability of the HM-1
class of unstructured heme-binding bundles to interface with a natural complex responsible
for covalent cofactor incorporation via thioether bond formation: the cytochrome c
maturation (Ccm) complex (Figure 5.10).

Figure 5.10: The cytochrome c maturation (Ccm) complex and the mechanism of heme c incorporation into
apo cytochrome c. Adapted from references 222,223. C-type cytochromes are integral to bacterial electron
transport processes, and are key components in several synthetic biology targets of interest including
extracellular electron transport pathways in E. coli224.

The first four-helix bundle aimed at testing the minimum requirements for
periplasm-localized c-heme incorporation was reported by Anderson et al 225, which will
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be referred to here as RA-2 (Figure 5.11). The experiment had three simple design
considerations: The first was to take the existing HM-1 construct and add histidineadjacent cysteines for reacting with the heme vinyls. The second was to include the 27a.a. N-terminal signal sequence from the periplasmic E. coli maltose binding protein
(MBP), which is known to be trafficked by Sec. The third was to induce elevated
expression of the Ccm complex via a second lac-inducible plasmid containing the
component proteins (CcmA-H), since the native E. coli Ccm genes are generally only
expressed natively under anaerobic conditions.

Figure 5.11: The first c-heme binding four helix bundle. A: Consensus sequence from 150 c-heme proteins
with CXXCH motifs from the PDB. B: The sequence of RA_2. This bis-his heme b binding site between
helices 1 and 3 from HM-1 was left intact, whereas the site between helices 2 and 4 had the thioether
attachment site incorportated. The N-terminal MBP and affinity purification tags are not shown. C:
Schematic illustration of the tertiary structure of the protein, with the b-heme shown in orange and the cheme shown in red.

MALDI-TOF mass spectrometry following purification of the protein confirmed
the covalent incorporation of the c-heme. The UV-vis spectrum of the reduced (ferrous)
holo-RA_2 exhibited the expected blue shift in the Soret, alpha, and beta absorption bands
relative to the b-heme protein, consistent with a modification of the vinyl groups on the
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conjugated heme (Figure 5.12A). Furthermore, the reduced pyridine hemochrome
spectrum of RA_2 is identical to that of horse heart cytochrome c and those reported for
natural c-type cytochromes and significantly shifted with respect to b-type heme containing
proteins(Figure 5.12B).

Figure 5.12: Spectroscopic characterization of the c-type and b-type heme-binding bundles. (A) UV/visible
spectra of ferrous 1 with bound b-heme (red) and purified 2 with covalently incorporated c-heme (blue)
reveals the expected blue-shift in the absorption spectrum of the c-type heme. (B) UV/visible spectra of the
pyridine hemochrome (a/b region) preparations of horse heart myoglobin (red) bovine cytochrome c (blue)
and RA_2 (black). Stereotypical peak positions for b-type heme and c-type heme are indicated by dashed
lines, highlighting the spectroscopic fingerprint for c-type heme in RA_2.

175

Figure 5.13: Schematic illustrating the mechanism of c-heme incorporation in four-helix bundles containing
the CXXCH motif.

With proof of principle in hand, we wanted to explore the capacity for these four
helix bundles to act as modules in longer length polymer chains while retaining domain
independence (in the sense that each heme binding site in each bundle remains functional).
Furthermore, it was of interest to see if processing by the Ccm complex following
membrane transport by the Sec translocon was limited to small proteins like cytochrome c
(~12 kDa) or single four-helix bundles (~15 kDa), or whether the constructs could be
expanded to much larger sizes in the interest of incorporating c-hemes into multi-module
constructs. We thus set out to characterize two different four-helix bundle “modules”, a
symmetric two b-heme-binding “B-type” bundle similar to constructs discussed in earlier
chapters, and a corresponding “C-type” bundle with the two sites modified for c-heme
attachment (Figure 5.14). For both modules, the four helix bundle-encoding region was
duplicated to create genes for a 2-, 3-, and 4-module protein, with the C-terminus of one
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module being connected to the N-terminus of the next via an “GSGGSGSGG” linker
sequence (Figure 5.15). The C-type bundles contained the N-terminal MBP- trafficking
sequences and were expressed in the low-copy pSHT vector and co-expressed with the
Pec86 plasmid (containing CcmA-H, as published previously), whereas the B-type bundles
were expressed in the high-copy pj414 vector. All of the B-type constructs up through four
modules express in high yield, with size confirmed by MALDI-TOF mass spectrometry.
Heme titrations for each construct indicates a heme binding capacity of ~2 hemes per
module, as intended. All of the C-type constructs express in reasonable yield, with the 2-,
3-, and 4-module constructs exhibiting a distribution of c-heme incorporation as measured
by MALDI-TOF. Fractions of the c-heme constructs with different equivalents of c-heme
bound were separable by HPLC, and for each of the larger constructs (2-, 3-, and 4modules) a fraction was obtained which via mass spectrometry exhibited all available cheme sites occupied.

Figure 5.14: Sequences of the B-type and c-type bundles

177

Figure 5.15: Illustration of the 2-,3-, and 4-bundle constructs evaluated for both the B-type and the C-type
bundle.
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Chapter 6 Summary and Conclusions
Minimal protein design, coupled with a forward engineering approach, can usefully
answer scientific questions, and the resulting products may additionally serve as useful
components in downstream applications. In terms of fundamental biophysical chemistry of
natural oxidoreductases, we chose two different systems to study, based on both their
importance in biology and biotechnology as well as the extent of mystery surrounding their
function.

6.1 Summary of Chapter 3
The first chemical mechanism was heme-mediated oxygen binding, as carried out
by natural globin proteins. The chemistry is remarkable in that the protein suppresses an
otherwise highly favorable and irreversible reaction of the ferrous oxygen-heme complex
( the “oxyferrous state”) to the ferric superoxide state, by more than eight orders of
magnitude in some cases. There was a lack of consensus on exactly which aspects of the
globin fold were essential for stable oxygen binding and which may be largely incidental.
Hypothesized key elements included the “distal histidine” as a stabilizing hydrogen bond
donor, the elevated midpoint potential of the heme as a suppressor of autooxidation, and
the existence of “pockets” inside the globin monomer as a kinetic gate of oxygen diffusion,
and the importance of allostery (particularly in studies of hemoglobin) in stabilizing the
oxygen-bound form of the protein.
Initial work recapitulated the bis-his based heme ligation characteristic of
neuroglobin and cytoglobin in a minimally designed dynamically structured four helix
bundle protein. Further variants then showed a transition from an initial sub-millisecond
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oxidation process to a spectroscopically observable oxyferrous state stable for tens of
seconds by systematically restricting interhelical dissociation by altering the loop topology
of the bundle. Substituting a heme a cofactor for the original heme b, which has the same
core structure with a ~200mV higher midpoint potential due to a peripheral substituent,
preserves the oxygen binding chemistry and exhibits a 2-fold increase in oxyferrous
lifetime. Recreating the same hexacoordinate active site in another dynamically-structured
bundle iteratively redesigned to have improved core packing yielded a marginal (50%)
increase in the lifetime of the oxyferrous state. For both of the single-chain bundles,
removing the core-facing glutamates that provide the energetic driving force for axial
histidine detachment abolishes observable oxyferrous state formation, and likely leads to
heme oxidation via outer sphere electron transfer. These results indicate that the elevated
heme midpoint potential in myoglobin and hemoglobin by itself cannot be responsible for
the ~10,000-fold extension of oxyferrous lifetime above natural hexacoordinate globins.
As long as molecular oxygen has access to the axial coordination of the heme iron,
improved solvent exclusion was alone sufficient for a ≥10,000-fold increase in oxyferrous
lifetime, indicating the mechanism of inner-sphere electron transfer in the oxyferrous
complex is mediated by a solvent species, and that the primary biological strategy to
preventing it is to provide a kinetic barrier to the interaction rather than altering the
thermodynamics. The results also suggest that there is an inherent limit in oxyferrous
lifetime to be achieved with a heme that is hexacoordinate in the unoxygenated state, as a
bound oxygen will unavoidably have to compete with the reattachment of the histidine it
had to displace. The next step was then to create a bundle with a pentacoordinate heme site,
which was achieved in several variants of coiled-coil helical bundles, which in contrast to
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the dynamically structured bundles had a far more static structure in both the apo and holo
states. The oxyferrous lifetime in these constructs showed a remarkable sensitivity to
protein backbone dynamics and what is hypothesized to be a difference in the degree of
left-handed supercoiling (and thus interfacial interhelical packing). One variant, in the
more-supercoiled construct with the oxygen-binding face of the heme in a more solvent
excluding environment, exhibited a ~10,000-fold increase in oxyferrous lifetime relative
to the hexacoordinate constructs and over a 100,000,000-fold increase above the baseline
for the model compound, and which was on par with the properties of myoglobin and
hemoglobin. It is reasonable to say that solvent exclusion is by far the most important factor
in determining the stability of the oxygen-bound state, irrespective of heme midpoint
potential, hydrogen bonding, or nuanced peripheral aspects of the protein fold. It is also
reasonable to expect more detailed aspects of protein dynamics to become increasingly
relevant to solvent exclusion-mediated oxyferrous lifetime extension, since they become
significant to water accessibility on the hours-to-days timescale of interest.

6.2 Summary of Chapter 4
The second chemical mechanism was flavin-mediated radical pair formation, as
carried out by photolyase/cryptochrome blue-light photoreceptors. The chemistry is
remarkable in that photo-excited flavin abstracts an electron from a nearby redox-active
amino acid, which can itself transfer the “hole” to other residues in an electron transport
chain that results in a separated pair of radicals. Due to the oscillation of the combined spin
system between singlet and triplet states, and the fact that charge recombination can only
readily occur from the singlet state, the lifetime of the charge-separated state in the
photolyase/cryptochrome family sensitive to external magnetic fields, and in the case of
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animal cryptochromes, this magnetic sensitivity is/was purported to be the biological basis
for magnetic sensitivity in some migratory birds as well as other species. There were a
number of unanswered questions concerning the basic biochemistry of such a mechanism.
It was not clear whether or not it was possible to observe a flavoprotein-born magnetic
field effect (MFE) at ambient conditions. It was also uncertain if it was only tryptophans,
or in part other residues like histidine and tyrosine near the conserved
photolyase/cryptochrome active site, that were important to the mechanism, and at the
same time whether a flavin•/tryp• was the identity of the final radical species. Other
questions included whether or not a single tryptophan within electron transfer distance of
the flavin was sufficient for a magnetically sensitive radical pair, and if so, how the
magnitude of the magnetic field effect for that pair compared with that of natural
cryptochromes.
Initial work recapitulated the light-induced radical-pair formation characteristic of
cryptochrome proteins in a series of minimally designed dynamically-structured four helix
bundle proteins containing a covalently-linked riboflavin derivative and a single
tryptophan. Analysis via transient absorption spectroscopy confirmed the generation of the
flavin semiquinone radical that was stable on the order of microseconds, and a lifetime that
was sensitive to an external applied magnetic field. MFE magnitudes of 16 and 17.5%
were observed for the two ET-competent constructs under ambient aqueous conditions,
comparable to those observed for several natural cryptochromes studied under cryogenic
conditions. Transient EPR studies of one the single-tryptophan constructs matched the
spectrum of wild-type DmCry, indicating that flavin•/tryp• is the magnetically sensitive
radical species in natural cryptochromes. Kinetic analyses of TA data supported a model
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for triplet-borne electron transfer from the flavin after photoexcitation and relaxation from
the singlet state, to form a flavin•/tryp• radical pair whose rate of intersystem crossing was
sensitive to applied magnetic fields. Building upon this work, a series of variants of this
same scaffold containing tyrosine in place of tryptophan were created to compare the
properties of the two amino acids in there capacity as electron donors. At the same time,
variants containing multiple tryptophans at various spacings and environments were
created to probe the differential behavior of a tryptophan electron transport chain relative
to a single tryptophan acting as an electron donor. Results indicate that the kinetics of
forward electron transport are qualitatively similar for tyrosine and tryptophan, but that the
MFE of the tyrosine variant is sharply diminished relative to its tryptophan analogue,
perhaps related to the lesser degree of hyperfine coupling available to a tyrosine-localized
radical. All of the double-tryptophan variants exhibit magnetic field effects, with the two
variants containing the solvent-exposed terminal tryptophan (W13W18 and W16W18)
displaying qualitatively different behavior in the time evolution of their magnetic field
effect magnitude. This suggests a potentially important role for an electron transport chain
in extending magnetic field sensitivity to longer timescales, and makes them an interesting
subject for further study.
Kinetic modeling of the single-tryptophan variants of the dynamically structured
bundles strongly suggests the protein can adopt at least one ET-competent and ETincompetent state, a behavior attributed to rotational/conformational flexibility of the
flavin and tryptophan resulting in different possible inter-cofactor separation distances.
The next step was then to create an analogous flavin binding protein in a more singularly
structured coiled coil helical bundle. A coiled-coil bundle modeled of the successful
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designs of the heme-binding proteins was modified to incorporate a conformationallyrestricted flavin-binding pocket near the covalent attachment site. The newly designed
scaffold binds flavin covalently, with fluorescence quenching experiments indicating that
the flavin resides in the intended binding pocket. Solvatochromism experiments
additionally indicate that interior tryptophans in the new scaffold are more rigidly
structured than similarly positioned tryptophans in the original dynamic scaffold, making
the new rigid scaffold a promising platform for future experiments. The MFE-validated
constructs of the dynamic scaffold, and potential variants of the new scaffold, would make
ideal units to build an ordered array of proteins for anisotropic experiments testing the
dependence of the MFE on the angle on inclination of the applied magnetic field.

6.3 Summary of Chapter 5
The last chapter applied a similar principle of “engineering for knowledge” up a
layer in the biological hierarchy to ask basic questions regarding protein-protein
interactions between synthetic constructs and more complex multi-component biological
machinery in E. coli. We contrasted the Sec transporter, which transports protein in an
unfolded configuration, with the Tat transporter, which only transports fully folded
proteins. The Tat transporter has several dissociable elements, and the mechanism by
which Tat as whole recognizes properly folded proteins and adapts to their dimensions is
poorly understood. In particular, it was unknown to what aspects of “unfoldedness” the Tat
transporter is able to discriminate against, e.g., whether exposed hydrophobic regions
where key (as may be the case with an aggregate or misfolded protein) or whether
differences in conformational flexibility played a role.
The work involved fusing a Tat signal peptide with three different variants of the
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BT6 heme binding bundle (capable of binding 2, 1, or zero hemes) and then expressing the
proteins in vivo to see to what extent the natively-expressed Tat transporter could
discriminate between them for transport into the periplasm. NMR studies confirmed that
the zero-heme binding variant had a great deal of conformational flexibility in its tertiary
structure, with the heme-binding variants becoming significantly more structured with each
heme binding site added. Accordingly, molecular biology assays confirmed that Tatmediated periplasmic transport efficiency was much higher for the more rigid structures
than the more flexible ones, confirming the Tat apparatus’ ability to sense protein
conformational flexibility.
The last project involved testing the limit of the Sec transporter insofar as the total
length of peptide it could reliably unfold and transport, and at the same time tested the
ability of the E. coli cytochrome c maturation complex to fully assemble covalentlyattached heme c cofactors in all of the binding sites. Variants of a previously characterized
BT6-like protein with a CXXCH site for thioester reactivity and a fused Sec signaling
peptide were made to include two c-heme sites per four helix bundles, and polymerized to
include up to four total helical modules (16 total helices). Results indicate that even the 16helix construct (8 c-heme sites, 60 kDa) can be fully transported through the Sec translocon
and react to completion with the Ccm complex, providing a proof-of-concept for the use
of similar polymerized protein domains in synthetic biology applications.
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Appendix A: Methods
A.1 DNA Prep and Gene Synthesis
The original designs for the BT6, SHF, MZH3, DDH2, and FMK3 proteins were
constructed as a synthetic gene from DNA2.0 or GeneArt in an ampicillin-resistant
cloning vector, and then cloned into their respective expression vector. Cloning was
carried out be double-restriction digest of the purified gene-carrying cloning vector
followed by treatment with 0.5u of calf intestinal phosphatase for 30 minutes at 37 °C.
The gene fragment was isolated by running the digest on a 1% agarose gel with SYBRSafe dye at 100mV for 20 minutes, excised using a razor blade under blue light
illumination, and purified using the Qiagen Gel Extraction kit. All downstream variants
of each scaffold were generated using PCR mutagenesis on the respective parent vector.
Mutagenesis was carried out using AccuPrime™ Pfx SuperMix (Invitrogen). A volume
of 22.5 μL of AccuPrime™ Pfx SuperMix was combined with 1 μL of solution
containing 100 ng of parent DNA, 0.5 μL of a 100 μM solution of each primer and 2.7 μL
of MasterAmp PCR Enhancer. The sample was cycled on an Eppendorf Master Cycler
Pro (model 6321) using the following procedure: initial denaturation at 95 °C for 5
minutes, followed by repeating a cycle of denaturation at 95 °C for 15 seconds, annealing
at 65 °C for 30 seconds, and extension at 68 °C for 5 minutes for a total of 18 times. A
final extension was done at 68 °C for 5 minutes and ended with a hold at 4 °C. Samples
were then digested with 0.5 μL of Dpn‐1 (New England Biolabs) for 1 hour at 37 °C. A
volume of 1 μL of this DNA was transformed into DH5 α cells (GeneChoice Genesee
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Scientific) and grown overnight on an LB agar ampicillin plate (75 mg/ml) at 37 °C. The
following day, four single colonies were picked and outgrown in LB media with
ampicillin and their DNA was extracted using a Miniprep Kit (Qiagen). The sequence
was verified at the University of Pennsylvania DNA sequencing Core Facility using a T7
promoter primer.

A.2 General Apo-protein expression and purification
All constructs except for BT6M2, BT6M1, and BT6M0 were designed with a six‐
histidine tag separated by a TEV cleavage site . All were expressed in E. coli BL21
(DE3) cells (GeneChoice Genesee Scientific). Two-liter cultures of TB media where
grown to OD600 0.7‐0.8 at 37 °C, followed by a 5‐hour induction with 1 mM IPTG. The
cells were harvested by centrifugation (10000 RPM, 5 minutes) and stored at 20 C until
use. Cells were thawed and suspended in Nivkel Wash buffer (20 mM NaH2PO4, 0.5 M
NaCl, 10 mM imidazole, pH 8.0) with 1% OTG, then homogenized and lysed by
sonication in a bath sonicator. The lysate was centrifuged (25,000g, 35 min) and the
supernatant applied to a Ni-NTA superflow resin (Qiagen) on an Akta Fast protein liquid
chromatography (FPLC) system. The fusion protein was eluted using Ni Elution buffer
(20 mM NaH2PO4, 0.5 M NaCl, 250 mM imidazole, pH 8.0), and cleaved by
recombinant tobacco etch virus N1a(TEV) protease overnight at room temperature in Ni
Elution buffer supplemented with 1 mM TCEP (reductant) and 0.5 mM EDTA. The
sample was dialyzed into Ni Wash buffer, and applied to the Ni-NTA column with the
flow through and wash collected. The sample was then concentrated to about 15 mL
using a stirred cell (Amicon model 8050) equipped with a 10,000 MWC filter. The
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sample was flash frozen in liquid nitrogen and stored at -20 °C until use.

A.3 Heme reconstitution into apo-proteins
Hemin (Sigma) stocks (1 mg ml-1) were prepared in 100% DMSO. Protein
concentrations were calculated by absorbance at 280 nm following the method described
by Gill and von Hippell (43), and using the experimentally determined extinction
coefficient of 32.6 mM-1 cm-1. Reconstitutions were conducted with a 10-fold molar
excess of hemin in buffer D (50 mM HEPES, pH 7.4, 200 mM NaCl, 20% (v/v) DMSO)
and incubated for 45 min at 25 °C, before being transferred to ice and buffer exchanged
into buffer B using Vivaspin centrifugal concentrators. Unbound cofactor was removed
by ion exchange chromatography on a DEAE-Sepharose (Sigma) column.

A.4 UV-visible absorption spectroscopy
Protein samples were buffer exchanged into buffer E (5 mM sodium phosphate
buffer, pH 7.4) and UV-visible absorption was measured in a 1-cm path length UV
cuvette in a Cary 60 UV-visible spectrophotometer (Agilent) at room temperature.

A.5 CD spectroscopy
Mean residue ellipticity ([θ]MRW) of protein samples were measured in a 1-mm
path length quartz cuvette on a Jasco J-810 spectropolarimeter with a Jasco PFD-425S
Peltier to enable temperature control. Spectra were obtained from 15 to 80 °C at 5 °C
intervals. Spectra were recorded continuously at a scan speed of 100 nm min-1, with 1nm
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resolution and a 4-s response with 4 accumulations. Ellipticity ([θ]) at 222 nm was
measured every 1 °C from 15 to 80 °C at 1 °C min-1 with a 4-s response. Melting
temperatures (Tm) and refolding temperatures (Tf) are the temperature at which 50% of
the protein is unfolded or folded, respectively, as determined by fitting melting data to a
sigmoidal Boltzmann distribution according to the following equation, where T is the
temperature, Tm is the melting (or folding) temperature, and T0 is the initial temperature
of the experiment.
[θ]222nm =

[θ]base
222nm

+

[θ]max
222nm
1 + exp (

Tm − T0
)
δT
δ[θ]

A.6 MALDI-TOF Mass Spectrometry
Samples were either taken directly from the HPLC or, if they had been
lyophilized, dissolved in 66% acetonitrile, 44% water + 0.1% TFA. A sample volume of
1 μL was mixed with 1 μL of saturated matrix solution (sinapinic acid in TFA) and
spotted on a sample target. The target was then dried under vacuum and measurements
taken in linear flight mode.

A.7 UV-visible Spectroscopy of Heme and Flavin Proteins
The sample was dissolved in redox buffer (20 mM KH2PO4, 100 mM KCl, pH
7.4). All
measurements were in this buffer unless otherwise stated.
UV‐visible spectra (Figure 2, Figure S4) were collected in a quartz cuvette (1 mL,
1 cm path) with a Varian Cary‐50 spectrophotometer at room temperature. The presence
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of a band at 475 nm indicated incorporation of the flavin under normal (oxidizing)
conditions. UV‐visible spectra used to monitor photodegradation and concentration prior
to transient absorption experiments were collected with a Varian Cary‐60 spectrometer,
using a small volume quartz cuvette (1 cm path length, 200 μL volume) at room
temperature.
Secondary structure was monitored by CD spectroscopy (Aviv Model 410) with a
quartz cuvette (400 μL, 1 mm path) from 200 nm to 300 nm at 25 C (Figure S3A). The
thermal stability was determined by monitoring the ellipticity at 222 nm every 2C from
2C to 98C (Figure S3B). The melting temperatures were calculated using a single term
Boltzmann fit. Typical concentration was 20‐30 μM.
Steady state fluorescence data where analyzed in a quartz fluorescence cuvette (1
ml, 1 cm path) on a Horiba Fluorolog 2 spectrophotometer at 20 C. All spectra where
corrected for fluctuations in lamp intensity. Typical concentrations were 3‐5 μM (OD475
0.05‐0.1). Quantum yield measurements were made by integrating the area under the
curve of the steady state spectrum relative a riboflavin standard (Ф = 0.267)2 and
correcting for concentration and extinction.
The steady state phosphorescence spectrum (Figure 2) was recorded on an
Edinburgh Instruments FS 920 Fluorimeter equipped with a liquid nitrogen dewar. A
sample volume of 200 μM was flash frozen in a glass tube and spectra taken at liquid
nitrogen temperatures.

A.8 Stopped Flow for Determining Oxyferrous Lifetimes in Heme
Proteins
Each protein was prepared to 10 μM in 20 mM TRIS, 20 mM NaCl pH 8 as
193

described above and stirred under argon for 90 minutes, then minimally reduced with
dithionite. These samples were then rapidly mixed with oxygen-saturated 20 mM TRIS,
20 mM NaCl pH 8 using an OLIS RSM-1000 Stopped-Flow Spectrophotometer© at
15°C. Spectra were obtained from 386 nm to 611 nm each millisecond. Single variable
deconvolution (SVD) analysis was performed to determine kinetics of oxyferrous
formation and decay and corroborated with kinetics of the reduced and oxyferrous Qband maximums of 558 nm and 574 nm, respectively. Decays were fit to a single
exponential.

A.9 Nuclear Magnetic Resonance (NMR) Spectroscopy on Heme
Proteins for Oxygen Binding Project
Protein was dissolved from lyophilized powder in 80% D2O phosphate buffered
saline (PBS) pD6.6 and 20% H2O PBS pH7. Sample was diluted in same buffer mixture
to 400 μM. Holo protein was assembled by adding heme from KOH hemin (Sigma
Aldrich©) stock titrated to 2:1 heme:protein ratio. Apo NMR was obtained using 250μL
in a microcell tube and holo NMR was obtained using standard 500 μL tube. Holo spectra
were taken with and without trimethylsilyl (TMS) capillary and aligned to determine
chemical shifts without TMS peak in final spectra. Apo spectra were aligned by
consistent peak at 3.7ppm. Spectra were taken using BBI© probe on Avance DMX 400
(9.4 Tesla) Bruker NMR©. 700 scans were taken of 16,384 points after 8 dummy scans
using ESCULPT© water suppression sequence and 45° flip angle.
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A.10 Heme Titrations
Protein was dissolved to desired concentration in 20 mM TRIS, 20 mM NaCl pH
8 in a 1 mL quartz cuvette. UV-visible spectra were taken from 0 to 3 equivalents heme
at 0.1 to 0.5 equivalent increments after equilibrium was reached, anywhere from 10
minutes to one hour, at room temperature. Heme was added from 0.7 mM 10% DMSO,
90% 20 mM TRIS 20 mM NaCl stock. The absorbance at 412 nm was plotted against
heme concentration and best fit for one-heme association constant using equation 1,
where H is heme, P is protein and extinction coefficients are for heme in bound and free
state. UV-visible spectra were taken on a Varian Cary 50 Bio Spectrometer©.
Abs = ([H] ∗ εfree )+(εbound + εfree )
∗

(K D + [P] + [H]) − √(K D + [P] + [H])2 − 4[P][H]
2

A.11 Flavin Coupling Protocol
The protein was flavinated using an optimized version of a protocol first
described in Farid et al. (2013).1 A typical 5 mL reaction contained concentrated protein
(a few hundred millimolar, in Ni-NTA Wash Buffer), a 3‐5 molar excess of 8‐
bromoriboflavin (in DMF, final DMF concentration not to exceed 20%), and TCEP at a
final concentration of 1.25 mM. The pH of the solution was adjusted to 9.0 with NaOH,
and stirred overnight at 50 °C while protected from light. The sample was purified on a
Waters reverse‐phase HPLC (C18 column Gracie, H2O + 0.1% TFA aqueous phase and
acetonitrile + 0.1% TFA organic phase), flash frozen in liquid nitrogen and lyophilized
(Figure S1). Flavination was verified by the presence of a 475 nm band on the HPLC
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detector as well as by ESI, matrix assisted laser desorption ionization mass spectrometry.

A. 12 Flavin Protein Electrochemical Characterization
Redox titrations were performed to determine the redox potential of the flavin
using a spectroelectrochemical system. A typical sample contained 10‐30 μM protein and
the following redox mediators: duroquinone (10 μM), pyocyanin (10 μM), 2‐hydroxy‐
1,4‐ naphthoquinone (10 μM), phenazine (10 μM), anthraquinone‐2‐sulfonate (20 μM),
benzyl viologen (10 μM), and methyl viologen (10 μM). The potential of the solution was
modulated from 0 mV to – 500 mV vs. S.H.E. using a CH Instruments model 600C
electrochemical analyser equipped with a Pine Instruments gold honeycomb electrode.
The electrode was coated to prevent protein build‐up by soaking in 2 mM cystamine for
45 minutes. The oxidation state of the system was monitored spectroscopically using an
Ocean Optics DH‐2000‐BAL light source and a fiber‐optic‐guided USB 4000 diode array
detector. The change from oxidized to reduced was monitored by the depletion in
absorbance of the S1 band region of the flavin (475 nm). The data were then fitted to a
Nernst equation (Eq. 1), where Ecell is the redox potential of the spectrochemical cell,
Em is the redox potential of the flavin, n is the number of electrons transferred and [ox,
red] is the concentration of oxidized or reduced species present at a particular Ecell.
Square wave voltammetry was used to record the midpoint potential of the
TrpH/TrpH●+ redox couple. A gold electrode was sonicated in an Alconox solution for 5
minutes in a bath sonicator followed by polishing with alumina slurry (20 nm) for 1
minute in a figure of eight motion. The electrode was then rinsed, and sonicated for 5
minutes in distilled water. Electrochemical cleaning was performed in 0.5 mM sulfuric
acid from 0.375 to 1.8 V for 50 cycles using a CH Instruments model 600C
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electrochemical analyser. The electrode was again rinsed with distilled water, then
DMSO, and coupled to dithiobis(succinimidyl propionate) (DSP, Lomant's Reagent) in
DMSO (4 mg/mL) for 30 minutes. The electrode was dipped into a concentrated protein
solution in redox buffer (100 μL) for 2 hours to couple it to the DSP‐bound electrode.
The electrode was placed into a cell containing redox buffer and equipped with a Pt
counter electrode and an Ag/AgCl reference electrode. The potential was swept from 0.7
V to 1.2 V vs. S.H.E. with a frequency of 300 Hz and a 25 mV step size. Each data point
was the average of five separate scans. The background current due to the gold electrode
was subtracted out in post‐processing.

A.13 Magnetic Field Effect Transient Absorption Experiments
To characterize photochemistry and measure the magnetic field effect of a
flavinated protein, a 250 μL of sample is placed in a quartz cuvette (Hellma 104.002F
QS, 10 mm path length, internal dimensions 2x10x45 mm) in the center of a cryostat
(Oxford Instruments, Optistat CF) with the temperature controlled at 25.0 ± 0.1 K.
Magnetic field pulses of approximately 4 ms duration were synchronized with the laser
flash and generated using home‐built Helmholtz coils. The maximum field at the position
of the sample is 20 mT. Data were collected by alternating measurements with the
magnetic field on and off. Proteins were prepared in redox buffer to a concentration of
approximately 30 μM. Dissolution of the protein resulted in a drop of the solution pH to a
value of between 6.8 and 7.0 when starting with a phosphate solution at pH 7.4. Samples
were centrifuged to remove any aggregates for 15 minutes at 9000 RPM and 4 C and then
measured by UV‐visible spectroscopy. Radical pairs were generated by flash photolysis
197

using a Sirah Cobra dye laser pumped by a Continuum Surelite I Nd:YAG laser.
Excitation was 5‐7 mJ at 450 nm using Coumarin 460 as the dye in analytical grade
methanol (Fischer Scientific). The repetition rate for data collection was 1 Hz for W13
and W16. This repetition rate was reduced for W20 and the control, where a 1‐2 minute
delay between shots was necessary to avoid complications caused by photoproduct
formation. Probe light was provided by a 1000 W xenon arc lamp (Oriel) passed through
water and long pass filters to minimize exposure of the sample to unwanted wavelengths.
The probe beam was set perpendicular to the pump excitation. Both pump and probe
beams were controlled by mechanical shutters to reduce photodegradation of the samples.
The transient absorption signal was detected using a monochromater (Oriel 77250) and
photomultiplier tube (Hamamatsu R928) connected to an oscilloscope (LeCroy
Waverunner LT342L). Data were transferred to a computer and analysed using Igor Pro
(Wavemetrics Inc.) software.

A.14 Ultrafast Transient Absorption Spectroscopy
Broadband (440–700 nm) pump-probe femtosecond transient absorption spectra
were recorded as described elsewhere 6. The samples were placed in a quartz cuvette
(Spectrocell FUV R-3002-T, 2 mm path length, internal dimensions 2x2x45 mm) and
maintained at 25 oC using a temperature controlled cuvette holder (QNW FLASH 300)
under continuous stirring with an 8 mm diameter by 0.6 mm thick magnetic stir disc.
Samples were interrogated by a Ti:Sapphire oscillating laser (KLM, ~80 MHz, 840 nm)
pumped by 532nm Nd:YAG (neodymium-doped yttrium aluminum garnet) amplified
using a regenerative amplifier to produce ~ 200 μJ, 120 fs pulses at ~250 Hz. This pulse
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was split into two beams to produce a white-light continuum probe (WLC) and a pump.
The WLC was generated by focusing the beam into a slowly translating CaF2 crystal. The
840 nm pump beam was frequency-doubled to 420 nm by second harmonic generation in
a 2 mm type-I BBO crystal.
The pump was chopped at 125 Hz using a mechanical chopped and focused with a
40 cm quartz lens, while the WLC was focused using an off-axis 90o aluminum parabolic
mirror (focal length 10 cm). The angle between the focused pump and probe was ~ 2° at
the sample. Their relative polarization was set to magic angle (54.7°) using a half-wave
plate in the pump. A CMOS camera with 25 μm square pixels was placed at the focus to
measure the diameters of the focused beams. This is was to ensure that the entire probed
region was covered by the pump. The optical alignment of the motorized pump delay stage
was checked to ensure overlap over the full 3.5 ns range. Typical pump and probe beam
diameters were 264 and 126 μm.
Near-IR fundamental remaining in the WLC was removed with a Schott BG39 and
liquid NiSO4 filters. Pump power was measured before and after the completed scans by
reflecting the pump pulse before the cuvette onto a calibrated silicon joulemeter (Molectron
J3-S10), read by a 400 MHz digital oscilloscope (LeCroy Teledyne). The WLC was
dispersed in a ¼ meter spectrograph with about 4 nm bandpass (Digikrom 240i) The signal
was detected using a -40 oC cooled CCD detector (Andor, 1024x32 pixels) at ~250 Hz. The
system was controlled using an in-house developed LabView program. Data was taken as
an average of 5 scans every 0.7 nm from 200 fs to 3.5 ns, on a log time scale by averaging
400 spectra per measurement.
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A.15 Data Analysis of Transient Absorption Data
Data was analyzed using Matlab 2015b (MathWorks), Origin 8.1 SR 3 (Origin Lab
Corporation), and Mathematica 9 (Wolfram). Five pre-zero scans were used as a
background correction along with a dark bias current. Chirp effects were minimized by
discarding data with delays between 0 and 1 ps. The data was smoothed using an adjacent
averaging filter (5 point window) and normalized to the absorption at the earliest stable
time point (bleach 1 ps, triplet and stimulated emission 25 ps). A 10 nm bin was selected
about each wavelength of interest. Data was fit to single or double exponential functions
using functions built into Origin 8.1 SR 3.
The smoothed light-induced difference spectra at a range of times were also
analyzed using global fit analysis7,8 with an in-house script written in Mathematica 9. The
dimensionality of the data was reduced using the single value decomposition (SVD)
function and then fit to first-order kinetic models, using the FindMinimum function.

A.16 Flavin Photoproduct characterization
During the course of spectroscopic characterization, an absorption band at 400 nm
began to appear concurrently with the disappearance of the 475 nm feature. We attributed
this to photodamage of the flavin. To identify this product, a 10 μM sample of flavin in
redox buffer was deoxygenated by exchanging the atmosphere with high purity argon
(Airgas) passed through a Vd scrubbing system for 30 minutes under stirring and
illuminated for 1 hour. The sample was then studied using mass spectrometry and
fluorescence spectroscopy. From the data it was concluded that the major degradation
product was protein‐coupled lumichrome, consistent with known photodegradation
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pathways of free flavins in solution.

A.17 Electron Transfer Rate Calculations
Predicted electron transfer rates were calculated using the Moser‐Dutton Ruler, an
empirical expression that relates the rate of electron transfer in proteins to the edge‐toedge distance between donor and acceptor (R, in Angstroms), the driving force of the
transfer (ΔG) and the reorganization energy (λ). The distance in the flavoproteins is a
rough estimate determined using the distance between the β carbon of the ligating
cysteine and the Trp. Each helical turn was approximately 5.6 Å. It should be noted that
these distances are obtained from a model of general protein structure and do not take
into account any conformational flexibility that may be present for the relevant cofactors.
The driving force was calculated as the difference between the excited state of the flavin
singlet or triplet (calculated from the S0 or T0 emission wavelength, respectively), and the
redox potential of the reduced flavin and oxidized tryptophan radical. The reorganization
energy is difficult to determine experimentally and a medium‐to‐large value was
estimated for small polar proteins. Therefore, these rates are strictly used as a rough
estimate for the relative timescales and behavior expected in the flavin proteins.

A.18 Transient EPR
X-band (9.5 GHz) transient EPR spectra of W13 recorded following pulsed laser
excitation of the sample, which was performed using an OPO system (BBO-355visible/IR, Opta, Bensheim, Germany) pumped by a Nd:YAG laser (GCR 190-10,
Spectra Physics, Santa Clara, CA) at a wavelength of 460 nm and a pulse energy of (1.0 5
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0.2) mJ at a repetition rate of 1 Hz (pulse duration: 6 ns). A laboratory-built spectrometer
was used in combination with a Bruker microwave bridge (ER046 MRT, Bruker,
Billerica, MA). The sample was placed in a synthetic quartz (Suprasil) tube with an inner
diameter of 1 mm, and irradiated in a dielectric resonator (ER 4118X-MD5, Bruker). The
resonator was immersed into a laboratory-built nitrogen gas-flow cryostat and EPR data
collected at a temperature of (270.050.1) K stabilized by a temperature controller
(ITC503, Oxford Instruments, Abingdon, UK). The microwave power was set to 2
mWand the microwave frequency controlled by a frequency counter (5352B, Keysight
Technologies, Boeblingen, Germany). Signal acquisition was performed with a transient
recorder (9354A, Teledyne LeCroy, Chestnut Ridge, NYA) at a bandwidth of 25 MHz.
Distortions of the signal baseline introduced by the laser pulse were corrected by
subtracting a signal collected at an off-resonant magnetic field position.

A.19 1H-NMR for Tat Transport Project
Spectra were recorded at 298 K on 0.2–0.5 mM protein samples in buffer E, with
the addition of 10% D2O (spectrometer lock), and 1 mM trimethylsilyl propanate
(reference standard). 1H NMR spectra were recorded using a Bruker Avance 800 MHz
spectrometer fitted with a 5-mm QXI room temperature probe, equipped with z axis
gradients. One-dimensional experiments were acquired as accumulations of 4096
transients over a spectral width of 24.038 kHz, corresponding to a proton spectral width
of 30.0 ppm. All data were processed using an EM window function and 5-Hz line
broadening, without linear prediction in TopSpin (Bruker). Spectra were referenced to
trimethylsilyl propanate at 0 ppm prior to overlay and analysis.
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A.20 E. coli fractionation for the Tat Transport Project
To avoid overloading the Tat system for in vivo transport assays, genes were
cloned into the KpnI and XbaI sites of the low copy number pEXT22 plasmid for
expression from a tightly controlled tac promoter. The pEXT22 constructs were cotransformed into E. coli BL21(DE3) cells along with empty pET-21a(+). Cultures (50 ml)
were grown at 37 °C with shaking (230 rpm) in LB medium with 30 _gml_1 of
kanamycin and 100_gml_1 of ampicillin in 250-ml Erlenmeyer flasks. At an A600 of
_0.6 expression was induced with 0.5 mM IPTG for 2 h. Cells were harvested by
centrifugation (3,900_g, 30 min, 4 °C) and washed with buffer F (100mM Tris acetate,
pH 8.2, 500mM sucrose, 5mM EDTA). To prepare cell-free lysates, cells were resuspended to A600 _2 in 2 ml of chilled Buffer C and lysed by sonication on ice. The
supernatant, following clarification by centrifugation (16,600 g, 30 min 4 °C), was
collected as the cell-free extract. Periplasmic fractions were obtained using a procedure
based on the EDTA/lysozyme/osmotic shock method. Briefly, cells were re-suspended to
A600 _10 in 500 _l of chilled Buffer F followed by the addition of 5 _l of 1 mg ml_1
lysozyme. 500 _l of chilled QH2O was added and cells were incubated on ice for 5 min
prior to the addition of 20 µl of 1 M MgSO4. Spheroplasts were pelleted by
centrifugation at 16,600 g for 30 min in a pre-chilled (4 °C) microcentrifuge and the
supernatant was collected as the periplasm.

A.21 Immunoblotting in the Tat Transport Project
Proteins were separated by SDS-PAGE on 12% BisTris gels (Invitrogen), transferred to
polyvinylidene difluoride membranes (Invitrogen), and incubated with anti- His6 (Bethyl
203

Laboratories, Inc.), anti-_-lactamase (Abcam), or anti-GroEL (Sigma) primary antibodies
followed by an appropriate horseradish peroxidase-conjugated secondary antibody
(Sigma). Chemiluminescence was detected using the WESTAR ETA C 2.0
chemiluminescent substrate (Cyanagen) on an Amersham Biosciences Imager 600 (GE
Healthcare).

A.22 Purification of Tat-exported proteins from E. coli periplasm
The E. coli W3110 TatExpress cell line was transformed with the pEXT22 vector
containing TorA–BT6, TorA– BT6M1, or TorA–BT6M0. 500-ml cultures were grown in
2-liter Erlenmeyer flasks at 30 °C with 220 rpm agitation. At an A600 of _0.6, protein
production was induced with 0.5 mM IPTG and cultures were incubated for 24 h, after
which cells were harvested by centrifugation (3,900 _ g, 30 min, 4 °C). To obtain
periplasmic fractions, cells were resuspended in 10 ml of chilled buffer F. 10 ml of
chilled milliQH2O was added followed by 800 _l of 1 mg ml_1 of lysozyme and samples
were incubated on ice for 10 min. 800 _l of 1 M MgSO4 was added and the solution was
centrifuged (16,600 g, 30 min, 4 °C) with the supernatant collected as the periplasm.
Periplasmic fractions were applied to a Chelating Sepharose Fast Flow column (GE
Healthcare) pre-equilibrated with 10 mg ml_1 of nickel sulfate. The column was washed
with 20 ml of buffer A and 20 ml of buffer G (50 mM HEPES, pH 7.4, 500 mM NaCl,
50mMimidazole). Protein was eluted with 10 ml of buffer H(50mM HEPES, pH 7.4,
100mM NaCl, 400 mM imidazole) and the elution fractions were collected.
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A.23 Structural Modeling and molecular dynamics refinement of
protein structures
To generate illustrative structural models for BT6, the amino acid sequence was
run through the PEP-FOLD structure prediction algorithm for a total of 100 simulations,
from which the five best-scoring structures were selected for further analysis. All five
structures were four-helix bundles in agreement with the schematic structure described by
Farid et al. From these, a structure with both pairs of histidines positioned closest to their
respective heme-ligating positions was selected as a starting structure. From this
structure, mutants BT6M1 and BT6M0 were generated using PyMOL version 1.7
(PyMOL Molecular Graphics System Version 1.7, Schrodinger, LLC). Hemes (0, 1, or 2)
were manually docked into the bis-His sites of the structures.
To relax the starting structure into an energy-minimized conformation, molecular
dynamics (MD) pre-processing, production runs, and post-processing were performed
with Gromacs version 4.6. MD simulations were performed using the CHARMM27 force
field for proteins and TIP3P model for water. For the heme cofactor, parameters were
used for reduced, deprotonated, bis-His–ligated heme included in the CHARMM27 force
field. Covalent bonds were explicitly specified between the heme iron and the ε-nitrogen
of the relevant histidine residues. NaCl was added to a total concentration of 150 mM.
Each structure was equilibrated for 100 ps in the NVT ensemble, followed by 100 ps in
the NPT ensemble. Temperature and pressure/density plots (following NVT and NPT
equilibrations, respectively) were checked for convergence before proceeding to
production MD runs of 50 ns. Following production runs, trajectories were corrected for
periodicity and centered on the protein. Snapshots of the trajectories at 50 ns were
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exported to .pdb files. Visualization of calculations and structures was performed with the
PyMOL Molecular Graphics System version 1.7.

A.24 DNA manipulation for Tat Project
Synthetic genes encoding protein variants codon optimized for expression in E.
coli were purchased from DNA2.0 (now ATUM) or Integrated DNA Technologies. Point
mutations were generated using the QuikChange II Site-directed Mutagenesis Kit
(Agilent). The TorA Tat signal peptide was amplified from E. coli genomic DNA and
joined in-frame to constructs by overlap extension-PCR using Q5 High-Fidelity DNA
Polymerase (New England Biolabs). All plasmids were sequence verified by automated
DNA sequencing (GATC Biotech). Competent E. coli JM109 (Promega) was used for
cloning and was grown in Luria-Bertani (LB) broth/agar supplemented with the
appropriate antibiotic(s).

A.25 Production and purification of untagged proteins for Tat
Project
The high copy number pJexpress414 plasmid was used for recombinant protein
production under control of an IPTG inducible T7 promoter. E. coli BL21(DE3)
containing the desired plasmid was grown with shaking (230 rpm) at 37 °C in LB broth
with 100 µg ml-1 ampicillin to an absorbance at 600 nm (A600) of ~0.6. At this point IPTG
was added to a final concentration of 1 mM to induce expression and the cultures were
incubated for a further 16 h at 37 °C. Cells were harvested by centrifugation (4,400 g, 15

206

min, 4 °C) and resuspended in buffer A (50 mM HEPES, pH 7.4, 500 mM NaCl, 5 mM
imidazole). Cells were lysed by sonication on ice and the lysate was clarified by
centrifugation (53,000 g, 30 min, 4 °C). The supernatant was filtered through a 0.45-µm
filter and applied to a Chelating Sepharose Fast Flow column (GE Healthcare)
preequilibrated with 10 mg ml-1 of nickel sulfate. The column was washed with 5 column
volumes of buffer A with the flow-through and wash was collected and pooled. The
pooled sample was buffer exchanged into buffer B (50mM HEPES, pH 7.4) and further
purified by ion exchange chromatography on a Fast Flow Q-Sepharose column (GE
Healthcare) with a linear gradient of 0–1 M NaCl in buffer B. Where required proteins
were further purified by size exclusion chromatography on a Superdex 200 Increase
column (GE Healthcare) in buffer C (50 mM HEPES, pH 7.4, 200 mM NaCl). Where
necessary protein was concentrated using Vivaspin centrifugal concentrators (Sartorius).

A.26 C-heme Protein Expression and Purification
The genes for the proteins were cloned into the periplasmic expression vector
pMal-p4x (NEB, USA), replacing the maltose binding protein (MBP) N-terminal fusion
partner with a tobacco etch virus protease (TEV) cleavable hexahistidine tag, leaving the
N-terminal signal peptide attached via the cleavable purication tag in the vector pSHT.
The signal peptide facilitates periplasmic export through the Sec translocon and is
designed for in vivo cleavage prior to c-type heme incorporation.
Synthetic genes were obtained from DNA2.0 (USA), and expressed from a
modified variant of pMal-p4x (pSHT) and the proteins were purified using a combination
of standard nickel-affinity chromatography and high performance liquid chromatography.
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Appendix B: SVD

B.1 Singular Value Decomposition and Global Fitting for Analysis of
Spectral Series
Singular value decomposition (SVD) and Global Fitting will be used extensively to
analyze the transient absorption spectral data in the chapter 3. SVD is used to
deconvolute complex overlapping spectra and extract the spectra of individual species,
particularly those with small populations or weak extinction coefficients. For the
uninitiated, the mathematics can be overwhelming and will be described very briefly. A
more in-depth discussion with a special application to transient absorption spectroscopy
can be found here103. SVD is a purely mathematical operation that takes data, (here,
time resolved spectra) and breaks it down into a linear combination of components. This
informs us about the minimum number of unique species present, which helps to select a
physically meaningful and mathematically sound model. These components can then be
fit to a model by weighing their relative contribution to the data set. This results in the
wavelength dependence of each component (spectra of each species) and its evolution
over time (rate constants).
Transient absorption data can be displayed as an m x n matrix (A) consisting of
intensity values at different wavelengths over time. The A matrix can be broken down
into the product of three matrices (Fig 1.13)
A = USV T
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(Eq A. 1)

U (m x n) is the left singular vector consisting of the absorption intensity information at
each wavelength, S is the diagonal rank matrix (n x n) informing on the number of unique
species present and VT (n x n) is the right singular vector containing the time evolution of
each unique component (in order for the matrix multiplication to work, we must use the
transpose of V, VT). Once the minimum number of components is determined, the data
set can then be reconstructing using only these:
A = U′ S′ V ′

T

T

V′ = CTP

(Eq A. 2)
(Eq A. 3)

P (r x r) is the linear parameter (weighting) matrix of each component at each time. P
contains the solutions to differential rate equations for each component at each time,
given a particular model. For example, if we have a simple two state model, A B, a
solution for determining the concentration of A at time t would be [A] = e-kt. CT (n x r)
is the transpose (again for matrix multiplication reasons) of the amplitude matrix of each
unique species (r) at each time. This can be thought of as the weighting parameter for
each component, and tells us its relative contribution to the total observed spectra at each
time. We then iterate through this parameter with a fitting algorithm (e.g.
MATHEMATICA FindMinimum) such that the difference between acquired data and the
model fit is minimized:
2

s 2 ||V ′ − C ′ P|| = min(X 2 )

(Eq A. 4)

CT now contains the rate constants of each relevant spectral species. Finally, owing to the
relation:
T

U ′ S′ V ′ = FC T
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(Eq A. 5)

We are able to use the output of the SVD, U’S’V’T, and the minimized CT to solve for F
(m x r), a matrix containing the intensities of each component at each wavelength; or
more simply put, the spectra of each component.

Figure B.1: A data matrix of time resolved transient absorption data (A) can be broken down into the
product of three matrices: U, the left singular vector consisting of the wavelength dependence of each
component, S, the square diagonal rank matrix informing on the significance of each component and VT the
right singular vector showing the time evolution of each component.
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Appendix C: Protein and DNA
Sequences
The upstream sequence contains the start codon (part of the of the NdeI restriction site
when used), the 6x histidine tag, linker and the TEV protease recognition site
(ENLYFQG). The “˅” indicates the proteolysis site of TEV protease, treatment by which
separates the purification tag from the rest of the protein, leaving only an N-terminal
glycine behind. An “*” indicates the stop codon.

Proteins from Chapter 3
HT-1
1.

CGGG ELWKLHEELLKKFEELLKLHEERLKKL (x4)

HT-2
1.

CGGG EIWKLHEEFLKKFEELLKLHEERLKKL (x4)

HT-3
1.

CGGG EIWKQHEEALKKFEEALKQFEELKKL (x4)

HT-4
1.

CGGG EIWKQHEDAQKFEEALKQFEELKQL (x4)

HD-3
1.
2.

G EIWKQHEDALQKFEEALNQFEDLKQL GGSGCGSG
G EIWKQHEDALQKFEEALNQFEDLKQL

HD-3 C38S
1.
2.

G EIWKQHEDALQKFEEALNQFEDLKQL GGSGSGSG
G EIWKQHEDALQKFEEALNQFEDLKQL
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HD-3 Glutamate-to-Alanine Knockout
1. G EIWKQHADALQKFAEALNQFADLKQL
GGSGCGSG
2. G EIWKQHADALQKFAEALNQFADLKQL

MT-2
MHHHHHHGGDGGTENLYFQ˅G
1. ELLKKLEELLKKLEELLKKLEELLKL
GGSGSGSGG
2. ELLKKLEELLKKLEELLKKLEELLKL
GGSGWGSGG
3. ELLKKLEELLKKLEELLKKLEELLKL
GGSGSGSGG
4. ELLKKLEELLKKLEELLKKLEELLKL

MT-3
MHHHHHHGGDGGTENLYFQ˅G
1. ELLKKHEELLKKLEELLKKLEELLKL
GGSGSGSGG
2. ELLKKHEELLKKLEELLKKLEELLKL
GGSGWGSGG
3. ELLKKHEELLKKLEELLKKLEELLKL
GGSGSGSGG
4. ELLKKHEELLKKLEELLKKLEELLKL

MT-4
MHHHHHHGGDGGTENLYFQ˅G
1. ELLKKHEEALKKLEELLKKAEEELKL
GGSGSGSGG
2. ELLKKHEEALKKLEELLKKLEEELKL
GGSGWGSGG
3. ELLKKHEEALKKLEELLKKLEELLKL
GGSGSGSGG
4. ELLKKHEEALKKLEELLKKAEELLKL

MT-5
MHHHHHHGGDGGTENLYFQ˅G
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1. ELLKKHEEALKKFEELLKKFEEELKL
GGSGSGSGG
2. ELLKKHEEALKKFEELLKKFEEELKL
GGSGWGSGG
3. ELLKKHEEALKKFEELLKKFEELLKL
GGSGSGSGG
4. ELLKKHEEALKKFEELLKKFEELLKL

MT-5 Glutamate-to-Alanine Knockout
MHHHHHHGGDGGTENLYFQ˅G
1. ELLKKHAEALKKFAELLKKFAEELKL
GGSGSGSGG
2. ELLKKHAEALKKFAELLKKFAEELKL
GGSGWGSGG
3. ELLKKHAEALKKFAELLKKFAELLKL
GGSGSGSGG
4. ELLKKHAEALKKFAELLKKFAELLKL

HM-1
MHHHHHHGGDGGTENLYFQ˅G
1. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
3. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIWKQHEDALQKFEEALNQFEDLKQL
HM-1 2nd site knockout
MHHHHHHGGDGGTENLYFQ˅G
1. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIWKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
3. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIWKQFEDALQKFEEALNQFEDLKQL

MZH3
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MGKGGHHHHHHGGDGENLYFQ˅G
1. SPELRQEHQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEK
ARN
2. PEKKSVLQKILEDEEKHIELLETLQQTGQEAQQLLQELQQTGQELWQL
GGSGG
3. PELRQKHQQLAQKIQQLLQKHQQLGAKILEDEEKHIELLETIL
GGSGG
4. DELRELLKGELQGIKQYRELQQLGQKAQQLVQKLQQTGQKLWQLG

MZH3 H9A
MGKGGHHHHHHGGDGENLYFQ˅G
1. SPELRQEAQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEK
ARN
2. PEKKSVLQKILEDEEKHIELLETLQQTGQEAQQLLQELQQTGQELWQL
GGSGG
3. PELRQKHQQLAQKIQQLLQKHQQLGAKILEDEEKHIELLETIL
GGSGG
4. DELRELLKGELQGIKQYRELQQLGQKAQQLVQKLQQTGQKLWQLG

MZH3 H110A
MGKGGHHHHHHGGDGENLYFQ˅G
1. SPELRQEHQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEK
ARN
2. PEKKSVLQKILEDEEKHIELLETLQQTGQEAQQLLQELQQTGQELWQL
GGSGG
3. PELRQKAQQLAQKIQQLLQKHQQLGAKILEDEEKHIELLETIL
GGSGG
4. DELRELLKGELQGIKQYRELQQLGQKAQQLVQKLQQTGQKLWQLG

MZH3 H110A T91A
MGKGGHHHHHHGGDGENLYFQ˅G
1. GSPELRQEHQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEK
ARN
2. PEKKSVLQKILEDEEKHIELLETLQQTGQEAQQLLQELQQAGQELWQL
GGSGG
3. PELRQKAQQLAQKIQQLLQKHQQLGAKILEDEEKHIELLETIL
GGSGG
4. DELRELLKGELQGIKQYRELQQLGQKAQQLVQKLQQTGQKLWQLG

DDH2
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MGKGGHHHHHHGGDGENLYFQ˅G
1. GGSPELRQEHQQLAQEFQQLLQEHQQLAREL
GGSGG
2. DPAEELQQTGQEAQQLLQELQQTGQELWQL
GGSGG
3. PELRQKHQQLAQKIQQLLQKHQQLARKL
GGSGG
4. DPAEKLQQTGQKAQQLVQKLQQTGQKLWQLG

DDH2a
MGKGGHHHHHHGGDGENLYFQ˅G
1. GGSPELRQEHQQLAQEFQQLLQEFQQLAREL
GGSGG
2. DPAEELQQTGQEAQQLLQELQQTGQELWQL
GGSGG
3. PELRQKHQQLAQKIQQLLQKFQQLARKL
GGSGG
4. DPAEKLQQTGQKAQQLVQKLQQTGQKLWQLG

DDH2a H10A
MGKGGHHHHHHGGDGENLYFQ˅G
1. GGSPELRQEAQQLAQEFQQLLQEFQQLAREL
GGSGG
2. DPAEELQQTGQEAQQLLQELQQTGQELWQL
GGSGG
3. PELRQKHQQLAQKIQQLLQKFQQLARKL
GGSGG
4. DPAEKLQQTGQKAQQLVQKLQQTGQKLWQLG

DDH2a H78A
MGKGGHHHHHHGGDGENLYFQ˅G
1. GGSPELRQEHQQLAQEFQQLLQEFQQLAREL
GGSGG
2. DPAEELQQTGQEAQQLLQELQQTGQELWQL
GGSGG
3. PELRQKAQQLAQKIQQLLQKFQQLARKL
GGSGG
4. DPAEKLQQTGQKAQQLVQKLQQTGQKLWQLG
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DDH2b
MGKGGHHHHHHGGDGENLYFQ˅G
1. GGSPELRQEFQQLAQEFQQLLQEHQQLAREL
GGSGG
2. DPAEELQQTGQEAQQLLQELQQTGQELWQL
GGSGG
3. PELRQKFQQLAQKIQQLLQKHQQLARKL
GGSGG
4. DPAEKLQQTGQKAQQLVQKLQQTGQKLWQLG

DDH2b H24A
MGKGGHHHHHHGGDGENLYFQ˅G
1. GGSPELRQEFQQLAQEFQQLLQEAQQLAREL
GGSGG
2. DPAEELQQTGQEAQQLLQELQQTGQELWQL
GGSGG
3. PELRQKFQQLAQKIQQLLQKHQQLARKL
GGSGG
4. DPAEKLQQTGQKAQQLVQKLQQTGQKLWQLG

DDH2b H92A
MGKGGHHHHHHGGDGENLYFQ˅G
1. GGSPELRQEFQQLAQEFQQLLQEHQQLAREL
GGSGG
2. DPAEELQQTGQEAQQLLQELQQTGQELWQL
GGSGG
3. PELRQKFQQLAQKIQQLLQKAQQLARKL
GGSGG
4. DPAEKLQQTGQKAQQLVQKLQQTGQKLWQLG

DDH3 H78A
MGKGGHHHHHHGGDGENLYFQ˅G
1. GGSPELRQEHQQLAQEFQQLLQEIQQLLREL
GGSGG
2. DPAEEIQQLLQEAQQLLQELQQTGQELWQL
GGSGG
3. PELRQKHQQLAQKIQQLIQKIQQLLRKL
GGSGG
4. DPAEKLQQLVQKAQQLVQKVQQTGQKLWQLG
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Proteins from Chapter 4
SHF control (C9)
MHHHHHHGGDGGTENLYFQ˅G
1. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKFEEALNQFEDLKQL
GGSGSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF W13
MHHHHHHGGDGGTENLYFQ˅G
1. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKWEEALNQFEDLKQL
GGSGSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF W14
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKFWEALNQFEDLKQL
GGSGSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF W15
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKFEWALNQFEDLKQL
GGSGSGSGG
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3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF W16
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKFEEWLNQFEDLKQL
GGSGSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF W17
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKFEEWLNQFEDLKQL
GGSGSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF W18
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKFEEALWQFEDLKQL
GGSGSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*
SHF W19
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKFEEALNWFEDLKQL
GGSGSGSG
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3. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF W20
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQHEDCLQKFEEALNQWEDLKQL
GGSGSGSGG
3. EIQKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQHEDALQKFEEALNQFEDLKQL*
SHF “W-Loop”
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKFEEALNQFEDLKQL
GGSWSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF Y13
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKYEEALNQFEDLKQL
GGSGSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*
SHF Y16
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKFEEYLNQFEDLKQL
GGSGSGSGG
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3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF Y20
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQHEDCLQKFEEALNQYEDLKQL
GGSGSGSGG
3. EIQKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQHEDALQKFEEALNQFEDLKQL*

SHF W13W16
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKWEEWLNQFEDLKQL
GGSGSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF W13W20
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKWEEALNQWEDLKQL
GGSGSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF W16W20
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKFEEWLNQWEDLKQL
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GGSGSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF W13Y16
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKWEEYLNQFEDLKQL
GGSGSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF W13Y20
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKWEEALNQYEDLKQL
GGSGSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

SHF W16Y20
MHHHHHHGGDGGTENLYFQ˅G
1. GEIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIQKQFEDCLQKFEEWLNQYEDLKQL
GGSGSGSGG
3. EIQKQFEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIQKQFEDALQKFEEALNQFEDLKQL*

FMK3 control (C128)
MHHHHHHGGDGGTENLYFQ˅G
1. GGSPELRQELQQLAQEFQQLLQEIQQLLREL
GGSGG
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3. DPAEEIQQLLQEAQQLLQELQQLAQELQQL
GGSGG
4. PELRQKLQQLAQKIQQLIQKIQQLLRKL
GGSGG
5. DPAEKLQQLVQKAQQLVQKVQQLCQKLQQLG
FMK3_close_W (“V124W”)
MHHHHHHGGDGGTENLYFQ˅G
1. GGSPELRQELQQLAQEFQQLLQEIQQLLREL
GGSGG
2. DPAEEIQQLLQEAQQLLQELQQLAQELQQL
GGSGG
3. PELRQKLQQLAQKIQQLIQKIQQLLRKL
GGSGG
4. DPAEKLQQLVQKAQQLVQKWQQLCQKLQQLG

FMK3_W14
MHHHHHHGGDGGTENLYFQ˅G
1. GGSPELRQELQQLWQEFQQLLQEIQQLLREL
GGSGG
2. DPAEEIQQLLQEAQQLLQELQQLAQELQQL
GGSGG
3. PELRQKLQQLAQKIQQLIQKIQQLLRKL
GGSGG
4. DPAEKLQQLVQKAQQLVQKVQQLCQKLQQLG

FMK3_W15
MHHHHHHGGDGGTENLYFQ˅G
1. GGSPELRQELQQLAWEFQQLLQEIQQLLREL
GGSGG
2. DPAEEIQQLLQEAQQLLQELQQLAQELQQL
GGSGG
3. PELRQKLQQLAQKIQQLIQKIQQLLRKL
GGSGG
4. DPAEKLQQLVQKAQQLVQKVQQLCQKLQQLG

FMK3_W16
MHHHHHHGGDGGTENLYFQ˅G
1. GGSPELRQELQQLAQWFQQLLQEIQQLLREL
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GGSGG
2. DPAEEIQQLLQEAQQLLQELQQLAQELQQL
GGSGG
3. PELRQKLQQLAQKIQQLIQKIQQLLRKL
GGSGG
4. DPAEKLQQLVQKAQQLVQKVQQLCQKLQQLG
FMK3_C128_F17W_I85A (“W17”)
MHHHHHHGGDGGTENLYFQ˅G
1. GGSPELRQELQQLAQEWQQLLQEIQQLLREL
GGSGG
2. DPAEEIQQLLQEAQQLLQELQQLAQELQQL
GGSGG
3. PELRQKLQQLAQKAQQLIQKIQQLLRKL
GGSGG
4. DPAEKLQQLVQKAQQLVQKVQQLCQKLQQLG

FMK3_W18
MHHHHHHGGDGGTENLYFQ˅G
1. GGSPELRQELQQLAQEFWQLLQEIQQLLREL
GGSGG
2. DPAEEIQQLLQEAQQLLQELQQLAQELQQL
GGSGG
3. PELRQKLQQLAQKIQQLIQKIQQLLRKL
GGSGG
4. DPAEKLQQLVQKAQQLVQKVQQLCQKLQQLG

FMK3_W19
MHHHHHHGGDGGTENLYFQ˅G
1. GGSPELRQELQQLAQEFQWLLQEIQQLLREL
GGSGG
2. DPAEEIQQLLQEAQQLLQELQQLAQELQQL
GGSGG
3. PELRQKLQQLAQKIQQLIQKIQQLLRKL
GGSGG
4. DPAEKLQQLVQKAQQLVQKVQQLCQKLQQLG

FMK3_W20
MHHHHHHGGDGGTENLYFQ˅G
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1. GGSPELRQELQQLAQEFQQWLQEIQQLLREL
GGSGG
2. DPAEEIQQLLQEAQQLLQELQQLAQELQQL
GGSGG
3. PELRQKLQQLAQKIQQLIQKIQQLLRKL
GGSGG
4. DPAEKLQQLVQKAQQLVQKVQQLCQKLQQLG

Proteins from Chapter 5
BT6
MNNNDLFQASRRRFLAQLGGLTVAGMLGPSLLTPRRATAAQA˅A
MGGDGENLYFQ˅G
1. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
3. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIWKQHEDALQKFEEALNQFEDLKQL
HHHHHH*
BT6 Tor-KK Knockout
MNNNDLFQASKKRFLAQLGGLTVAGMLGPSLLTPRRATAAQA˅A
MGGDGENLYFQ˅G
1. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
3. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIWKQHEDALQKFEEALNQFEDLKQL
HHHHHH*

BT6M1
MNNNDLFQASRRRFLAQLGGLTVAGMLGPSLLTPRRATAAQA˅A
MGGDGENLYFQ˅G
1. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIWKQAEDALQKFEEALNQFEDLKQL
GGSGSGSGG
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3. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIWKQHEDALQKFEEALNQFEDLKQL
HHHHHH*

BT6M0
MNNNDLFQASRRRFLAQLGGLTVAGMLGPSLLTPRRATAAQA˅A
MGGDGENLYFQ˅G
1. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
2. EIWKQAEDALQKFEEALNQFEDLKQL
GGSGSGSGG
3. EIWKQAEDALQKFEEALNQFEDLKQL
GGSGSGSGG
4. EIWKQHEDALQKFEEALNQFEDLKQL
HHHHHH*

GL-8 B-type
MHHHHHHGGDGGTENLYFQ˅G
1. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
2. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGSGSGG
3. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGKGSGG
4. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
5. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
6. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGSGSGG
7. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGKGSGG
8. EIWKQHEDALQKFEEALNQFEDLKQL

GL-12 B-type
MHHHHHHGGDGGTENLYFQ˅G
1. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
2. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGSGSGG
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3. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGKGSGG
4. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
5. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
6. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGSGSGG
7. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGKGSGG
8. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
9. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
10. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGSGSGG
11. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGKGSGG
12. EIWKQHEDALQKFEEALNQFEDLKQL

GL-16 B-type
MHHHHHHGGDGGTENLYFQ˅G
1. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
2. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGSGSGG
3. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGKGSGG
4. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
5. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
6. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGSGSGG
7. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGKGSGG
8. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
9. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
10. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGSGSGG
11. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGKGSGG
12. EIWKQHEDALQKFEEALNQFEDLKQL
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GGSGSGSGG
13. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
14. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGSGSGG
15. EIKQRAEDALRKFEEALKRFEDKKQK
GGSGKGSGG
16. EIWKQHEDALQKFEEALNQFEDLKQL

GL-8 C-type
MKIKTGARILALALTTMMFSASALAKHHHHHHGSSGENLYFQ˅G
1. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
2. ECIACHEDALRKFEEALKRFEDKKQK
GGSGSGSGG
3. ECIACHEDALRKFEEALKRFEDKKQK
GGSGKGSGG
4. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
5. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
6. ECIACHEDALRKFEEALKRFEDKKQK
GGSGKGSGG
7. ECIACHEDALRKFEEALKRFEDKKQK
GGSGSGSGG
8. EIWKQHEDALQKFEEALNQFEDLKQL

GL-12 C-type
MKIKTGARILALALTTMMFSASALAKHHHHHHGSSGENLYFQ˅G
1. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
2. ECIACHEDALRKFEEALKRFEDKKQK
GGSGSGSGG
3. ECIACHEDALRKFEEALKRFEDKKQK
GGSGKGSGG
4. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
5. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
6. ECIACHEDALRKFEEALKRFEDKKQK
GGSGSGSGG
7. ECIACHEDALRKFEEALKRFEDKKQK
GGSGKGSGG
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8. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
9. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
10. ECIACHEDALRKFEEALKRFEDKKQK
GGSGSGSGG
11. ECIACHEDALRKFEEALKRFEDKKQK
GGSGKGSGG
12. EIWKQHEDALQKFEEALNQFEDLKQL

GL-16 C-type
MKIKTGARILALALTTMMFSASALAKHHHHHHGSSGENLYFQ˅G
1. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
2. ECIACHEDALRKFEEALKRFEDKKQK
GGSGSGSGG
3. ECIACHEDALRKFEEALKRFEDKKQK
GGSGKGSGG
4. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
5. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
6. ECIACHEDALRKFEEALKRFEDKKQK
GGSGSGSGG
7. ECIACHEDALRKFEEALKRFEDKKQK
GGSGKGSGG
8. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
9. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
10. ECIACHEDALRKFEEALKRFEDKKQK
GGSGSGSGG
11. ECIACHEDALRKFEEALKRFEDKKQK
GGSGKGSGG
12. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGSGSGG
13. EIWKQHEDALQKFEEALNQFEDLKQL
GGSGKGSGG
14. ECIACHEDALRKFEEALKRFEDKKQK
GGSGSGSGG
15. ECIACHEDALRKFEEALKRFEDKKQK
GGSGKGSGG
16. EIWKQHEDALQKFEEALNQFEDLKQL*
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Expression Vector DNA Sequences
PJ414Express vector (NdeI site, XhoI site)
CTCATGACCAAAATCCCTTAACGTGAGTTACGCGCGCGTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAG
ATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCT
ACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAG
CGCAGATACCAAATACTGTTCTTCTAGTGTAGCCGTAGTTAGCCCACCACTTCAAGAACTCTGTAGCACCG
CCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGG
GTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGC
CCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTT
CCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCT
TCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTT
TGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCC
TTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGC
CTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGG
AAGGCGAGAGTAGGGAACTGCCAGGCATCAAACTAAGCAGAAGGCCCCTGACGGATGGCCTTTTTGCGTTT
CTACAAACTCTTTCTGTGTTGTAAAACGACGGCCAGTCTTAAGCTCGGGCCCCCTGGGCGGTTCTGATAAC
GAGTAATCGTTAATCCGCAAATAACGTAAAAACCCGCTTCGGCGGGTTTTTTTATGGGGGGAGTTTAGGGA
AAGAGCATTTGTCAGAATATTTAAGGGCGCCTGTCACTTTGCTTGATATATGAGAATTATTTAACCTTATA
AATGAGAAAAAAGCAACGCACTTTAAATAAGATACGTTGCTTTTTCGATTGATGAACACCTATAATTAAAC
TATTCATCTATTATTTATGATTTTTTGTATATACAATATTTCTAGTTTGTTAAAGAGAATTAAGAAAATAA
ATCTCGAAAATAATAAAGGGAAAATCAGTTTTTGATATCAAAATTATACATGTCAACGATAATACAAAATA
TAATACAAACTATAAGATGTTATCAGTATTTATTATCATTTAGAATAAATTTTGTGTCGCCCTTCCGCGAA
ATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACT
TTTGAAGGAGATATACATATG...
...CTCGAGCCCCCTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCCCCTGAGAC
GCGTCAATCGAGTTCGTACCTAAGGGCGACACCCCCTAATTAGCCCGGGCGAAAGGCCCAGTCTTTCGACT
GAGCCTTTCGTTTTATTTGATGCCTGGCAGTTCCCTACTCTCGCATGGGGAGTCCCCACACTACCATCGGC
GCTACGGCGTTTCACTTCTGAGTTCGGCATGGGGTCAGGTGGGACCACCGCGCTACTGCCGCCAGGCAAAC
AAGGGGTGTTATGAGCCATATTCAGGTATAAATGGGCTCGCGATAATGTTCAGAATTGGTTAATTGGTTGT
AACACTGACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCT
GATAAATGCTTCAATAATATTGAAAAAGGAAGAATATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCC
TTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGA
TCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCC
CCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGAC
GCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCAC
AGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACA
CTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGG
GATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACAC
CACGATGCCTGTAGCGATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCC
GGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCT
GGCTGGTTTATTGCTGATAAATCCGGAGCCGGTGAGCGTGGTTCTCGCGGTATCATCGCAGCGCTGGGGCC
AGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATA
GACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAAGCGGCGCGCCATCGAATGGCGCAAAAC
CTTTCGCGGTATGGCATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATATGAAACCAGTAACGT
TATACGATGTCGCAGAGTATGCCGGTGTCTCTTATCAGACCGTTTCCCGCGTGGTGAACCAGGCCAGCCAC
GTTTCTGCGAAAACGCGGGAAAAAGTGGAAGCGGCGATGGCGGAGCTGAATTACATTCCCAACCGCGTGGC
ACAACAACTGGCGGGCAAACAGTCGTTGCTGATTGGCGTTGCCACCTCCAGTCTGGCCCTGCACGCGCCGT
CGCAAATTGTCGCGGCGATTAAATCTCGCGCCGATCAACTGGGTGCCAGCGTGGTGGTGTCGATGGTAGAA
CGAAGCGGCGTCGAAGCCTGTAAAGCGGCGGTGCACAATCTTCTCGCGCAACGCGTCAGTGGGCTGATCAT
TAACTATCCGCTGGATGACCAGGATGCCATTGCTGTGGAAGCTGCCTGCACTAATGTTCCGGCGTTATTTC
TTGATGTCTCTGACCAGACACCCATCAACAGTATTATTTTCTCCCATGAGGACGGTACGCGACTGGGCGTG
GAGCATCTGGTCGCATTGGGTCACCAGCAAATCGCGCTGTTAGCGGGCCCATTAAGTTCTGTCTCGGCGCG
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TCTGCGTCTGGCTGGCTGGCATAAATATCTCACTCGCAATCAAATTCAGCCGATAGCGGAACGGGAAGGCG
ACTGGAGTGCCATGTCCGGTTTTCAACAAACCATGCAAATGCTGAATGAGGGCATCGTTCCCACTGCGATG
CTGGTTGCCAACGATCAGATGGCGCTGGGCGCAATGCGCGCCATTACCGAGTCCGGGCTGCGCGTTGGTGC
GGATATCTCGGTAGTGGGATACGACGATACCGAAGATAGCTCATGTTATATCCCGCCGTTAACCACCATCA
AACAGGATTTTCGCCTGCTGGGGCAAACCAGCGTGGACCGCTTGCTGCAACTCTCTCAGGGCCAGGCGGTG
AAGGGCAATCAGCTGTTGCCAGTCTCACTGGTGAAAAGAAAAACCACCCTGGCGCCCAATACGCAAACCGC
CTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGT
GA

PMAL vector (NdeI site, BamHI site)
CCGACACCATCGAATGGTGCAAAACCTTTCGCGGTATGGCATGATAGCGCCCGGAAGAGAGTCAATTCAGG
GTGGTGAATGTGAAACCAGTAACGTTATACGATGTCGCAGAGTATGCCGGTGTCTCTTATCAGACCGTTTC
CCGCGTGGTGAACCAGGCCAGCCACGTTTCTGCGAAAACGCGGGAAAAAGTGGAAGCGGCGATGGCGGAGC
TGAATTACATTCCCAACCGCGTGGCACAACAACTGGCGGGCAAACAGTCGTTGCTGATTGGCGTTGCCACC
TCCAGTCTGGCCCTGCACGCGCCGTCGCAAATTGTCGCGGCGATTAAATCTCGCGCCGATCAACTGGGTGC
CAGCGTGGTGGTGTCGATGGTAGAACGAAGCGGCGTCGAAGCCTGTAAAGCGGCGGTGCACAATCTTCTCG
CGCAACGCGTCAGTGGGCTGATCATTAACTATCCGCTGGATGACCAGGATGCCATTGCTGTGGAAGCTGCC
TGCACTAATGTTCCGGCGTTATTTCTTGATGTCTCTGACCAGACACCCATCAACAGTATTATTTTCTCCCA
TGAAGACGGTACGCGACTGGGCGTGGAGCATCTGGTCGCATTGGGTCACCAGCAAATCGCGCTGTTAGCGG
GCCCATTAAGTTCTGTCTCGGCGCGTCTGCGTCTGGCTGGCTGGCATAAATATCTCACTCGCAATCAAATT
CAGCCGATAGCGGAACGGGAAGGCGACTGGAGTGCCATGTCCGGTTTTCAACAAACCATGCAAATGCTGAA
TGAGGGCATCGTTCCCACTGCGATGCTGGTTGCCAACGATCAGATGGCGCTGGGCGCAATGCGCGCCATTA
CCGAGTCCGGGCTGCGCGTTGGTGCGGATATCTCGGTAGTGGGATACGACGATACCGAAGACAGCTCATGT
TATATCCCGCCGTTAACCACCATCAAACAGGATTTTCGCCTGCTGGGGCAAACCAGCGTGGACCGCTTGCT
GCAACTCTCTCAGGGCCAGGCGGTGAAGGGCAATCAGCTGTTGCCCGTCTCACTGGTGAAAAGAAAAACCA
CCCTGGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAG
GTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTAAGTTAGCTCACTCATTAGGCACAAT
TCTCATGTTTGACAGCTTATCATCGACTGCACGGTGCACCAATGCTTCTGGCGTCAGGCAGCCATCGGAAG
CTGTGGTATGGCTGTGCAGGTCGTAAATCACTGCATAATTCGTGTCGCTCAAGGCGCACTCCCGTTCTGGA
TAATGTTTTTTGCGCCGACATCATAACGGTTCTGGCAAATATTCTGAAATGAGCTGTTGACAATTAATCAT
CGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCCAGTCCGTTTAGGTG
TTTTCACGAGCACTTCACCAACAAGGACCATAGCATATG...
...GGATCCTCTAGAGTCGACCTGCAGGCAAGCTTGGCACTGGCCGTCGTTTTACAACGTCGTGACTGGGA
AAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAG
AGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGCAGCTTGGCTGTTTTGGC
GGATGAGATAAGATTTTCAGCCTGATACAGATTAAATCAGAACGCAGAAGCGGTCTGATAAAACAGAATTT
GCCTGGCGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGAAACGCCGTAGCGCCG
ATGGTAGTGTGGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGGCATCAAATAAAACGAAAGGCTCAGTC
GAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATCCGCCGG
GAGCGGATTTGAACGTTGCGAAGCAACGGCCCGGAGGGTGGCGGGCAGGACGCCCGCCATAAACTGCCAGG
CATCAAATTAAGCAGAAGGCCATCCTGACGGATGGCCTTTTTGCGTTTCTACAAACTCTTTTGTTTATTTT
TCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAA
AGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGT
TTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACA
TCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTCCCAATGATGAGC
ACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAACTCGGTCGCCG
CATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGA
CAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCTGACAACG
ATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTG
GGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAA
CGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAG
GCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGG
AGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAG
TTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCA
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CTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTACCCCGGTTGAT
AATCAGAAAAGCCCCAAAAACAGGAAGATTGTATAAGCAAATATTTAAATTGTAAACGTTAATATTTTGTT
AAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTT
ATAAATCAAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAG
AACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACC
CAAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTA
GAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGG
GCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCG
TTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAAT
CTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTC
TTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTA
GGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGC
TGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGT
CGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTA
CAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAG
GGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGT
TTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCC
AGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATC
CCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCG
AGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGC
GGTATTTCACACCGCATATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGTAT
ACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCC
TGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCA
GAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCTGCGGTAAAGCTCATCAGCGTGGTCGTGCAGCG
ATTCACAGATGTCTGCCTGTTCATCCGCGTCCAGCTCGTTGAGTTTCTCCAGAAGCGTTAATGTCTGGCTT
CTGATAAAGCGGGCCATGTTAAGGGCGGTTTTTTCCTGTTTGGTCACTGATGCCTCCGTGTAAGGGGGATT
TCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGAGGATGCTCACGATACGGGTTACTGATGATGAAC
ATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACTGGCGGTATGGATGCGGCGGGACCAGAGAAAAATC
ACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGATGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGC
GATGCAGATCCGGAACATAATGGTGCAGGGCGCTGACTTCCGCGTTTCCAGACTTTACGAAACACGGAAAC
CGAAGACCATTCATGTTGTTGCTCAGGTCGCAGACGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCGCGT
ATCGGTGATTCATTCTGCTAACCAGTAAGGCAACCCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCAC
GATCATGCGCACCCGTGGCCAGGACCCAACGCTGCCCGAAATT

pEXT22 (KpnI site, XbaI site)
TTCGAGCTCGGTACC...
...TCTAGAGTCGACCTGCAGGCATGCAAGCTTCTGTTTTGGCGGATGAGAGAAGAAATTCGTCGCCCGCC
ATAAACTGCCAGGCATCAAATTAAGCAGAAGGCCATCCTGACGGATGGCCTTTTTGCGTTTCTACAAACTC
TTCCTGTCTAGCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATAC
ATTCAAATATGTATCCGCTCATGAGCTTCACGCTGCCGCAAGCACTCAGGGCGCAAGGGCTGCTAAAGGAA
GCGGAACACGTAGAAAGCCAGTCCGCAGAAACGGTGCTGACCCCGGATGAATGTCAGCTACTGGGCTATCT
GGACAAGGGAAAACGCAAGCGCAAAGAGAAAGCAGGTAGCTTGCAGTGGGCTTACATGGCGATAGCTAGAC
TGGGCGGTTTTATGGACAGCAAGCGAACCGGAATTGCCAGCTGGGGCGCCCTCTGGTAAGGTTGGGAAGCC
CTGCAAAGTAAACTGGATGGCTTTCTTGCCGCCAAGGATCTGATGGCGCAGGGGATCAAGATCTGATCAAG
AGACAGGATGAGGATCGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTG
GAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGGCTGTC
AGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAGGACGAGG
CAGCGCGGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCG
GGAAGGGACTGGCTGCTATTGGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGA
GAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACC
ACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTG
GACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCATGCCCGACGGCGA
GGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGAT
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TCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCT
GAAGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCG
CATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGAGCGGGACTCTGGGGTTCGAAATGACCGACCAAGC
GACGCCCAACCTGCCATCACGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATCG
TTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAGTTCTTCGCCCACCCCGAT
ATTGATTACGTGTTTGAATCATTGCATCGCCTGTAAATTTTTAACTTGTCCTATTTTTGTCATTACCACGT
ATATACACATGTATAACAATTCAGATATCGTTACCAGGATATGCCGCATCAGCGGCATGGAAGGCGGCACT
CTGTTGTTTCATATGATACAGGAGTAAAACCGCCGAAGCCCGGCGTAAGCCGGTACTGATTGATAGATTTC
ACCTTACCCATCCCCAGCCCTGCCAGACCATACCCGCTTTCAGCCATGAGAGAGCTTCTGTGCGCGGTCGG
AGTGGTCCCGACGAGGGTTTACCCGAAGTCGGGGCGTATCTCCGCGTTAGCGGGCCGTCAGGGCCGCTTAC
GAGCGTGTACTGAGAACTTCCAGCGAGAAGACTGACAGCGATGATGAAGTAGTTACAACATTCATAATTAA
AAGCGACTCTGTTCCGGCCCTTCGGGCCGGGGCGGGGCCGCTTTTCAGTTATGAGGGAGGGGCTTTGTGGT
TTCAGTTCTGCGCTGGACCGGGGTTTTTCTGGTGGTTGTGTCTGAGTGTTGTAACTAAAGCGGCTCCGGTA
GGGGCCCGCCGCTTGCGGTGGGAGGTGCATATCTGTCTGTCCACAGGACAGGCAGTGAATAGGTTTTCTTT
TTAAATGAATGTAATTAAGTAGTTTAAAGGAGATATAAACAGGTGTTTAAAAGATACATTGCACCCTGTAA
CGCTGGCGGATGGCGCTTTATGACATGAACGGTTGTAACCTTATGGGGAAGTCCCTTGCAGTTTAATGTGG
ATAAGCAAAATTCCCCGTCTGTGAGGCGTGTTTTGTATCGAAAACAGGGGGGGCCGGATGCACCAGAAGCT
GGATGATGAGGTTGTTTTTTGTATGTGGTGCTGATTTTTTGTGCGCTGTCGGGCTTCAGACGTGCGGAAGC
CTCCGGCGCAGGCCGGATTATTCAGAGGAGGTCACTTTCAGGGGGAAGCTGTGGCCAGCCGGCTGTAATTA
CGGTTACGTGACAGAATCATGCGCTCCTTCACACGACGCTCAACTTCGCGTTTTACCGCCTCACGATTGGC
AGTGAAGCGCCCTTCCGCGATTTCGCGCGTCAGCTGCCGTTTCACCAGGGTGACAATATCCTGACGTTCCC
TGTCCGCATCACGACGCGCACGGGCACGCTTTATTCCCCGGGACTTAAGCTCTGTCTGATAACTGCGAAAA
CGCTCACGAACAAAACGCCAGGCTTTCGCTATCAGTTCATCCATGCCCAGGGTATCCAGCCCCTGCTTTTT
GCGTTGTTTGTTTTCCCATACCACACGGCTGCGGCGCGCGGCGGCCACTGCCTCCTCTGATACATCGAGGG
CAGCAAACAGTGCAGATGTGAACGTGATATCGGTCGGAATGTAGCACCCGATAAGCGGGTCATATTCCGTC
TGGTAGGTAATCAGTCCCAGCTCTGACAGGAACGTCAGGGCCCGGGTGGCACGGGTGATGGAGAGTTTTCC
GGCAGCAGACTCCGTCGCCAGTCCGCACTCAATGGCCAGCGTGGTGATGGAGCACTGGACGCGGTTGGCCA
GCGGGTCATAGTGGAAACACAGCCCCTGCAGGAGCGCATCAATAGCCCGTCGACGCAGCACTGGTGGCATG
CGTCGACGCAGACCACGCGAACGGGCATGCGCCACATGAATGGCGAAATCAAAACGGGAAGTGAAGCCCAC
CGCCTTTTCCATCAGTTTTTCGCAGAACTTCAGCGTTCCTGCACCTTCACGGGGTGTAAACACCGGATTCG
GGTTCTTTACCTGGCGGTAATACGTTTGGTGAAGATCAGTCACACCATCCTGCACTTACAATGCGCAGAAG
GAGCGAGCACAGAAAGAAGTCTTGAACTTTTCCGGGCATATAACTATACTCCCCGCATAGCTGAATTGTTG
GCTATACGGTTTAAGTGGGCCCCGGTAATCTTTTCGTACTCGCAAAAGTTGAAGAAGATTATCGGGGTTTT
TGCTTTTCTGGCTCCTGTAAATCCACATCAGAACCAGTTCCTTGCCACCTTACGGCGTGGCCAGCCACAAA
ATTCCTTAAACGATCAGTAATCTAGCACTAATCTTCTGAACACTCAAGAATGTAAGCCCATCATCACATGC
ATCGTTTTGCGCTTCACTTTTTATCAGTGCGGTCAGAACTTCAGCCTGAGTCAGACCATCTTCATGACACA
TTTGCATGAGCATGGCCTTATACTTTGGTTCAAGAAATACTTTTACTTCCTTGAACGAAGCTCTTTTACGG
GCCACTGATAATCTTTGTTTCTCTGCATCAGAAAGCGGATTCCCCTTTCTGTATGCTCGTTTTGCGCCAGA
TGAGGAAGTCACTGCATTTTCTGTCTGCGACATCTCGCCTCCTCAATACTCAAACAGGGATCGTTTCGCAG
AGGATACTACAGTTTTTTGAAATCAGCGACTTGAGAATTGTGACGAAGATCTGTGTTGGCGCACAAATCAA
CGGGGATTACTGTCGTTTAATGTGATTTAAACTGTGAAATAGTATGGTTTTCAGTTATTGAAACGCCGGGA
GCGGGGAAAACTTGCTTTTTCCCGTTTCCGGGGTTGGACAACTGAGCAACGCGAAGGCGTCAGCTACGATG
TTCCGGGGACTGCTGATCAGCCCCTGTTGTATTCAGCCATTCTCCGGTCATCCGAACGCCAGCAAGACGTA
GCCCAGCGCGTCGGCCAATTCGCGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGG
GAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGC
CAGGGTGGTTTTTCTTTTCACCAGTGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAGA
GTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGTTGACGGCGGG
ATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATATCCGCACCAACGCGCAGCCCGGA
CTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGATGC
CCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCCCGTTCCGCTATC
GGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAACTTAA
TGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTACCGT
CTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAACATTA
GTGCAGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTGACGCG
TTGCGCGAGAAGATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACACCACCA
CGCTGGCACCCAGTTGATCGGCGCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGGGCCAGA
CTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGGGAATGTA
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ATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGTTCACCA
CGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAACGTTACTGGTTTCACATTC
ACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTTTTGCACCATTCGATGGT
GTCAACGTAAATGCATGCCGCTTCGCCTTCGCGCGCGAATTGGCCGCCATGCCGGCGATAATGGCCTGCTT
CTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGAAGGCTTGAGCGAGGGCGTGCAAGATTCCGAATACCG
CAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGAAAATGACCCAGAGCGCTGCC
GGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCGACGATAGTCATGCCCCGCGC
CCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGCGGAGCTTATCGACTGCACGGTGCAC
CAATGCTTCTGGCGTCAGGCAGCCATCGGAAGCTGTGGTATGGCTGTGCAGGTCGTAAATCACTGCATAAT
TCGTGTCGCTCAAGGCGCACTCCCGTTCTGGATAATGTTTTTTGCGCCGACATCATAACGGTTCTGGCAAA
TATTCTGAAATGAGCTGTTGACAATTAATCATCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAAT
TTCACACAGGAAACAGA
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